These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
13-1,
Nihonbashi
1-chome
|
|
(Jurisdiction of incorporation or organization)
|
(Address of principal executive offices)
|
Title of Each Class
|
Trading Symbol(s)
|
Name of Each Exchange On Which Registered
|
||
|
|
|
* |
Not for trading, but only in connection with the registration of the American Depositary Shares, each representing one share of Common Stock.
|
|
Accelerated filer ☐ |
Non-accelerated
filer ☐
|
Emerging growth company
|
|
International Financial Reporting Standards as issued
by the International Accounting Standards Board ☐
|
Other ☐ |
Page
|
||||
PART I
|
||||
Item 1.
|
2 | |||
Item 2.
|
2 | |||
Item 3.
|
2 | |||
Item 4.
|
23 | |||
Item 4A.
|
46 | |||
Item 5.
|
46 | |||
Item 6.
|
88 | |||
Item 7.
|
111 | |||
Item 8.
|
112 | |||
Item 9.
|
113 | |||
Item 10.
|
113 | |||
Item 11.
|
121 | |||
Item 12.
|
136 | |||
PART II
|
||||
Item 13.
|
138 | |||
Item 14.
|
138 | |||
Item 15.
|
138 | |||
Item 16A.
|
139 | |||
Item 16B.
|
139 | |||
Item 16C.
|
139 | |||
Item 16D.
|
140 | |||
Item 16E.
|
140 | |||
Item 16F.
|
141 | |||
Item 16G.
|
141 | |||
Item 16H.
|
143 | |||
PART III
|
||||
Item 17.
|
144 | |||
Item 18.
|
144 | |||
Item 19.
|
145 | |||
F-1
|
Millions of yen, except per share data and percentages
|
||||||||||||||||||||
Year ended March 31
|
||||||||||||||||||||
2017
|
2018
|
2019
|
2020
|
2021
|
||||||||||||||||
Statement of income data:
|
||||||||||||||||||||
Revenue
|
¥ | 1,715,516 | ¥ | 1,972,158 | ¥ | 1,835,118 | ¥ | 1,952,482 | ¥ | 1,617,235 | ||||||||||
Interest expense
|
312,319 | 475,189 | 718,348 | 664,653 | 215,363 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net revenue
|
1,403,197 | 1,496,969 | 1,116,770 | 1,287,829 | 1,401,872 | |||||||||||||||
Non-interest
expenses
|
1,080,402 | 1,168,811 | 1,154,471 | 1,039,568 | 1,171,201 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Income (loss) before income taxes
|
322,795 | 328,158 | (37,701 | ) | 248,261 | 230,671 | ||||||||||||||
Income tax expense
|
80,229 | 103,866 | 57,010 | 28,894 | 70,274 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net income (loss)
|
¥ | 242,566 | ¥ | 224,292 | ¥ | (94,711 | ) | ¥ | 219,367 | ¥ | 160,397 | |||||||||
Less: Net income attributable to noncontrolling interests
|
2,949 | 4,949 | 5,731 | 2,369 | 7,281 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net income (loss) attributable to Nomura Holdings, Inc. (“NHI”) shareholders
|
¥ | 239,617 | ¥ | 219,343 | ¥ | (100,442 | ) | ¥ | 216,998 | ¥ | 153,116 | |||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Balance sheet data (period end):
|
||||||||||||||||||||
Total assets
(1)
|
¥ | 42,531,972 | ¥ | 40,343,947 | ¥ | 40,969,439 | ¥ | 43,999,815 | ¥ | 42,516,480 | ||||||||||
Total NHI shareholders’ equity
|
2,789,916 | 2,749,320 | 2,631,061 | 2,653,467 | 2,694,938 | |||||||||||||||
Total equity
|
2,843,791 | 2,799,824 | 2,680,793 | 2,731,264 | 2,756,451 | |||||||||||||||
Common stock
|
594,493 | 594,493 | 594,493 | 594,493 | 594,493 | |||||||||||||||
Per share data:
|
||||||||||||||||||||
Net income (loss) attributable to NHI shareholders—basic
|
¥ | 67.29 | ¥ | 63.13 | ¥ | (29.90 | ) | ¥ | 67.76 | ¥ | 50.11 | |||||||||
Net income (loss) attributable to NHI shareholders
—
|
65.65 | 61.88 | (29.92 | ) | 66.20 | 48.63 | ||||||||||||||
Total NHI shareholders’ equity
(2)
|
790.70 | 810.31 | 794.69 | 873.26 | 879.79 | |||||||||||||||
Cash dividends
(2)
|
20.00 | 20.00 | 6.00 | 20.00 | 35.00 | |||||||||||||||
Cash dividends in USD
(3)
|
$ | 0.18 | $ | 0.19 | $ | 0.05 | $ | 0.19 | $ | 0.32 | ||||||||||
Weighted average number of shares outstanding (in thousands)
(4)
|
3,560,776 | 3,474,593 | 3,359,565 | 3,202,370 | 3,055,526 | |||||||||||||||
Return on equity
(5)
:
|
8.7 | % | 7.9 | % | (3.7 | %) | 8.2 | % | 5.7 | % |
(1) |
Due to Accounting Standards Update
2014-09,
“
Revenue from Contracts with Customers
|
(2) |
Calculated using the number of shares outstanding at year end.
|
(3) |
Calculated using the Japanese Yen—U.S. Dollar exchange rate as of the respective fiscal year end date, the noon buying rate in New York City for cable transfers in foreign currencies as certified for customs purposes by the Federal Reserve Bank of New York.
|
(4) |
The number shown is used to calculate basic earnings per share.
|
(5) |
Calculated as net income (loss) attributable to NHI shareholders divided by total NHI shareholders’ equity.
|
·
|
Risks Relating to the Business Environment
|
1
|
Our business may be materially affected by financial markets, economic conditions and market fluctuations in Japan and elsewhere around the world
|
(1) |
The
COVID-19
pandemic has affected our business, clients and employees and this may continue in the future
|
(2) |
Natural disaster, terrorism, military dispute and infectious disease other than
COVID-19
could adversely affect our business
|
(3) |
Governmental fiscal and monetary policy changes in Japan, or in any other country or region where we conduct business may affect our business, financial condition and results of operations
|
(4) |
Brexit may adversely affect our business on various fronts
|
(5) |
Transition from LIBOR to alternative rate indices or among IBORs may adversely affect our business
|
(6) |
Extended market declines and decreases in market participants can reduce liquidity and lead to material losses
|
2
|
The financial services industry faces intense competition
|
(1) |
Competition with other financial firms and financial services by
non-financial
companies is increasing
|
(2) |
Increased consolidation, business alliance and cooperation in the financial services industry mean increased competition for us
|
(3) |
Our global business continues to face a challenging environment and may require further revisions to its business model
|
3
|
Event risk may cause losses in our trading and investment assets as well as market and liquidity risk
|
4
|
Environmental, Social and Governance (“ESG”) factors including climate change and broader associated policy changes in each jurisdiction could adversely affect our business
|
·
|
Risks Relating to Our Businesses
|
5
|
Our business may incur losses due to various factors in the conduct of its operations
|
(1) |
We may incur significant losses from our trading and investment activities
|
(2) |
Holding large and concentrated positions of securities and other assets may expose us to large losses
|
(3) |
Our hedging strategies may not prevent losses
|
(4) |
Our risk management policies and procedures may not be fully effective in managing risk
|
(5) |
Market risk may increase other risks that we face
|
(6) |
Our brokerage and asset management revenues may decline
|
(7) |
Our investment banking revenues may decline
|
(8) |
Our electronic trading business revenues may decline
|
6
|
We may be exposed to losses when third parties do not perform their obligations to us
|
(1) |
Defaults by a large financial institution could adversely affect the financial markets generally and us specifically
|
(2) |
There can be no assurance as to the accuracy of the information about, or the sufficiency of the collateral we use in managing, our credit risk
|
(3) |
Our clients and counterparties may be unable to perform their obligations to us as a result of political or economic conditions
|
7
|
We are a holding company and depend on payments from our subsidiaries
|
8
|
We may not be able to realize gains we expect, and may even suffer losses, on our investments in equity securities and
non-trading
debt securities
|
9
|
We may face an outflow of clients’ assets due to losses of cash reserve funds or debt securities we offer
|
·
|
Risks Relating to Our Financial Position
|
10
|
We may have to recognize impairment losses with regard to the amount of goodwill, tangible and intangible assets recognized on our consolidated balance sheets
|
11
|
Liquidity risk could impair our ability to fund operations and jeopardize our financial condition
|
(1) |
We may be unable to access unsecured or secured funding
|
(2) |
We may be unable to sell assets
|
(3) |
Lowering of our credit ratings could impact our funding
|
12
|
Equity investments in affiliates and other investees accounted for under the equity method in our consolidated financial statements may decline significantly over a period of time and result in us incurring impairment losses
|
·
|
Risks Relating to Legal, Compliance and Other Operational Issues
|
13
|
Misconduct or fraud by an employee, director or officer, or any third party, could occur, and our reputation in the market and our relationships with clients could be harmed
|
14
|
A failure to identify and appropriately address conflicts of interest could adversely affect our business
|
15
|
Our business is subject to substantial legal, regulatory and reputational risks
|
(1) |
Legal liability may occur due to market downturn and could adversely affect our business, financial condition and results of operations
|
(2) |
Extensive regulation of our businesses limits our activities and may subject us to significant penalties and losses
|
(3) |
Tightening of regulations applicable to the financial system and financial industry could adversely affect our business, financial condition and results of operations
|
(4) |
Deferred tax assets may be impacted due to a change in business condition or in laws and regulations, resulting in an adverse effect on our operating results and financial condition
|
16
|
Unauthorized disclosure or misuse of personal information held by us may adversely affect our business
|
17
|
System failure, information leakage and the cost of maintaining sufficient cybersecurity could adversely affect our business
|
·
|
Risks Related to Holding or Trading of our Shares and ADRs
|
18
|
Because of daily price range limitations under Japanese stock exchange rules, you may not be able to sell your shares of the Company’s common stock at a particular price on any particular trading day, or at all
|
19
|
Under Japan’s unit share system, holders of the Company’s shares constituting less than one unit are subject to transfer, voting and other restrictions
|
20
|
As a holder of ADRs, you will have fewer rights than a shareholder has and you will have to act through the depositary to exercise these rights
|
21
|
Rights of shareholders under Japanese law may be more limited than under the laws of other jurisdictions
|
22
|
The Company’s shareholders of record on a record date may not receive the dividend they anticipate
|
23
|
It may not be possible for investors to secure personal jurisdiction within the U.S. over the Company or the Company’s directors or executive officers, or to enforce against the Company or those persons judgments obtained in U.S. courts predicated upon the civil liability provisions of the federal securities laws of the U.S.
|
·
|
Special Note Regarding Forward-looking Statements
|
·
|
Risks Relating to the Business Environment
|
1.
|
Our business may be materially affected by financial markets, economic conditions and market fluctuations in Japan and elsewhere around the world
|
2.
|
The financial services industry faces intense competition
|
3.
|
Event risk may cause losses in our trading and investment assets as well as market and liquidity risk
|
• |
sudden and significant reductions in credit ratings with regard to financial instruments held by our trading and investment businesses by major rating agencies,
|
• |
sudden changes in trading, tax, accounting, regulatory requirements, laws and other related rules which may make our trading strategy obsolete, less competitive or no longer viable, or
|
• |
an unexpected failure in a corporate transaction in which we participate resulting in our not receiving the consideration we should have received, as well as bankruptcy, deliberate acts of fraud, and administrative penalty with respect to the issuers of our trading and investment assets.
|
4.
|
Environmental, Social and Governance (“ESG”) factors including climate change and broader associated policy changes in each jurisdiction could adversely affect our business
|
- |
Physical Risk: The risk of physical damage or the impairment of the operating capability of the assets of Nomura Group, clients and business partners due to climate change. This includes the potential impact of extreme weather events, fire and sea level flooding.
|
- |
Transition Risk: The risks associated with accelerated policy and external changes associated with the move towards addressing climate risk. This includes changes in government policies, industrial policy or carbon based taxes, changes in social or other preferences and rapid changes in technologies which have the potential to leave stranded assets that are no longer viable.
|
5.
|
Our business may incur losses due to various factors in the conduct of its operations.
|
6.
|
We may be exposed to losses when third parties do not perform their obligations to us
|
• |
holding securities issued by third parties, or
|
• |
the execution of securities, futures, currency or derivative transactions that fail to settle at the required time due to non-delivery by the counterparty, such as financial institutions and hedge funds which are counterparties to credit default swaps or systems failure by clearing agents, exchanges, clearing houses or other financial infrastructure.
|
7.
|
We are a holding company and depend on payments from our subsidiaries
|
8.
|
We may not be able to realize gains we expect, and may even suffer losses, on our investments in equity securities and
non-trading
debt securities
|
9.
|
We may face an outflow of clients’ assets due to losses of cash reserve funds or debt securities we offer
|
·
|
Risks Relating to Our Financial Position
|
10.
|
We may have to recognize impairment losses with regard to the amount of goodwill, tangible and intangible assets recognized on our consolidated balance sheets
|
11.
|
Liquidity risk could impair our ability to fund operations and jeopardize our financial condition
|
• |
We incur large trading losses,
|
• |
The level of our business activity decreases due to a market downturn,
|
• |
Regulatory authorities take significant action against us, or
|
• |
Our credit rating is downgraded.
|
12.
|
Equity investments in affiliates and other investees accounted for under the equity method in our consolidated financial statements may decline significantly over a period of time and result in us incurring impairment losses
|
·
|
Risks Relating to Legal, Compliance and Other Operational Issues
|
13.
|
Misconduct or fraud by an employee, director or officer, or any third party, could occur, and our reputation in the market and our relationships with clients could be harmed
|
14.
|
A failure to identify and appropriately address conflicts of interest could adversely affect our business
|
15.
|
Our business is subject to substantial legal, regulatory and reputational risks
|
16.
|
Unauthorized disclosure or misuse of personal information held by us may adversely affect our business
|
17.
|
System failure, the information leakage and the cost of maintaining sufficient cybersecurity could adversely affect our business
|
·
|
Risks Related to Holding or Trading of our Shares and ADRs
|
18.
|
Because of daily price range limitations under Japanese stock exchange rules, you may not be able to sell your shares of the Company’s common stock at a particular price on any particular trading day, or at all
|
19.
|
Under Japan’s unit share system, holders of the Company’s shares constituting less than one unit are subject to transfer, voting and other restrictions
|
20.
|
As a holder of ADSs, you will have fewer rights than a shareholder has and you will have to act through the depositary to exercise these rights
|
21.
|
Rights of shareholders under Japanese law may be more limited than under the laws of other jurisdictions
|
22.
|
The Company’s shareholders of record on a record date may not receive the dividend they anticipate
|
23.
|
It may not be possible for investors to secure personal jurisdiction within the U.S. over the Company or the Company’s directors or executive officers, or to enforce against the Company or those persons judgments obtained in U.S. courts predicated upon the civil liability provisions of the federal securities laws of the U.S.
|
·
|
Special Note Regarding Forward-looking Statements
|
• |
the quality, range and prices of our products and services,
|
• |
our ability to originate and develop innovative client solutions,
|
• |
our ability to maintain and develop client relationships,
|
• |
our ability to access and commit capital resources,
|
• |
our ability to retain and attract qualified employees, and
|
• |
our general reputation.
|
• |
the monetary and fiscal policies of national governments and international economic organizations,
|
• |
economic, political and social developments both within and between Japan, the U.S., Europe and other major industrialized and developing countries and regions, such as the
COVID-19
pandemic since 2020, and
|
• |
increasing digitalization beyond the traditional financial sector
|
• |
Phase 1: Initial Responses
(completed). As part of this phase, we reviewed all of the transactions with our existing prime brokerage clients, as well as large positions in our other financing-related businesses, and concentrated positions in
non-risk
origination businesses. As a result, we have concluded that there are no transactions similar to those triggering the U.S. Prime Brokerage Event, namely no other prime brokerage transactions which are excessively leveraged or any other transactions by our non-risk origination businesses with significant concentrated exposures.
|
• |
Phase 2: Review of Prime Brokerage Risk Management Framework
(in progress). As part of this phase, we are taking actions to enhance the monitoring of concentrated positions, revise our margin rates applicable to clients and to enhance management of margin rates for individual transactions (including internal approvals and other processes).
|
• |
Phase 3: Comprehensive Review of Wholesale Risk Framework
(in progress). We have already completed our comprehensive internal review of the risk management framework in the Wholesale division, and have initiated a further review by third-party risk management experts. We are also reviewing our organizational structure and staffing within risk management function in order to strengthen further our risk management framework.
|
• |
Phase 4: Enhance Global Risk Governance
(in progress): We are considering actions to strengthen the functions of our risk management committees, including expanding the scope of our Wholesale division’s risk monitoring beyond our financing businesses to include other businesses in the Wholesale division. We are also working to promote a better understanding of further proactive risk management capabilities among front office teams.
|
• |
Continue to fulfill our responsibility as capital market intermediary and liquidity provider in order to maintain the financing required by companies and trading activities by market participants.
|
• |
Support the recovery of the economy and corporate activities while ensuring the safety of our clients, communities and employees and their families.
|
• |
Maintain a robust financial position and ensured sufficient liquidity in a highly volatile and stressful market environment.
|
• |
Growth strategy for sustainable improvement of corporate value
|
• |
Digitalization to provide new value-added services and convenience to clients
|
• |
Initiatives for Sustainability
|
• |
Retail Division
|
• |
Investment Management Division
|
•
|
Wholesale Division
|
• |
Risk Management and Compliance, etc.
|
Name
|
Country/Region
|
Ownership
Interest |
||||
(%)
|
||||||
Nomura Holdings, Inc.
|
Japan | — | ||||
Nomura Securities Co., Ltd.
|
Japan | 100 | ||||
Nomura Asset Management Co., Ltd.
|
Japan | 100 | ||||
The Nomura Trust & Banking Co., Ltd.
|
Japan | 100 | ||||
Nomura Babcock & Brown Co., Ltd.
|
Japan | 100 | ||||
Nomura Capital Investment Co., Ltd.
|
Japan | 100 | ||||
Nomura Investor Relations Co., Ltd.
|
Japan | 100 | ||||
Nomura Funds Research and Technologies Co., Ltd.
|
Japan | 100 | ||||
Nomura Research & Advisory Co., Ltd.
|
Japan | 100 | ||||
Nomura Business Services Co., Ltd.
|
Japan | 100 | ||||
Nomura Facilities, Inc.
(1)
|
Japan | 100 | ||||
Nomura Institute of Capital Markets Research
|
Japan | 100 | ||||
Nomura Healthcare Co., Ltd.
|
Japan | 100 | ||||
Nomura Agri Planning & Advisory Co., Ltd.
|
Japan | 100 | ||||
Nomura Land and Building Co., Ltd.
(1)
|
Japan | 100 | ||||
Nomura Financial Products & Services, Inc.
|
Japan | 100 | ||||
Nomura Institute of Estate Planning
|
Japan | 100 | ||||
N-Village
Co., Ltd.
|
Japan | 100 | ||||
Nomura Capital Partners Co., Ltd.
|
Japan | 100 | ||||
Nomura Mezzanine Partners Co., Ltd.
|
Japan | 100 | ||||
Corporate Design Partners Co., Ltd.
|
Japan | 100 | ||||
Nomura Kagayaki Co., Ltd.
|
Japan | 100 | ||||
Nomura Asia Pacific Holdings Co., Ltd.
|
Japan | 100 | ||||
Nomura International (Hong Kong) Limited
|
Hong Kong | 100 | ||||
Nomura Singapore Limited
|
Singapore | 100 | ||||
Nomura Securities Singapore Pte. Ltd.
|
Singapore | 100 | ||||
Nomura Australia Limited
|
Australia | 100 | ||||
PT Nomura Sekuritas Indonesia
|
Indonesia | 96 | ||||
Nomura Asia Investment (Fixed Income) Pte. Ltd.
|
Singapore | 100 | ||||
Nomura Asia Investment (Singapore) Pte. Ltd.
|
Singapore | 100 | ||||
Capital Nomura Securities Public Co., Ltd.
|
Thailand | 99 | ||||
Nomura Financial Advisory and Securities (India) Private Limited
|
India | 100 | ||||
Nomura Holding America Inc.
|
U.S. | 100 | ||||
Nomura Securities International, Inc.
|
U.S. | 100 | ||||
Nomura Corporate Research and Asset Management Inc.
|
U.S. | 100 | ||||
Nomura Derivative Products Inc.
|
U.S. | 100 | ||||
Nomura America Mortgage Finance, LLC
|
U.S. | 100 | ||||
Nomura Global Financial Products, Inc.
|
U.S. | 100 | ||||
NHI Acquisition Holding, Inc.
|
U.S. | 100 | ||||
Instinet Incorporated
|
U.S. | 100 | ||||
Nomura Europe Holdings plc
|
U.K. | 100 | ||||
Nomura International plc
|
U.K. | 100 | ||||
Nomura Bank International plc
|
U.K. | 100 | ||||
Nomura Financial Products Europe GmbH
|
Germany | 100 | ||||
Banque Nomura France
|
France | 100 | ||||
Nomura Bank (Luxembourg) S.A.
|
Luxemburg | 100 | ||||
Nomura Bank (Switzerland) Ltd.
|
Switzerland | 100 | ||||
Nomura Europe Finance N.V.
|
The Netherlands | 100 | ||||
Nomura European Investment Limited
|
U.K. | 100 | ||||
Nomura Asia Investment (India Powai) Pte. Ltd.
|
Singapore | 100 | ||||
Nomura Services India Private Limited
|
India | 100 | ||||
Nomura International Funding Pte. Ltd.
|
Singapore | 100 | ||||
Nomura Orient International Securities Co., Ltd.
|
China | 51 |
(1) |
Wholly owned subsidiaries, Nomura Facilities, Inc. (“NFI”) and Nomura Land and Building Co., Ltd. (“NLB”), merged effective on April 1, 2021. NFI is a surviving entity and NLB is an absorbed entity. The company name has been changed to Nomura Properties Inc.
|
1.
|
Diluted net income attributable to Nomura Holdings’ shareholders per share.
|
Year ended March 31 (Billions of yen)
|
||||||||||||||||||||
2019*
|
2020
|
% Change from
previous year |
2021
|
% Change from
previous year |
||||||||||||||||
Recurring revenue assets
|
¥
|
—
|
|
¥
|
15,300
|
|
|
—
|
%
|
¥
|
18,200
|
|
|
19.0
|
%
|
|||||
Consulting-related revenue
|
¥
|
—
|
|
¥
|
14.9
|
|
|
—
|
%
|
¥
|
13.4
|
|
|
-10.1
|
%
|
|||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net inflows of cash and securities
|
¥
|
—
|
|
¥
|
-429.4
|
|
|
—
|
%
|
¥
|
887.7
|
|
|
—
|
%
|
|||||
Active clients
|
|
—
|
|
|
1,071,000
|
|
|
—
|
%
|
|
1,019,000
|
|
|
-4.9
|
%
|
|||||
|
|
|
|
|
|
|
|
|
|
* |
These segment KPIs have been defined and introduced since 2020 hence there is no number to be provided for the year of 2019.
|
Year ended March 31
|
||||||||||||||||||||
2019*
1
|
2020
|
% Change from
previous year |
2021
|
% Change from
previous year |
||||||||||||||||
Cost-to-income
|
|
105*
1
|
%
|
|
86
|
%
|
|
-18.1
|
%
|
|
91
|
%
|
|
5.8
|
%
|
|||||
Revenue/modified RWA
|
|
5.0
|
%
|
|
6.5
|
%
|
|
30.0
|
%
|
|
6.4
|
%
|
|
-1.5
|
%
|
|||||
|
|
|
|
|
|
|
|
|
|
(1) |
Excludes the ¥81 billion goodwill impairment included in
Non-interest
expenses
|
Millions of yen, except percentages
|
||||||||||||||||||||
Year ended March 31
|
||||||||||||||||||||
2019
|
2020
|
% Change from
previous year |
2021
|
% Change from
previous year |
||||||||||||||||
Non-interest
revenues:
|
||||||||||||||||||||
Commissions
|
¥ | 293,069 | ¥ | 308,805 | 5.4 | % | ¥ | 376,897 | 22.1 | % | ||||||||||
Fees from investment banking
|
101,521 | 103,222 | 1.7 | 108,681 | 5.3 | |||||||||||||||
Asset management and portfolio service fees
|
245,519 | 238,202 | (3.0 | ) | 230,047 | (3.4 | ) | |||||||||||||
Net gain on trading
|
342,964 | 356,609 | 4.0 | 310,040 | (13.1 | ) | ||||||||||||||
Gain (loss) on private equity and debt investments
|
1,007 | (93 | ) | — | 12,734 | — | ||||||||||||||
Gain (loss) on investments in equity securities
|
(6,983 | ) | (14,726 | ) | — | 14,053 | — | |||||||||||||
Other
|
81,057 | 165,991 | 104.8 | 208,317 | 25.5 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total
Non-interest
revenues
|
1,058,154 | 1,158,010 | 9.4 | 1,260,769 | 8.9 | |||||||||||||||
Net interest revenue
|
58,616 | 129,819 | 121.5 | 141,103 | 8.7 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net revenue
|
1,116,770 | 1,287,829 | 15.3 | 1,401,872 | 8.9 | |||||||||||||||
Non-interest
expenses
|
1,154,471 | 1,039,568 | (10.0 | ) | 1,171,201 | 12.7 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Income (loss) before income taxes
|
(37,701 | ) | 248,261 | — | 230,671 | (7.1 | ) | |||||||||||||
Income tax expense
|
57,010 | 28,894 | (49.3 | ) | 70,274 | 143.2 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net income (loss)
|
¥ | (94,711 | ) | ¥ | 219,367 |
—
|
% | ¥ | 160,397 | (26.9 | )% | |||||||||
Less: Net income attributable to noncontrolling interests
|
5,731 | 2,369 | (58.7 | ) | 7,281 | 207.3 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net income (loss) attributable to NHI shareholders
|
¥ | (100,442 | ) | ¥ | 216,998 | — | % | ¥ | 153,116 | (29.4 | )% | |||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Return on equity
|
(3.7 | )% | 8.2 | % | 5.7 | % |
Millions of yen
|
||||||||||||||||||||
Year ended March 31
|
||||||||||||||||||||
2019
|
2020
|
% Change from
previous year |
2021
|
% Change from
previous year |
||||||||||||||||
Non-interest
revenue
|
¥ | 331,743 | ¥ | 329,983 | (0.5 | )% | ¥ | 366,271 | 11.0 | % | ||||||||||
Net interest revenue
|
7,737 | 6,376 | (17.6 | ) | 2,538 | (60.2 | ) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net revenue
|
339,480 | 336,359 | (0.9 | ) | 368,809 | 9.6 | ||||||||||||||
Non-interest
expenses
|
289,990 | 286,926 | (1.1 | ) | 276,480 | (3.6 | ) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Income before income taxes
|
¥ | 49,490 | ¥ | 49,433 | (0.1 | )% | ¥ | 92,329 | 86.8 | % | ||||||||||
|
|
|
|
|
|
|
|
|
|
Millions of yen
|
||||||||||||
Year ended March 31
|
||||||||||||
2020
|
2021
|
% Change from
previous year |
||||||||||
Commissions
|
¥ | 153,170 | ¥ | 187,678 | 22.5 | % | ||||||
Brokerage commissions
|
61,207 | 92,589 | 51.3 | |||||||||
Commissions for distribution of investment trusts
|
66,940 | 68,352 | 2.1 | |||||||||
Other commissions
|
25,023 | 26,737 | 6.9 | |||||||||
Net gain on trading
|
56,756 | 58,357 | 2.8 | |||||||||
Fees from investment banking
|
23,239 | 20,354 | (12.4 | ) | ||||||||
Asset management fees
|
92,139 | 88,996 | (3.4 | ) | ||||||||
Others
|
4,679 | 10,886 | 132.7 | |||||||||
|
|
|
|
|
|
|||||||
Non-interest
revenues
|
¥ | 329,983 | ¥ | 366,271 | 11.0 | % | ||||||
|
|
|
|
|
|
Trillions of yen
|
||||||||||||||||||||
Year ended March 31, 2020
|
||||||||||||||||||||
Balance at
beginning of year
|
Gross inflows
|
Gross outflows
|
Market
appreciation /
(depreciation)
|
Balance at
end of year
|
||||||||||||||||
Equities
|
¥ | 71.9 | ¥ | 12.4 | ¥ | (13.4 | ) | ¥ | (8.2 | ) | ¥ | 62.7 | ||||||||
Debt securities
|
18.8 | 29.3 | (27.3 | ) | (2.4 | ) | 18.4 | |||||||||||||
Stock investment trusts
|
9.0 | 3.1 | (3.2 | ) | (1.3 | ) | 7.6 | |||||||||||||
Bond investment trusts
|
6.8 | 0.9 | (0.5 | ) | 0.1 | 7.3 | ||||||||||||||
Overseas mutual funds
|
1.1 | 0.1 | (0.1 | ) | (0.1 | ) | 1.0 | |||||||||||||
Others
|
7.1 | 0.8 | (1.0 | ) | 0.1 | 7.0 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total
|
¥ | 114.7 | ¥ | 46.6 | ¥ | (45.5 | ) | ¥ | (11.8 | ) | ¥ | 104.0 | ||||||||
|
|
|
|
|
|
|
|
|
|
Trillions of yen
|
||||||||||||||||||||
Year ended March 31, 2021
|
||||||||||||||||||||
Balance at
beginning of year
|
Gross inflows
|
Gross outflows
|
Market
appreciation /
(depreciation)
|
Balance at
end of year
|
||||||||||||||||
Equities
|
¥ | 62.7 | ¥ | 24.4 | ¥ | (24.9 | ) | ¥ | 20.1 | ¥ | 82.3 | |||||||||
Debt securities
|
18.4 | 12.3 | (9.9 | ) | (2.7 | ) | 18.1 | |||||||||||||
Stock investment trusts
|
7.6 | 3.1 | (3.0 | ) | 2.5 | 10.2 | ||||||||||||||
Bond investment trusts
|
7.3 | 1.4 | (0.6 | ) | (0.1 | ) | 8.0 | |||||||||||||
Overseas mutual funds
|
1.0 | 0.2 | (0.1 | ) | (0.0 | ) | 1.1 | |||||||||||||
Others
|
7.0 | 0.9 | (0.7 | ) | (0.3 | ) | 6.9 | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total
|
¥ | 104.0 | ¥ | 42.3 | ¥ | (39.2 | ) | ¥ | 19.5 | ¥ | 126.6 | |||||||||
|
|
|
|
|
|
|
|
|
|
Millions of yen
|
||||||||||||||||||||
Year ended March 31
|
||||||||||||||||||||
2019
|
2020
|
% Change from
previous year |
2021
|
% Change from
previous year |
||||||||||||||||
Non-interest
revenue
|
¥ | 89,607 | ¥ | 85,190 | (4.9 | )% | ¥ | 126,874 | 48.9 | % | ||||||||||
Net interest revenue
|
8,238 | 7,415 | (10.0 | ) | 7,900 | 6.5 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net revenue
|
97,845 | 92,605 | (5.4 | ) | 134,774 | 45.5 | ||||||||||||||
Non-interest
expenses
|
63,660 | 63,833 | 0.3 | 60,529 | (5.2 | ) | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Income before income taxes
|
¥ | 34,185 | ¥ | 28,772 | (15.8 | )% | ¥ | 74,245 | 158.0 | % | ||||||||||
|
|
|
|
|
|
|
|
|
|
Billions of yen
|
||||||||||||||||||||
Year ended March 31, 2020
|
||||||||||||||||||||
Balance at
beginning of year
|
Gross inflows
|
Gross outflows
|
Market
appreciation /
(depreciation)
|
Balance at
end of year
|
||||||||||||||||
Nomura Asset Management Co., Ltd .
|
¥ | 53,371 | ¥ | 26,098 | ¥ | (25,076 | ) | ¥ | (3,745 | ) | ¥ | 50,648 | ||||||||
Nomura Corporate Research and Asset Management Inc.
|
3,011 | 568 | (739 | ) | (351 | ) | 2,489 | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Combined total
|
56,382 | 26,666 | (25,815 | ) | (4,096 | ) | 53,137 | |||||||||||||
Shared across group companies
|
(5,008 | ) | (882 | ) | 1,501 | 577 | (3,812 | ) | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total
|
51,374 | 25,784 | (24,314 | ) | (3,519 | ) | 49,325 | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Billions of yen
|
||||||||||||||||||||
Year ended March 31, 2021
|
||||||||||||||||||||
Balance at
beginning of year
|
Gross inflows
|
Gross outflows
|
Market
appreciation /
(depreciation)
|
Balance at
end of year
|
||||||||||||||||
Nomura Asset Management Co., Ltd .
|
¥ | 50,648 | ¥ | 28,675 | ¥ | (27,705 | ) | ¥ | 14,540 | ¥ | 66,158 | |||||||||
Nomura Corporate Research and Asset Management Inc.
|
2,489 | 871 | (910 | ) | 771 | 3,221 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Combined total
|
53,137 | 29,546 | (28,615 | ) | 15,311 | 69,379 | ||||||||||||||
Shared across group companies
|
(3,812 | ) | (1,141 | ) | 1,414 | (1,187 | ) | (4,726 | ) | |||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total
|
49,325 | 28,405 | (27,201 | ) | 14,124 | 64,653 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
March 31
|
||||||||||||
2019
|
2020
|
2021
|
||||||||||
Total of publicly offered investment trusts
|
28 | % | 28 | % | 28 | % | ||||||
Stock investment trusts
|
26 | % | 26 | % | 26 | % | ||||||
Bond investment trusts
|
45 | % | 44 | % | 44 | % |
Millions of yen
|
||||||||||||||||||||
Year ended March 31
|
||||||||||||||||||||
2019
|
2020
|
% Change from
previous year |
2021
|
% Change from
previous year |
||||||||||||||||
Non-interest
revenue
|
¥ | 496,484 | ¥ | 506,203 | 2.0 | % | ¥ | 524,019 | 3.5 | % | ||||||||||
Net interest revenue
|
58,904 | 142,416 | 141.8 | 167,337 | 17.5 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net revenue
|
555,388 | 648,619 | 16.8 | 691,356 | 6.6 | |||||||||||||||
Non-interest
expenses
|
666,787 | 556,399 | (16.6 | ) | 627,051 | 12.7 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Income (loss) before income taxes
|
¥ | (111,399 | ) | ¥ | 92,220 |
—
|
% | ¥ | 64,305 | (30.3 | )% | |||||||||
|
|
|
|
|
|
|
|
|
|
Millions of yen
|
||||||||||||||||||||
Year ended March 31
|
||||||||||||||||||||
2019
|
2020
|
% Change from
previous year |
2021
|
% Change from
previous year |
||||||||||||||||
Wholesale net revenue:
|
||||||||||||||||||||
Global Markets net revenue
|
¥ | 453,044 | ¥ | 562,927 | 24.3 | % | ¥ | 575,533 | 2.2 | % | ||||||||||
Investment Banking net revenue
|
102,344 | 85,692 | (16.3 | ) | 115,823 | 35.2 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net revenue
|
¥ | 555,388 | ¥ | 648,619 | 16.8 | % | ¥ | 691,356 | 6.6 | % | ||||||||||
|
|
|
|
|
|
|
|
|
|
Critical
accounting policy |
Critical accounting
estimates |
Underlying subjective key
assumptions by management |
Effect of changes in estimates and
assumptions during year ended March 31, 2021 (including impact of COVID-19) |
|||
Fair value of financial instruments
Note 2
“Fair value measurements”
|
Estimating fair value for financial instruments |
A significant portion of our financial instruments is carried at fair value. The fair value of these financial instruments are not only measured at quoted price but by other factors including valuation models and assumptions with judgement.
Election of appropriate valuation techniques
• For financial instruments measured at fair value where quoted prices are available in active markets, Nomura generally uses the prices as level 1 inputs for determining the fair value of these financial instruments.
• For financial instruments where such quoted prices are not available, fair value of the financial instruments are measured by level 2 or level 3 input. Significant judgment is involved in selection of appropriate valuation techniques and validation of assumptions applied in models because the fair value measured could be varied by the selection of those models and assumptions. When selecting valuation techniques, various factors such as the particular circumstances where these financial instruments are traded, availability of reliable inputs, maximizing the use of relevant observable inputs and minimizing the use of unobservable inputs are considered.
|
See Note 2
“Fair value measurements”
Although we have observed recovery in the financial markets, effects of the ongoing COVID-19 pandemic may still have adverse impact on price transparency of for certain financial instruments
Balance of financial instrument with level 3 hierarchy (assets net of derivative liabilities) during the year decreased from ¥722 billion to ¥566 billion. Level 3 financial assets as a proportion of total financial assets carried at fair value on a recurring basis was 5% as of March 31, 2021 (5% as of March 31, 2020.)
See Note 2,
“Fair Value of Financial Instruments”
|
Critical
accounting policy |
Critical accounting
estimates |
Underlying subjective key
assumptions by management |
Effect of changes in estimates and
assumptions during year ended March 31, 2021 (including impact of COVID-19) |
|||
Significance of level 3 inputs
• Fair value measurement is more judgmental in respect of level 3 financial instruments, which are valued based on significant non-market based unobservable inputs
|
||||||
Litigation provisions
Note 21
“Commitments, contingencies and guarantees”
|
Determination of whether a loss is probable and measurement of provisions and reasonably possible loss
|
In the normal course of business, Nomura is involved in investigations, lawsuits and other legal proceedings and, as a result, may suffer loss from any penalties or settlements Nomura chooses to make to resolve the matter could be significant to Nomura’s results of operation.
Determination if a loss is probable
• Recognition of litigation provisions are only required if a loss is probable and can be reasonably estimated.
• Significant judgment required in deciding whether loss from litigation, investigations, claims or other actions is probable or just reasonably possible.
• Such judgment usually involves consideration of external legal counsel opinion, our own historical experiences in court and similar matters, the progress of regulatory investigation or litigation proceedings and management or our counterparty’s appetite to settle the matter.
• If a loss is only considered to be reasonably possible, no provision is required.
Measurement of a probable / reasonably possible loss
• Once a loss has been determined as being probable of occurring, a provision is recognized when a loss is probable and the amount of such loss or range of loss can be reasonably estimated.
|
See Note 21 “
Commitments, contingencies and guarantees
While
COVID-19
continues to delay the potential resolution of certain litigation matters, no direct significant impact on litigation provisions as of March 31, 2021 and reasonably possible loss disclosed.
If we concluded as of June 25, 2021 that for those cases where an estimate of the range of reasonably possible losses can be made, such loss was actually now probable, we would recognize additional legal provisions through earnings of ¥48 billion. However this does not include the impact of probable losses where we cannot reasonably estimate the loss. See Note.21.
|
Critical
accounting policy |
Critical accounting
estimates |
Underlying subjective key
assumptions by management |
Effect of changes in estimates and
assumptions during year ended March 31, 2021 (including impact of COVID-19) |
|||
• Where a loss is not probable but reasonably possible and an estimate of the range of reasonably possible losses can be made based on current information available as of the date of its consolidated financial statements, the reasonably possible maximum loss in excess of amounts recognized as a liability is disclosed.
• This determination is often inherently difficult due to the uncertainties, especially for legal claims or regulatory review that are indeterminate or still at an early stage.
• Similarly for other matters, there could be a wide range of possible outcomes.
• For certain exceptional matters, given the inherent complexities where we believe a loss is probable or reasonably possible, we may be unable to reasonably estimate the loss and therefore we are unable to recognize a provision or disclose the reasonably possible maximum loss in excess of amounts recognized as a liability for the matter. In these situations, we disclose this fact.
|
Billions of yen
|
||||||||||||||||||||
March 31, 2021
|
||||||||||||||||||||
Level 1
|
Level 2
|
Level 3
|
Counterparty
and Cash
Collateral
Netting
|
Total
|
||||||||||||||||
Financial assets measured at fair value (Excluding derivative assets)
|
¥ | 7,862 | ¥ | 8,446 | ¥ | 673 | ¥ | — | ¥ | 16,981 | ||||||||||
Derivative assets
|
43 | 15,801 | 162 | (14,786 | ) | 1,220 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total
|
¥ | 7,905 | ¥ | 24,247 | ¥ | 835 | ¥ | (14,786 | ) | ¥ | 18,201 | |||||||||
|
|
|
|
|
|
|
|
|
|
Billions of yen
|
||||||||
March 31, 2020
|
||||||||
Assets
|
Liabilities
|
|||||||
Listed derivatives
|
¥ | 559 | ¥ | 716 | ||||
OTC derivatives
|
1,383 | 1,093 | ||||||
|
|
|
|
|||||
¥ | 1,942 | ¥ | 1,809 | |||||
|
|
|
|
|||||
Billions of yen
|
||||||||
March 31, 2021
|
||||||||
Assets
|
Liabilities
|
|||||||
Listed derivatives
|
¥ | 179 | ¥ | 543 | ||||
OTC derivatives
|
1,041 | 952 | ||||||
|
|
|
|
|||||
¥ | 1,220 | ¥ | 1,495 | |||||
|
|
|
|
Billions of yen
|
||||||||||||||||||||||||||||
March 31, 2021
|
||||||||||||||||||||||||||||
Years to Maturity
|
|
|
||||||||||||||||||||||||||
Less than
1 year
|
1 to 3
years
|
3 to 5
years
|
5 to 7
years
|
More than
7 years
|
Cross-maturity
netting
(1)
|
Total
fair value
|
||||||||||||||||||||||
OTC derivative assets
|
¥ | 1,572 | ¥ | 1,138 | ¥ | 803 | ¥ | 488 | ¥ | 2,699 | ¥ | (5,659 | ) | ¥ | 1,041 | |||||||||||||
OTC derivative liabilities
|
1,769 | 1,095 | 775 | 566 | 2,172 | (5,425 | ) | 952 |
(1) |
Represents the impact of netting derivative assets with derivative liabilities for the same counterparty across maturity band categories. Derivative assets and derivative liabilities with the same counterparty in the same maturity category are netted within the maturity category. This column also includes cash collateral netting with the same counterparty.
|
Millions of yen
|
||||||||||||
March 31, 2021
|
||||||||||||
Funded
|
Unfunded
|
Total
|
||||||||||
Europe
|
¥ | 3,454 | ¥ | 80,888 | ¥ | 84,342 | ||||||
Americas
|
8,322 | 94,058 | 102,380 | |||||||||
Asia and Oceania
|
16,171 | 11,388 | 27,559 | |||||||||
|
|
|
|
|
|
|||||||
Total
|
¥ | 27,947 | ¥ | 186,334 | ¥ | 214,281 | ||||||
|
|
|
|
|
|
Millions of yen
|
||||
March 31, 2021
|
||||
Deferred tax assets
|
||||
Depreciation, amortization and valuation of fixed assets
|
¥ | 22,770 | ||
Investments in subsidiaries and affiliates
|
20,220 | |||
Valuation of financial instruments
|
73,905 | |||
Accrued pension and severance costs
|
19,947 | |||
Other accrued expenses and provisions
|
60,280 | |||
Operating losses
|
353,326 | |||
Lease liabilities
|
52,251 | |||
Other
|
15,011 | |||
|
|
|||
Gross deferred tax assets
|
617,710 | |||
Less
—
|
(428,014 | ) | ||
|
|
|||
Total deferred tax assets
|
189,696 | |||
|
|
|||
Deferred tax liabilities
|
||||
Investments in subsidiaries and affiliates
|
85,636 | |||
Valuation of financial instruments
|
40,807 | |||
Undistributed earnings of foreign subsidiaries
|
2,486 | |||
Valuation of fixed assets
|
23,521 | |||
Right-of-use
|
51,671 | |||
Other
|
5,546 | |||
|
|
|||
Total deferred tax liabilities
|
209,667 | |||
|
|
|||
Net deferred tax assets (liabilities)
|
¥ | (19,971 | ) | |
|
|
Billions of yen
|
||||||||||||||||
Average for
year ended
March 31, 2020
|
March 31,
2020
|
Average for
year ended
March 31, 2021
|
March 31,
2021
|
|||||||||||||
Cash, cash equivalents and time deposits
(1)
|
¥ | 2,323.6 | ¥ | 2,540.4 | ¥ | 2,775.9 | ¥ | 2,765.0 | ||||||||
Government debt securities
|
2,371.5 | 2,412.2 | 3,082.8 | 2,641.2 | ||||||||||||
Others
(2)
|
310.6 | 401.8 | 254.0 | 252.1 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total liquidity portfolio
|
¥ | 5,005.7 | ¥ | 5,354.4 | ¥ | 6,112.7 | ¥ | 5,658.3 | ||||||||
|
|
|
|
|
|
|
|
(1) |
Cash, cash equivalents, and time deposits include nostro balances and deposits with both central banks and market counterparties that are readily available to support the liquidity position of Nomura.
|
(2) |
Others include other liquid financial assets such as money market funds and U.S. agency securities.
|
Billions of yen
|
||||||||||||||||
Average for
year ended
March 31, 2020
|
March 31,
2020
|
Average for
year ended
March 31, 2021
|
March 31,
2021
|
|||||||||||||
Japanese Yen
|
¥ | 1,500.6 | ¥ | 1,341.9 | ¥ | 2,298.1 | ¥ | 966.5 | ||||||||
U.S. Dollar
|
2,219.9 | 2,732.5 | 2,441.2 | 3,367.1 | ||||||||||||
Euro
|
818.4 | 789.5 | 795.1 | 793.5 | ||||||||||||
British Pound
|
310.5 | 315.5 | 405.4 | 333.8 | ||||||||||||
Others
(1)
|
156.3 | 175.0 | 172.9 | 197.5 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total liquidity portfolio
|
¥ | 5,005.7 | ¥ | 5,354.4 | ¥ | 6,112.7 | ¥ | 5,658.3 | ||||||||
|
|
|
|
|
|
|
|
(1) |
Includes other currencies such as the Australian dollar, the Canadian dollar and the Swiss franc.
|
Billions of yen
|
||||||||
March 31, 2020
|
March 31, 2021
|
|||||||
NHI and NSC
(1)
|
¥ | 1,382.9 | ¥ | 981.8 | ||||
Major broker-dealer subsidiaries
|
2,645.8 | 2,632.6 | ||||||
Bank subsidiaries
(2)
|
775.8 | 752.6 | ||||||
Other affiliates
|
549.9 | 1,291.3 | ||||||
|
|
|
|
|||||
Total liquidity portfolio
|
¥ | 5,354.4 | ¥ | 5,658.3 | ||||
|
|
|
|
(1) |
NSC, a broker-dealer located in Japan, holds an account with the Bank of Japan (“BOJ”) and has direct access to the BOJ Lombard facility through which same day funding is available for our securities pool. Any liquidity surplus at NHI is lent to NSC via short-term intercompany loans, which can be unwound immediately when needed.
|
(2) |
Includes Nomura Bank International plc (“NBI”), Nomura Singapore Limited and Nomura Bank Luxembourg S.A.
|
Billions of yen
|
||||||||
March 31, 2020
|
March 31, 2021
|
|||||||
Net liquidity value of other unencumbered assets
|
¥ | 2,573.6 | ¥ | 2,771.6 | ||||
Liquidity portfolio
|
5,354.4 | 5,658.3 | ||||||
|
|
|
|
|||||
Total
|
¥ | 7,928.0 | ¥ | 8,429.9 | ||||
|
|
|
|
Billions of yen
|
||||||||
March 31, 2020
|
March 31, 2021
|
|||||||
Short-term bank borrowings
|
¥ | 572.1 | ¥ | 265.8 | ||||
Other loans
|
154.3 | 138.7 | ||||||
Commercial paper
|
525.1 | 460.0 | ||||||
Deposits at banking entities
|
1,116.2 | 1,149.9 | ||||||
Certificates of deposit
|
12.1 | 83.6 | ||||||
Debt securities maturing within one year
|
692.5 | 831.5 | ||||||
|
|
|
|
|||||
Total short-term unsecured debt
|
¥ | 3,072.3 | ¥ | 2,929.5 | ||||
|
|
|
|
Billions of yen
|
||||||||
March 31, 2020
|
March 31, 2021
|
|||||||
Long-term deposits at banking entities
|
¥ | 147.9 | ¥ | 109.0 | ||||
Long-term bank borrowings
|
2,591.5 | 2,635.2 | ||||||
Other loans
|
82.5 | 74.2 | ||||||
Debt securities
(1)
|
3,522.1 | 3,877.9 | ||||||
|
|
|
|
|||||
Total long-term unsecured debt
|
¥ | 6,344.0 | ¥ | 6,696.3 | ||||
|
|
|
|
(1) |
Excludes long-term debt securities issued by consolidated special purpose entities and similar entities that meet the definition of variable interest entities under ASC 810 “
Consolidation
Long-term borrowings
Transfer and Servicing.
|
• |
Stressed scenario—To maintain adequate liquidity during a severe market-wide liquidity event without raising funds through unsecured financing or through the liquidation of assets for a year; and
|
• |
Acute stress scenario—To maintain adequate liquidity during a severe market-wide liquidity event coupled with credit concerns regarding Nomura’s liquidity position, without raising funds through unsecured funding or through the liquidation of assets for 30 days.
|
• |
No liquidation of assets;
|
• |
No ability to issue additional unsecured funding;
|
• |
Upcoming maturities of unsecured debt (maturities less than one year);
|
• |
Potential buybacks of our outstanding debt;
|
• |
Loss of secured funding lines particularly for less liquid assets;
|
• |
Fluctuation of funding needs under normal business circumstances;
|
• |
Cash deposits and free collateral
roll-off
in a stress event;
|
• |
Widening of haircuts on outstanding repo funding;
|
• |
Additional collateralization requirements of clearing banks and depositories;
|
• |
Drawdown on loan commitments;
|
• |
Loss of liquidity from market losses;
|
• |
Assuming a
two-notch
downgrade of our credit ratings, the aggregate fair value of assets that we would be required to post as additional collateral in connection with our derivative contracts; and
|
• |
Legal and regulatory requirements that can restrict the flow of funds between entities in the Nomura Group.
|
Billions of yen
|
||||||||
Year Ended March 31
|
||||||||
2020
|
2021
|
|||||||
Net cash provided by (used in) operating activities
|
¥ | (15.9 | ) | ¥ | 665.8 | |||
Net income
|
219.4 | 160.4 | ||||||
Trading assets and private equity and debt investments
|
(2,754.7 | ) | 1,468.4 | |||||
Trading liabilities
|
429.0 | 777.7 | ||||||
Securities purchased under agreements to resell, net of securities sold under agreements to repurchase
|
2,224.4 | (1,453.9 | ) | |||||
Securities borrowed, net of securities loaned
|
291.8 | (1,242.5 | ) | |||||
Other, net
|
(425.7 | ) | 955.7 | |||||
Cash flows from investing activities:
|
216.3 | (139.0 | ) | |||||
Cash flows from financing activities:
|
332.1 | (269.9 | ) | |||||
Long-term borrowings, net
|
(38.4 | ) | (1.0 | ) | ||||
Increase in short-term borrowings, net
|
656.2 | (325.2 | ) | |||||
Increase (decrease) in deposits received at banks, net
|
(93.3 | ) | 126.2 | |||||
Other, net
|
(192.5 | ) | (69.9 | ) | ||||
Effect of exchange rate changes on cash, cash equivalents, restricted cash and restricted cash equivalents
|
(27.3 | ) | 60.8 | |||||
|
|
|
|
|||||
Net increase in cash, cash equivalents, restricted cash and restricted cash equivalents
|
505.2 | 317.7 | ||||||
Cash, cash equivalents, restricted cash and restricted cash equivalents at beginning of the year
|
2,687.1 | 3,192.3 | ||||||
|
|
|
|
|||||
Cash, cash equivalents, restricted cash and restricted cash equivalents at end of the year
|
¥ | 3,192.3 | ¥ | 3,510.0 | ||||
|
|
|
|
Billions of yen, except ratios
|
||||||||
March 31
|
||||||||
2020
|
2021
|
|||||||
NHI shareholders’ equity
|
¥
|
2,653.5
|
|
¥
|
2,694.9
|
|
||
Total assets
|
|
43,999.8
|
|
|
42,516.5
|
|
||
Adjusted assets
(1)
|
|
28,092.7
|
|
|
26,477.0
|
|
||
Leverage ratio
(2)
|
|
16.6 x
|
|
|
15.8 x
|
|
||
Adjusted leverage ratio
(3)
|
|
10.6 x
|
|
|
9.8 x
|
|
(1) |
Represents total assets less
Securities purchased under agreements to resell
Securities borrowed
non-GAAP
financial measure and is calculated as follows:
|
(2) |
Equals total assets divided by NHI shareholders’ equity.
|
(3) |
Equals adjusted assets divided by NHI shareholders’ equity.
|
Billions of yen
|
||||||||
March 31
|
||||||||
2020
|
2021
|
|||||||
Total assets
|
¥
|
43,999.8
|
|
¥
|
42,516.5
|
|
||
Less:
|
||||||||
Securities purchased under agreements to resell
|
|
12,377.3
|
|
|
10,775.1
|
|
||
Securities borrowed
|
|
3,529.8
|
|
|
5,264.4
|
|
||
|
|
|
|
|||||
Adjusted assets
|
¥
|
28,092.7
|
|
¥
|
26,477.0
|
|
||
|
|
|
|
Fiscal year ended or ending March 31,
|
First Quarter
|
Second Quarter
|
Third Quarter
|
Fourth Quarter
|
Total
|
|||||||||||||||
2016
|
¥ | — | ¥ | 10.00 | ¥ | — | ¥ | 3.00 | ¥ | 13.00 | ||||||||||
2017
|
— | 9.00 | — | 11.00 | 20.00 | |||||||||||||||
2018
|
— | 9.00 | — | 11.00 | 20.00 | |||||||||||||||
2019
|
— | 3.00 | — | 3.00 | 6.00 | |||||||||||||||
2020
|
— | 15.00 | — | 5.00 | 20.00 | |||||||||||||||
2021
|
— | 20.00 | — | 15.00 | 35.00 |
Billions of yen, except ratios
|
||||||||
March 31
|
||||||||
2020
|
2021
|
|||||||
Common equity Tier 1 capital
|
¥ | 2,404.6 | ¥ | 2,522.1 | ||||
Tier 1 capital
|
2,571.5 | 2,840.5 | ||||||
Total capital
|
2,602.4 | 2,845.2 | ||||||
Risk-Weighted Assets
|
||||||||
Credit risk-weighted assets
|
7,634.7 | 8,550.9 | ||||||
Market risk equivalent assets
|
5,549.3 | 4,951.6 | ||||||
Operational risk equivalent assets
|
2,490.5 | 2,448.5 | ||||||
|
|
|
|
|||||
Total risk-weighted assets
|
¥ | 15,674.5 | ¥ | 15,951.0 | ||||
|
|
|
|
|||||
Consolidated Capital Adequacy Ratios
|
||||||||
Common equity Tier 1 capital ratio
|
15.34 | % | 15.81 | % | ||||
Tier 1 capital ratio
|
16.40 | % | 17.80 | % | ||||
Consolidated capital adequacy ratio
|
16.60 | % | 17.83 | % | ||||
External TLAC as a percentage of risk-weighted assets
|
— | 23.06 | % |
Nomura Holdings, Inc.
|
Short-term Debt
|
Long-term Debt
|
||
S&P Global Ratings
|
A-2
|
BBB+ (Stable) | ||
Moody’s Investors Service
|
—
|
Baa1 (Negative) | ||
Fitch Ratings
|
F1 |
A-
(Stable)
|
||
Rating and Investment Information, Inc.
|
a-1
|
A(Stable) | ||
Japan Credit Rating Agency, Ltd.
|
—
|
AA-
(Stable)
|
||
Nomura Securities Co., Ltd.
|
Short-term Debt
|
Long-term Debt
|
||
S&P Global Ratings
|
A-2
|
A-
(Stable)
|
||
Moody’s Investors Service
|
P-2
|
A3 (Negative) | ||
Fitch Ratings
|
F1 |
A-
(Stable)
|
||
Rating and Investment Information, Inc.
|
a-1
|
A+ (Stable) | ||
Japan Credit Rating Agency, Ltd.
|
—
|
AA-
(Stable)
|
• |
an obligation under a guarantee contract;
|
• |
a retained or contingent interest in assets transferred to an
off-balance
sheet entity or similar arrangement that serves to provide credit, liquidity or market risk support to such entity;
|
• |
any obligation, including a contingent obligation, under a contract that would be accounted for as a derivative instrument; or
|
• |
any obligation, including a contingent obligation, arising out of a variable interest in an
off-balance
sheet entity that is held by, and material to, us, where such entity provides financing, liquidity, market risk or credit risk support to, or engages in leasing, hedging or research and development services with, us.
|
• |
In connection with our banking and financing activities, we enter into various guarantee arrangements with counterparties in the form of standby letters of credit and other guarantees, which generally have fixed expiration dates.
|
• |
In connection with our operating activities, we issue Japanese Yen and
non-Japanese
Yen denominated long-term borrowings which incur variable and fixed interest payments in accordance with our funding policy.
|
• |
We lease office space, residential facilities for employees, motor vehicles, equipment and technology assets in the ordinary course of business both in Japan and overseas as lessee. These arrangements predominantly consist of operating leases;
|
• |
Separately we sublease certain real estate and equipment through operating lease arrangements.
|
• |
We lease certain equipment and facilities in Japan and overseas which are classified as finance lease agreements.
|
• |
We have purchase obligations for goods and services which include payments for construction, advertising, and computer and telecommunications maintenance agreements.
|
• |
In connection with our banking and financing activities, we enter into contractual commitments to extend credit, which generally have fixed expiration dates;
|
• |
In connection with our investment banking activities, we enter into agreements with clients under which we commit to underwrite securities that may be issued by clients.
|
• |
As a member of certain central clearing counterparties, Nomura is committed to provide liquidity facilities through entering into reverse repo transactions backed by government and government agency debt securities with those counterparties in a situation where a default of another clearing member occurs.
|
• |
We have commitments to invest in interests in various partnerships and other entities and commitments to provide financing for investments related to those partnerships.
|
Millions of yen
|
||||||||||||||||||||
Total
contractual
amount
|
Years to maturity
|
|||||||||||||||||||
Less than
1 year
|
1 to 3
years
|
3 to 5
years
|
More than
5 years
|
|||||||||||||||||
Standby letters of credit and other guarantees
|
¥ | 206,072 | ¥ | 174,864 | ¥ | 11,722 | ¥ | 281 | ¥ | 19,205 | ||||||||||
Long-term borrowings
(1)
|
7,851,677 | 463,710 | 1,451,430 | 2,375,311 | 3,561,226 | |||||||||||||||
Contractual interest payments
(2)
|
714,585 | 90,749 | 148,389 | 106,442 | 369,005 | |||||||||||||||
Operating lease commitments
(3)
|
218,717 | 42,411 | 60,702 | 46,952 | 68,652 | |||||||||||||||
Purchase obligations
(4)
|
121,604 | 30,120 | 26,367 | 64,649 | 468 | |||||||||||||||
Commitments to extend credit
(5)
|
2,301,943 | 1,506,760 | 198,334 | 204,430 | 392,419 | |||||||||||||||
Commitments to invest
|
136,367 | 111,576 | 2,339 | 4,338 | 18,114 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total
|
¥ | 11,550,965 | ¥ | 2,420,190 | ¥ | 1,899,283 | ¥ | 2,802,403 | ¥ | 4,429,089 | ||||||||||
|
|
|
|
|
|
|
|
|
|
(1) |
The amounts disclosed within long-term borrowings exclude financial liabilities recognized within long-term borrowings as a result of transfers of financial assets that are accounted for as financings rather than sales in accordance with ASC 860. These are not borrowings issued for our own funding purposes and therefore do not represent actual contractual obligations by us to deliver cash.
|
(2) |
The amounts represent estimated future interest payments related to long-time borrowings based on the period through to their maturity and applicable interest rates as of March 31, 2021.
|
(3) |
The amounts of operating lease commitments are undiscounted future minimum lease payments. The amounts of finance lease contracts were immaterial.
|
(4) |
The minimum contractual obligations under enforceable and legally binding contracts that specify all significant terms. Amounts exclude obligations that are already reflected on our consolidated balance sheets as liabilities or payables. Includes the commitment to purchase parts of the redeveloped real estate in Tokyo Nihonbashi district from the redevelopment association.
|
(5) |
Contingent liquidity facilities to central clearing counterparties are included.
|
Name
(Date of Birth)
|
Responsibilities and Status within Nomura/
Other Principal Business Activities
|
Business Experience
|
||||
Koji Nagai
(Jan. 25, 1959)
|
Director
Chairman of Board Directors
Member of the Nomination Committee
Member of the Compensation Committee
Director and Chairman of Nomura Securities Co., Ltd.
|
Apr. 1981 | Joined the Company | |||
Apr. 2003 | Director of Nomura Securities Co., Ltd. | |||||
Jun. 2003 | Senior Managing Director of Nomura Securities Co., Ltd. | |||||
Apr. 2007 | Executive Managing Director of Nomura Securities Co., Ltd. | |||||
Oct. 2008 | Senior Corporate Managing Director of Nomura Securities Co., Ltd. | |||||
Apr. 2009 | Executive Managing Director and Executive Vice President of Nomura Securities Co., Ltd. | |||||
Apr. 2011 |
Co-COO
and Deputy President of Nomura Securities Co., Ltd.
|
|||||
Apr. 2012 |
Senior Managing Director of the Company
Director and President of Nomura Securities Co., Ltd.
|
|||||
Aug. 2012 |
Representative Executive Officer & Group CEO of the Company
Director and President of Nomura Securities Co., Ltd.
|
|||||
Jun. 2013 |
Director, Representative Executive Officer & Group CEO of the Company
Director and President of Nomura Securities Co., Ltd.
|
|||||
Apr. 2017 |
Director, Representative Executive Officer, President & Group CEO of the Company
Director and Chairman of Nomura Securities Co., Ltd.
|
|||||
Apr. 2020 |
Director and Chairman of the Company (Current)
Director and Chairman of Nomura Securities Co., Ltd. (Current)
|
Name
(Date of Birth)
|
Responsibilities and Status within Nomura/
Other Principal Business Activities
|
Business Experience
|
||||
Kentaro Okuda
(Nov. 7, 1963)
|
Director, Representative Executive Officer, President and Group CEO
Representative Director and President of Nomura Securities Co., Ltd.
|
Apr. 1987 | Joined the Company | |||
Apr. 2010 | Senior Managing Director of Nomura Securities Co., Ltd. | |||||
Apr. 2012 | Senior Corporate Managing Director of Nomura Securities Co., Ltd. | |||||
Aug. 2012 |
Senior Corporate Managing Director of the Company
Senior Corporate Managing Director of Nomura Securities Co., Ltd.
|
|||||
Apr. 2013 |
Senior Managing Director of the Company
Senior Corporate Managing Director of Nomura Securities Co., Ltd.
|
|||||
Apr. 2015 |
Senior Managing Director of the Company
Executive Vice President of Nomura Securities Co., Ltd.
|
|||||
Apr. 2016 |
Senior Managing Director of the Company
Executive Managing Director and Executive Vice President of Nomura Securities Co., Ltd.
|
|||||
Apr. 2017 |
Senior Managing Director of the Company
Executive Vice President of Nomura Securities Co., Ltd.
|
|||||
Apr. 2018 |
Executive Managing Director, and Group
Co-COO
and Head of Americas (based in New York) of the Company
Director, Executive Managing Director and Deputy President of Nomura Securities Co., Ltd.
|
|||||
Apr. 2019 |
Executive Managing Director and Deputy President, Group
Co-COO
of the Company
|
|||||
Apr. 2020 |
Representative Executive Officer and President, Group CEO of the Company
Representative Director of Nomura Securities Co., Ltd.
|
|||||
Jun. 2020 |
Director, Representative Executive Officer, President & Group CEO of the Company
Representative Director of Nomura Securities Co., Ltd.
|
|||||
Jun. 2021 |
Director, Representative Executive Officer, President & Group CEO of the Company (Current)
Representative Director and President of Nomura Securities Co., Ltd. (Current)
|
Name
(Date of Birth)
|
Responsibilities and Status within Nomura/
Other Principal Business Activities
|
Business Experience
|
||||
Tomoyuki Teraguchi
(Aug. 4, 1962)
|
Director, Representative Executive Officer and Deputy President
Representative Director and Deputy President of Nomura Securities Co., Ltd.
|
Apr. 1986 | Joined the Company | |||
Apr. 2009 | Senior Managing Director and Global Equity Strategy Office of Nomura Securities Co., Ltd. | |||||
Apr. 2011 | Senior Managing Director and Global Markets Joint COO of Nomura Securities Co., Ltd. | |||||
Feb. 2013 | Senior Managing Director and Global Markets COO of Nomura Securities Co., Ltd. | |||||
Apr. 2013 | Senior Managing Director, Global Markets COO and Global Research of Nomura Securities Co., Ltd. | |||||
Apr. 2016 |
Senior Managing Director, Group Compliance Head and Operations of the Company
Representative Executive Officer, Compliance Division and Operations of Nomura Securities Co., Ltd., Internal Control Supervisory Manager
|
|||||
Apr. 2017 |
Senior Managing Director, Group Compliance Head and Operations of the Company
Representative Executive Officer, Senior Corporate Managing Director, Compliance Division and Operations of Nomura Securities Co., Ltd., Internal Control Supervisory Manager
|
|||||
May. 2019 |
Executive Managing Director and Chief Compliance Officer of the Company
Representative Director, Executive Vice President, Compliance and Legal of Nomura Securities Co., Ltd., Internal Control Supervisory Manager
|
|||||
Apr. 2020 |
Executive Managing Director, Chief of Staff and Chief Compliance Officer of the Company
Representative Director and Deputy President, Compliance and Legal of Nomura Securities Co., Ltd., Internal Control Supervisory Manager
|
Name
(Date of Birth)
|
Responsibilities and Status within Nomura/
Other Principal Business Activities
|
Business Experience
|
||||
Apr. 2021 |
Representative Executive Officer, Deputy President, Chief of Staff and Chief Compliance Officer of the Company
Representative Director and Deputy President and Chief of Staff of Nomura Securities Co., Ltd.
|
|||||
Jun. 2021 |
Director, Representative Executive Officer, Deputy President, Chief of Staff and Chief Compliance Officer of the Company (Current)
Representative Director, Deputy President and Chief of Staff of Nomura Securities Co., Ltd. (Current)
|
|||||
Shoji Ogawa
(Aug. 9, 1964)
|
Director
Member of the Audit Committee
(full-time)
Statutory Auditor of Nomura Financial Products & Services, Inc.
|
Apr. 1987 | Joined the Company | |||
Apr. 2007 | Head of Investment Banking Strategic Planning Dept of Nomura Securities Co., Ltd. | |||||
Oct. 2008 | Head of Capital Markets Dept. and Capital Solutions Dept. of Nomura Securities Co., Ltd. | |||||
Jul. 2009 | Head of Capital Markets Dept. of Nomura Securities Co., Ltd. | |||||
Apr. 2012 | Head of Investment Banking Strategic Planning Dept. of Nomura Securities Co., Ltd. | |||||
Jul. 2013 |
Head of Office of Audit Committee of the Company
Head of Office of Audit Committee of Nomura Securities Co., Ltd.
|
|||||
Aug. 2016 |
Head of Office of
Non-Executive
Directors and Audit Committee of the Company
Head of Office of
Non-Executive
Directors and Audit Committee of Nomura Securities Co., Ltd.
|
|||||
Apr. 2017 |
Senior Managing Director and Group Internal Audit of the Company
Senior Managing Director and Internal Audit of Nomura Securities Co., Ltd.
|
|||||
Apr. 2021 | Advisor of the Company | |||||
Jun. 2021 | Director of the Company (Current) |
Name
(Date of Birth)
|
Responsibilities and Status within Nomura/
Other Principal Business Activities
|
Business Experience
|
||||
Kazuhiko Ishimura
(Sep. 18, 1954)
|
Outside Director
Chairman of the Nomination Committee
Chairman of the Compensation Committee
Outside Director of TDK Corporation
Outside Director of IHI Corporation
President of the National Institute of Advanced Industrial Science and Technology
|
Apr. 1979 | Joined Asahi Glass Co., Ltd. (currently, AGC Inc.) (“AGC”) | |||
Jan. 2006 | Executive Officer and GM of Kansai Plant of AGC | |||||
Jan. 2007 | Senior Executive Officer and GM of Electronics & Energy General Division of AGC | |||||
Mar. 2008 | Representative Director and President & COO of AGC | |||||
Jan. 2010 | Representative Director and President & CEO of AGC | |||||
Jan. 2015 | Representative Director & Chairman of AGC | |||||
Jan. 2018 | Director & Chairman of AGC | |||||
Jun. 2018 | Outside Director of the Company (Current) | |||||
Mar. 2020 | Director of AGC | |||||
Apr. 2020 | President of the National Institute of Advanced Industrial Science and Technology (Current) | |||||
Takahisa Takahara
(Jul. 12, 1961)
|
Outside Director
Member of the Nomination Committee
Member of the Compensation Committee
Representative Director, President & CEO of Unicharm Corporation
Outside Director of Calbee, Inc.
|
Apr. 1991 | Joined Unicharm Corporation | |||
Jun. 1995 | Director of Unicharm Corporation | |||||
Apr. 1996 | Director, General Manager of Procurement Division and Deputy General Manager of International Division of Unicharm Corporation | |||||
Jun. 1997 | Senior Director of Unicharm Corporation | |||||
Apr. 1998 | Senior Director, General Manager of Feminine Hygiene Business Division of Unicharm Corporation | |||||
Oct. 2000 | Senior Director, Responsible for Management Strategy of Unicharm Corporation | |||||
Jun. 2001 | Representative Director, President of Unicharm Corporation | |||||
Jun. 2004 | Representative Director, President & CEO of Unicharm Corporation (Current) | |||||
Jun. 2021 | Outside Director of the Company (Current) |
Name
(Date of Birth)
|
Responsibilities and Status within Nomura/
Other Principal Business Activities
|
Business Experience
|
||||
Noriaki Shimazaki
(Aug. 19, 1946)
|
Outside Director
Chairman of the Audit Committee
Director of Nomura Securities Co., Ltd.
Outside Director of Loginet Japan Co., Ltd.
|
Apr. 1969 | Joined Sumitomo Corporation | |||
Jun. 1998 | Director of Sumitomo Corporation | |||||
Apr. 2002 | Representative Director and Managing Director of Sumitomo Corporation | |||||
Jan. 2003 | Member of the Business Accounting Council of the Financial Services Agency | |||||
Apr. 2004 | Representative Director and Senior Managing Executive Officer of Sumitomo Corporation | |||||
Apr. 2005 | Representative Director and Executive Vice President of Sumitomo Corporation | |||||
Jan. 2009 | Trustee of the IASC (currently, IFRS Foundation) | |||||
Jul. 2009 | Special Advisor of Sumitomo Corporation | |||||
Jun. 2011 |
Director of the Financial Accounting Standards Foundation
Chairman of Self-regulation Board and Public Governor of the Japan Securities Dealers Association
|
|||||
Sep. 2013 |
Advisor of the IFRS Foundation Asia-Oceania Office
Advisor of the Japanese Institute of Certified Public Accountants (Current)
|
|||||
Jun. 2016 |
Outside Director of the Company (Current)
Director of Nomura Securities Co., Ltd. (Current)
|
|||||
Aug. 2019 | Senior Advisor of the IFRS Foundation Asia-Oceania Office (Current) | |||||
Mari Sono
(Feb. 20, 1952)
|
Outside Director
Member of the Audit Committee
Auditor of WASEDA University
|
Oct. 1976 | Joined NISSHIN Audit Corporation(*) | |||
Mar. 1979 | Registered as Certified Public Accountant | |||||
Nov. 1988 | Partner of CENTURY Audit Corporation(*) | |||||
Nov. 1990 | Member of “Certified Public Accountant Examination System Subcommittee”, Certified Public Accountant Examination and Investigation Board, Ministry of Finance |
Name
(Date of Birth)
|
Responsibilities and Status within Nomura/
Other Principal Business Activities
|
Business Experience
|
||||
Apr. 1992 | Member of “Business Accounting Council”, Ministry of Finance | |||||
Dec. 1994 | Senior Partner, CENTURY Audit Corporation(*) | |||||
Oct. 2002 | Member of Secretariat of the Information Disclosure, Cabinet Office (currently, Secretariat of the Information Disclosure and Personal Information Protection Review Board, Ministry of Internal Affairs and Communications) | |||||
Apr. 2005 | External Comprehensive Auditor, Tokyo | |||||
Jul. 2008 | Senior Partner of Ernst & Young ShinNihon LLC | |||||
Aug. 2012 | Retired Ernst & Young ShinNihon LLC | |||||
Dec. 2013 | Commissioner of the Securities and Exchange Surveillance Commission | |||||
Jun. 2017 |
Outside Director of the Company (Current)
*Each of the corporation is currently Ernst & Young ShinNihon LLC
|
|||||
Laura Simone Unger
(Jan. 8, 1961)
|
Outside Director
Independent Director of CIT Group Inc.
Independent Director of Navient Corporation
Independent Director of Nomura Holding America Inc.
Independent Director of Nomura Securities International, Inc.
Independent Director of Nomura Global Financial Products Inc.
|
Jan. 1988 | Enforcement Attorney of U.S. Securities and Exchange Commission (SEC) | |||
Oct. 1990 | Counsel of U.S. Senate Committee on Banking, Housing, and Urban Affairs | |||||
Nov. 1997 | Commissioner of SEC | |||||
Feb. 2001 | Acting Chairperson of SEC | |||||
Jul. 2002 | Regulatory Expert of CNBC | |||||
May 2003 | Independent Consultant of JPMorgan Chase & Co. | |||||
Aug. 2004 | Independent Director of CA Inc. | |||||
Jan. 2010 | Special Advisor of Promontory Financial Group | |||||
Dec. 2010 | Independent Director of CIT Group Inc. (Current) | |||||
Nov. 2014 | Independent Director of Navient Corporation (Current) | |||||
Jun. 2018 | Outside Director of the Company (Current) |
Name
(Date of Birth)
|
Responsibilities and Status within Nomura/
Other Principal Business Activities
|
Business Experience
|
||||
Victor Chu
(Jun. 20, 1957)
|
Outside Director
Chairman and Chief Executive Officer of First Eastern Investment Group
Chair of Council, University College London
Co-Chair,
International Business Council of the World Economic Forum
Independent Director of Airbus SE
|
Dec. 1982 | Solicitor of the Supreme Court, Hong Kong | |||
Jan. 1988 | Chairman and Chief Executive Officer of First Eastern Investment Group (Current) | |||||
Oct. 1988 | Director and Council Member of the Hong Kong Stock Exchange | |||||
Jun. 1992 | Advisory Committee Member of the Securities and Futures Commission, Hong Kong | |||||
Aug. 2003 | Foundation Board Member of the World Economic Forum | |||||
Apr 2018 | Independent Director of Airbus SE (Current) | |||||
Jun. 2021 | Outside Director of the Company (Current) | |||||
J.Christopher Giancarlo
(May 12, 1959)
|
Outside Director
Senior Counsel of Willkie Farr & Gallagher LLP
Independent Director of the American Financial Exchange
Chairman of Common Securitization Solutions LLC
Independent Director of BlockFi Inc.
Principal of Digital Dollar Project
|
Sep. 1984 | Associate Attorney of Mudge Rose Guthrie Alexander & Ferdon | |||
Oct. 1985 | Associate Attorney of Curtis, Mallet-Prevost, Colt & Mosle | |||||
Jan. 1992 | Attorney, Founding Partner of Giancarlo & Gleiberman | |||||
Sep. 1997 | Attorney, (Equity) Partner of Thelen Reid Brown Raysman & Steiner | |||||
Apr. 2000 | Vice President and Legal Counsel of Fenics Software | |||||
Apr. 2001 | Executive Vice President of GFI Group Inc. | |||||
Jun. 2014 | Commissioner of the U.S. Commodity Futures Trading Commission | |||||
Jan. 2017 | Chairman of the U.S. Commodity Futures Trading Commission | |||||
Oct. 2019 | Independent Director of the American Financial Exchange (Current) | |||||
Jan. 2020 | Senior Counsel of Willkie Farr & Gallagher LLP (Current) | |||||
Jun. 2021 | Outside Director of the Company (Current) |
Name
(Date of Birth)
|
Responsibilities and Status within Nomura/
Other Principal Business Activities
|
Business Experience
|
||||
Patricia Mosser
(Feb. 14, 1956)
|
Outside Director
Senior Research Scholar*
Director of the MPA Program in Economic Policy Management*
Director of Central Banking and Financial Policy*
*Positions at Columbia University, School of International and Public Affairs
|
Jul. 1986 | Assistant Professor, Economics Department, Columbia University | |||
Jan. 1991 | Economist and Vice President of the Federal Reserve Bank of New York (FRBNY) | |||||
Nov. 2006 | Senior Vice President, FRBNY, Member of the FX Forum, Executive Meeting of East Asia and Pacific (EMEAP) Central Banks, Bank for International Settlements | |||||
Jan. 2007 | Board Member of the American Economic Association’s Committee on the Status of Women in the Economics Profession | |||||
Jun. 2007 | Member of the Markets Committee, Bank for International Settlements | |||||
Jan 2009 | Acting Systemic Open Market Account Manager for the Federal Open Market Committee (FOMC) | |||||
Oct. 2013 | Deputy Director of the Office of Financial Research (OFR), U.S. Treasury Department | |||||
Oct. 2013 | Member of the Deputies Committee of the Financial Stability Oversight Council (FSOC) | |||||
Jun. 2015 | Senior Research Scholar and Director of Central Banking and Financial Policy at Columbia University’s School of International and Public Affairs (Current) | |||||
Jun. 2021 | Outside Director of the Company (Current) |
Name
(Date of Birth)
|
Responsibilities and Status within Nomura/
Other Principal Business Activities
|
Business Experience
|
||||
Kentaro Okuda
(Nov. 7, 1963)
|
See “
Directors
|
See “
Directors
|
||||
Tomoyuki Teraguchi
(Aug. 4, 1962)
|
See “
Directors
|
See “
Directors
|
||||
Toshiyasu Iiyama
(Feb. 24, 1965)
|
Executive Managing Director
Head of China Committee
Chief Health Officer
Representative Director and Deputy President of Nomura Securities Co., Ltd.
|
Apr. 1987 | Joined the Company | |||
Apr. 2012 | Senior Managing Director of Nomura Securities Co., Ltd. | |||||
Apr. 2015 |
Senior Managing Director of the Company
Senior Managing Director of Nomura Securities Co., Ltd.
|
|||||
Apr. 2016 |
Senior Managing Director of the Company
Senior Corporate Managing Director of Nomura Securities Co., Ltd.
|
|||||
Apr. 2018 |
Senior Managing Director of the Company
Executive Officer and Executive Vice President of Nomura Securities Co., Ltd.
|
|||||
Apr. 2019 |
Senior Managing Director of the Company
Executive Vice President of Nomura Securities Co., Ltd.
|
|||||
Apr. 2020 |
Senior Managing Director of the Company
Representative Director and Deputy President of Nomura Securities Co., Ltd.
|
|||||
Apr. 2021 |
Executive Managing Director and Chief Health Officer of the Company (Current)
Representative Director and Deputy President of Nomura Securities Co., Ltd. (Current)
|
|||||
Takumi Kitamura
(Nov. 26, 1966)
|
Executive Managing Director
Chief Financial Officer
Director, Executive Vice President of Nomura Securities Co., Ltd.
|
Apr. 1990 | Joined the Company | |||
Apr. 2016 |
Executive Managing Director and Chief Financial Officer of the Company
Executive Managing Director and Financial Officer of Nomura Securities Co., Ltd.
|
Name
(Date of Birth)
|
Responsibilities and Status within Nomura/
Other Principal Business Activities
|
Business Experience
|
||||
Apr. 2019 |
Executive Managing Director and Chief Financial Officer of the Company
Director and Senior Corporate Managing Director of Nomura Securities Co., Ltd.
|
|||||
Apr. 2021 |
Executive Managing Director and Chief Financial Officer of the Company (Current)
Director, Executive Vice President of Nomura Securities Co., Ltd. (Current)
|
|||||
Sotaro Kato
(Oct. 9, 1969)
|
Executive Managing Director
Chief Risk Officer
Director and Senior Corporate Managing
Director of Nomura Securities Co., Ltd.
|
Sep. 2002 | Joined the Company | |||
Apr. 2020 |
Executive Managing Director and Chief Risk Officer of the Company (based in New York) (Current)
Director and Senior Corporate Managing Director of Nomura Securities Co., Ltd. (Current)
|
|||||
Toru Otsuka
(Jun. 5, 1967)
|
Executive Managing Director
Chief Strategy Officer
Director and Senior Corporate Managing
Director of Nomura Securities Co., Ltd.
|
Apr. 1991 | Joined the Company | |||
Apr. 2018 |
Senior Managing Director of the Company
Senior Managing Director of Nomura Securities Co., Ltd.
|
|||||
May. 2019 |
Senior Managing Director and Chief Strategy Officer of the Company
Senior Managing Director of Nomura Securities Co., Ltd.
|
|||||
Apr. 2021 |
Executive Managing Director and Chief Strategy Officer of the Company (Current)
Director and Senior Corporate Managing Director of Nomura Securities Co., Ltd. (Current)
|
Items
|
Before revision
|
After revision
|
||
Key performance implementation (KPI) regarding Performance-Linked Compensation |
Pre-Tax
Income (PTI)
Earnings Per Share (EPS)
Dividend Per Share
Share price
|
Return on Equity (ROE)
(1)
|
||
Determination method for amounts of Performance-Linked Compensation |
(Comprehensive consideration method)
In addition to 4 (four) types of indicators above, each responsibility, performance, and trends of compensation of other global competitive firms and the industry etc. are comprehensively considered.
|
(Determination of the achievement of KPI targets by qualitative evaluation etc.)
Determined by considering qualitative evaluation etc. by the Compensation Committee, based on the level of achievement in actual value against the target value regarding KPI.
|
||
Determination method for compensation of each Statutory Officers | Determined linkage with each KPI for compensation in align with each responsibility in advance. At the end of the fiscal year, finally determined by considering each contribution, performance of its responsible area, qualitative evaluation etc. | |||
Nominating Committee and Compensation Committee |
(On and before June 23, 2019) Chairman: Nobuyuki Koga (chairman of board of directors,
non-executive
director)
Member: Hiroshi Kimura (outside directors)
Member: Kazuhiko Ishimura (outside directors)
|
(On and after June 21, 2021) Chairman: Kazuhiko Ishimura (outside directors)
Member: Takahisa Takahara (outside directors)
Member: Koji Nagai (chairman of board of directors,
non-executive
director)
|
(1) |
The reason for selecting ROE as KPI is that it is set out in management vision and business strategy, which is publicly announced on May 19, 2020, as the most important indicator for assessment of business growth.
|
• |
Base salary is determined based on factors such as professional background, career history, responsibilities and compensation standards of related business fields.
|
• |
A portion of base salary may be paid in equity linked awards with appropriate vesting periods to ensure that medium to long-term interests of Directors and Executive Officers are closely aligned with those of shareholders.
|
• |
Yearly bonuses of Directors and Executive Officers are determined by taking into account both quantitative and qualitative factors. Quantitative factors include performance of the Group and the division. Qualitative factors include achievement of individual goals and subjective assessment of individual contribution.
|
• |
Depending on the level of bonus payment, a portion of payment in cash may be deferred. In addition, a portion of deferred bonus may be paid in equity linked awards with appropriate vesting periods in lieu of cash to ensure that medium to long-term interests of Directors and Executive Officers are closely aligned with those of shareholders. Such deferred bonus may be unpaid or forfeited under specific circumstances.
|
• |
Long-term incentive plans may be awarded to Directors and Executive Officers, depending on their individual responsibilities and performance.
|
• |
Payments under long-term incentive plans are made when a certain degree of achievements are accomplished. Payments are made in equity linked awards with appropriate vesting periods to ensure that medium to long-term interests of Directors and Executive Officers are closely aligned with those of shareholders.
|
(Millions of yen, except percentages)
|
||||||||||||||||||||||||||
Base Salary (Fixed Compensation)
|
Yearly Bonus (Variable Compensation)
|
Total
Compensation (TC) |
||||||||||||||||||||||||
Base cash
salary
|
Equity-linked
compensation |
Subtotal
|
Cash
Bonus
|
Deferred
Compensation |
Subtotal
|
|||||||||||||||||||||
102.0 | 17.4 | 119.4 | 100.5 | 100.5 | 201.0 | 320.4 | ||||||||||||||||||||
31.8 | % | 5.4 | % | 37.3 | % | 31.4 | % | 31.4 | % | 62.7 | % | 100.0 | % |
• |
With respect to the President and the Group CEO, given the overall responsibility of business execution of the Nomura Group, the basic amount of the Yearly Bonus is calculated based on the level of achievement in actual value against the target value regarding ROE. In addition, TC, including the Base Salary and the Yearly Bonus, is determined by considering, as needed, qualitative evaluation etc. by the Compensation Committee.
|
• |
With respect to the Executive Officers, same as the President and the Group CEO, given the responsibility of business execution for the Nomura Group, an individual ratio is applied to calculate their basic amounts of the Yearly Bonus. In addition, the Yearly Bonus and TC are determined by reflecting the qualitative evaluation etc. such as the performance and contribution for their responsible area.
|
• |
With respect to the chairman of the Board of Directors, it is treated in the same matter as the Executive Officers.
|
Performance Indicator
|
Target value
|
Actual value for the Fiscal Year
|
||||||
ROE
|
8.0 | % | 5.7 | % |
3) |
Yearly Bonus of Director of the audit committee member and Outside Directors
|
4) |
Matters relating to
Non-Monetary
Compensation
|
Type of award
|
Key features
|
|||
RSU awards
|
•
|
Settled in Nomura’s common stock.
|
||
• |
Graded vesting period is set as three years in principle.
|
|||
• |
It is introduced as the Deferred Compensation since the fiscal year ended March 31, 2018.
|
|||
• |
In principle, it has been granted in May every year.
|
|||
NSU awards
|
•
|
Linked to the price of Nomura’s common stock and cash—settled.
|
||
• |
Same as RSU awards, graded vesting period is set as three years in principle.
|
|||
• |
Following the introduction of RSU as a principle vehicle in 2018 NSU awards are less commonly used in Nomura.
|
|||
•
|
Same as RSU awards, in principle, it has been granted in May every year.
|
• |
Alignment of interests with shareholders.
|
• |
Clawback by prescribing requirements such as voluntary retirement and violation of regulations.
|
• |
Medium-term incentives (*) and retention by providing an opportunity for the economic value of Deferred Compensation at the time of grant to be increased by a rise in shares during a period of time from grant to vesting.
|
* |
In line with the introduction of RSU, among the equity-linked compensation, as the principal vehicle for Deferred Compensation, in principle, Nomura’s common stock will be paid instead of cash over the three year deferral period from the fiscal year following the fiscal year in which the deferred compensation was granted. Since the number of shares to be paid is determined based on the Nomura’s share price at the time of grant, the increase in Nomura’s share price will increase the economic value of Deferred Compensation at the time of vest. Since the increase in share prices reflects the increase in corporate value, alignment of interest with that of shareholders, in addition to medium-term incentive effects for the Directors and Executive Officers, will be achieved.
|
• |
Promotion of cross-divisional collaboration and cooperation by providing a common goal of increasing corporate value over the medium to long term.
|
Number of
People
(1)
|
Millions of yen
|
|||||||||||||||||||
Year ended March 31, 2021
|
||||||||||||||||||||
Base Salary
(2,3)
|
Performance-
linked compensation
(4)
|
Non-monetary
compensation (Deferred Compensation)
(5)
|
Total
|
|||||||||||||||||
Directors
|
10 | ¥ | 290 | ¥ | 66 | ¥ | 226 | ¥ | 582 | |||||||||||
(Outside Directors included in above)
|
(6 | ) | (130 | ) | ( — | ) | ( — | ) | (130 | ) | ||||||||||
Executive Officers
|
6 | 420 | 240 | 364 | 1,024 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total
|
16 | ¥ | 710 | ¥ | 306 | ¥ | 590 | ¥ | 1,606 | |||||||||||
|
|
|
|
|
|
|
|
|
|
(1) |
The number of people includes two Directors who retired in June 2020. There were eight Directors and six Executive Officers as of March 31, 2021. Compensation to Directors who were concurrently serving as Executive Officers is included in that of Executive Officers.
|
(2) |
Base Salary of ¥710 million includes other compensation (commuter pass allowance) of ¥850 thousand.
|
(3) |
In addition to base salary of Executive Officers, ¥16 million of corporate housing costs, such as housing allowance and related tax adjustments, were provided.
|
(4) |
Out of the Yearly Bonus, amounts to be paid in cash after the Fiscal Year close are shown.
|
(5) |
Deferred compensation (such as RSU and stock options) granted during and prior to the fiscal year ended March 31, 2021 is recognized as expense in the financial statements for the fiscal year ended March 31, 2021.
|
(6) |
Subsidiaries of the Company paid ¥65 million to Outside Directors as compensation, etc. for their directorship at those subsidiaries for the fiscal year ended March 31, 2021.
|
(7) |
The Company abolished retirement bonuses to Directors in 2001.
|
Millions of yen
|
||||||||||||||||||||||||||||||||
Fixed Remuneration
(Basic Compensation)
|
Variable Compensation
(1)
|
|||||||||||||||||||||||||||||||
Name
|
Company
|
Category
|
Base Salary
|
Equity
Compensation
(RSUs)
|
Total
|
Cash
Bonus
|
Deferred
Compensation
(RSUs, etc.)
|
Total
|
Total
|
|||||||||||||||||||||||
Koji Nagai
|
Nomura | Chairman of the Board of Directors | ¥ | 91.2 | ¥ | 0 | ¥ | 91.2 | ¥ | 50.5 | ¥ | 50.5 | ¥ | 101.0 | ¥ | 192.2 | ||||||||||||||||
Kentaro Okuda
(2)
|
Nomura |
Director,
Representative
Executive
Officer
(Group CEO)
|
¥ | 102.0 | ¥ | 17.4 | ¥ | 119.4 | ¥ | 100.5 | ¥ | 100.5 | ¥ | 201.0 | ¥ | 320.4 | ||||||||||||||||
Toshio Morita
|
Nomura |
Executive Managing
Director
(Group
Co-COO)
|
¥ | 84.0 | ¥ | 15.0 | ¥ | 99.0 | ¥ | 54.7 | ¥ | 54.7 | ¥ | 109.3 | ¥ | 208.3 | ||||||||||||||||
Tomoyuki Teraguchi
|
Nomura |
Executive
Managing Director
|
¥ | 66.0 | ¥ | 13.2 | ¥ | 79.2 | ¥ | 32.9 | ¥ | 32.9 | ¥ | 65.8 | ¥ | 145.0 |
(1) |
Variable Compensation indicates the amount determined as remuneration based on the performance during the fiscal year ended March 31, 2021.
|
(2) |
In addition to basic compensation, ¥16 million of corporate housing costs, such as housing allowance and related tax adjustments, were provided.
|
Date
|
Summary of the discussion and the resolution
|
Attendance records
of the member
|
||
April 24, 2020
|
Discussion: The yearly bonus of the previous fiscal year
|
perfect attendance
|
||
May 8, 2020
|
Resolution: The yearly bonus of the previous fiscal year
|
perfect attendance
|
||
June 24, 2020
|
Resolution: The appointment of the Director with the right to convoke the board of directors meetings and the Director who reports the executions of the committee’s duties to the board of the directors meetings.
Resolution: The compensation policies
Resolution: Individual base salary of the Directors and Executive Officers
Discussion: Transformation of the determination process of the Directors and Executive Officers compensation (bonus).
|
perfect attendance
|
||
August 25, 2020
|
Discussion: Transformation of the determination process of the Directors and Executive Officers compensation (bonus).
|
perfect attendance
|
||
October 28, 2020
|
Discussion: Transformation of the determination process of the Directors and Executive Officers compensation (bonus).
|
perfect attendance
|
||
December 3, 2020
|
Resolution: Transformation of the determination process of the Directors and Executive Officers compensation (bonus).
|
perfect attendance
|
||
March 26, 2021
|
Resolution: Individual base salary of the Directors and Executive Officers.
Discussion: The yearly bonuses of the Fiscal Year.
Discussion: The determination process of the Directors and Executive Officers compensation (bonus).
|
perfect attendance
|
March 31, 2021
|
||||||||||||||||
Series of SARs
|
Allotment Date
|
Number of
Shares under
SARs
|
Exercise Period
of SARs
|
Exercise
Price per
Share under
SARs
|
Paid-in
Amount for
SARs
|
|||||||||||
Stock Acquisition Rights No.47
|
June 5, 2012 | 29,200 |
From April 20, 2016
to April 19, 2021
|
¥ | 1 | ¥ | 0 | |||||||||
Stock Acquisition Rights No.48
|
June 5, 2012 | 411,900 |
From April 20, 2017
to April 19, 2022
|
1 | 0 | |||||||||||
Stock Acquisition Rights No.49
|
June 5, 2012 | 36,500 |
From October 20, 2015
to April 19, 2021
|
1 | 0 | |||||||||||
Stock Acquisition Rights No.50
|
June 5, 2012 | 39,700 |
From October 20, 2016
to April 19, 2022
|
1 | 0 | |||||||||||
Stock Acquisition Rights No.54
|
June 5, 2013 | 79,100 |
From April 20, 2016
to April 19, 2021
|
1 | 0 |
March 31, 2021
|
||||||||||||||||
Series of SARs
|
Allotment Date
|
Number of
Shares under
SARs
|
Exercise Period
of SARs
|
Exercise
Price per
Share under
SARs
|
Paid-in
Amount for
SARs
|
|||||||||||
Stock Acquisition Rights No.57
|
June 5, 2014 | 87,200 |
From April 20, 2016
to April 19, 2021
|
1 | 0 | |||||||||||
Stock Acquisition Rights No.58
|
June 5, 2014 | 720,900 |
From April 20, 2017
to April 19, 2022
|
1 | 0 | |||||||||||
Stock Acquisition Rights No.61
|
June 5, 2014 | 840,600 |
From March 31, 2017
to March 30, 2022
|
1 | 0 | |||||||||||
Stock Acquisition Rights No.62
|
November 18, 2014 | 2,670,700 |
From November 18, 2016
to November 17, 2021
|
738 | 0 | |||||||||||
Stock Acquisition Rights No.63
|
June 5, 2015 | 80,500 |
From April 20, 2016
to April 19, 2021
|
1 | 0 | |||||||||||
Stock Acquisition Rights No.64
|
June 5, 2015 | 659,500 |
From April 20, 2017
to April 19, 2022
|
1 | 0 | |||||||||||
Stock Acquisition Rights No.65
|
June 5, 2015 | 1,029,200 |
From April 20, 2018
to April 19, 2023
|
1 | 0 | |||||||||||
Stock Acquisition Rights No.68
|
November 18, 2015 | 2,565,800 |
From November 18, 2017
to November 17, 2022
|
802 | 0 | |||||||||||
Stock Acquisition Rights No.69
|
June 7, 2016 | 686,600 |
From April 20, 2017
to April 19, 2022
|
1 | 0 | |||||||||||
Stock Acquisition Rights No.70
|
June 7, 2016 | 1,100,400 |
From April 20, 2018
to April 19, 2023
|
1 | 0 | |||||||||||
Stock Acquisition Rights No.71
|
June 7, 2016 | 1,330,000 |
From April 20, 2019
to April 19, 2024
|
1 | 0 | |||||||||||
Stock Acquisition Rights No.72
|
June 7, 2016 | 203,200 |
From October 30, 2016
to October 29, 2021
|
1 | 0 | |||||||||||
Stock Acquisition Rights No.74
|
November 11, 2016 | 2,370,400 |
From November 11, 2018
to November 10, 2023
|
593 | 0 | |||||||||||
Stock Acquisition Rights No.75
|
June 9, 2017 | 852,600 |
From April 20, 2018
to April 19, 2023
|
1 | 0 | |||||||||||
Stock Acquisition Rights No.76
|
June 9, 2017 | 1,003,900 |
From April 20, 2019
to April 19, 2024
|
1 | 0 | |||||||||||
Stock Acquisition Rights No.77
|
June 9, 2017 | 1,541,400 |
From April 20, 2020
to April 19, 2025
|
1 | 0 | |||||||||||
Stock Acquisition Rights No.78
|
June 9, 2017 | 811,800 |
From April 20, 2021
to April 19, 2026
|
¥ | 1 | ¥ | 0 | |||||||||
Stock Acquisition Rights No.79
|
June 9, 2017 | 809,900 |
From April 20, 2022
to April 19, 2027
|
1 | 0 | |||||||||||
Stock Acquisition Rights No.80
|
June 9, 2017 | 136,200 |
From April 20, 2023
to April 19, 2028
|
1 | 0 | |||||||||||
Stock Acquisition Rights No.81
|
June 9, 2017 | 136,200 |
From April 20, 2024
to April 19, 2029
|
1 | 0 | |||||||||||
Stock Acquisition Rights No.82
|
June 9, 2017 | 276,700 |
From October 30, 2017
to October 29, 2022
|
1 | 0 | |||||||||||
Stock Acquisition Rights No.83
|
June 9, 2017 | 63,900 |
From April 30, 2018
to April 29, 2023
|
1 | 0 | |||||||||||
Stock Acquisition Rights No.84
|
November 17, 2017 | 2,475,300 |
From November 17, 2019
to November 16, 2024
|
684 | 0 | |||||||||||
Stock Acquisition Rights No.85
|
November 20, 2018 | 2,316,300 |
From November 20, 2020
to November 19, 2025
|
573 | 0 |
(1) |
SARs (including those granted to Directors and Executive Officers of Nomura which are stated in the table below) are issued in conjunction with deferred compensation plan.
|
(2) |
The number of shares issuable under SARs is subject to adjustments under certain circumstances including stock splits.
|
March 31, 2021
|
||||||||
Numbers of Holders
|
||||||||
Series of SARs
|
Number of
Shares under
SARs
|
Directors and
Executive Officers
(excluding
Outside Directors)
|
||||||
Stock Acquisition Rights No.58
|
91 | 1 | ||||||
Stock Acquisition Rights No.61
|
126 | 1 | ||||||
Stock Acquisition Rights No.64
|
69 | 1 | ||||||
Stock Acquisition Rights No.65
|
438 | 2 | ||||||
Stock Acquisition Rights No.69
|
145 | 1 | ||||||
Stock Acquisition Rights No.70
|
635 | 3 | ||||||
Stock Acquisition Rights No.71
|
634 | 3 | ||||||
Stock Acquisition Rights No.75
|
687 | 3 | ||||||
Stock Acquisition Rights No.76
|
687 | 3 | ||||||
Stock Acquisition Rights No.77
|
860 | 4 |
March 31,
|
||||||||||||
2019
|
2020
|
2021
|
||||||||||
Japan
|
15,852 | 15,748 | 15,330 | |||||||||
Europe
|
2,909 | 2,691 | 2,769 | |||||||||
Americas
|
2,357 | 2,120 | 2,152 | |||||||||
Asia and Oceania
|
6,746 | 6,070 | 6,151 | |||||||||
|
|
|
|
|
|
|||||||
Total
|
27,864 | 26,629 | 26,402 | |||||||||
|
|
|
|
|
|
Name
|
Number of
Shareholdings
|
|||
Koji Nagai
|
328,228 | |||
Kentaro Okuda
|
189,416 | |||
Tomoyuki Teraguchi
|
171,128 | |||
Shoji Ogawa
|
31,784 | |||
Kazuhiko Ishimura
|
— | |||
Takahisa Takahara
|
881 | |||
Noriaki Shimazaki
|
21,175 | |||
Mari Sono
|
— | |||
Laura Simone Unger
|
(1,000ADR |
)
(1)
|
||
Victor Chu
|
— | |||
J.Christopher Giancarlo
|
— | |||
Patricia Mosser
|
— | |||
|
|
|||
Total
|
742,612 | |||
|
|
|||
(1) ADRs are not included in the total.
Executive Officers
|
|
|||
Name
|
Number of
Shareholdings
|
|||
Kentaro Okuda
|
See above | |||
Tomoyuki Teraguchi
|
See above | |||
Toshiyasu Iiyama
|
80,707 | |||
Takumi Kitamura
|
55,741 | |||
Sotaro Kato
|
5,714 | |||
Toru Otsuka
|
20,938 | |||
|
|
|||
Total
|
163,100 | |||
|
|
(1) |
Financial instruments business prescribed in the Financial Instruments and Exchange Law;
|
(2) |
Banking business prescribed in the Banking Law and trust business prescribed in the Trust Business Law; and
|
(3) |
Any other financial services and any business incidental or related to such financial services.
|
(4) |
Other than as prescribed in the items above, any other business ancillary or related to survey and research in connection with the economy, financial or capital markets, or infrastructure or undertaking the outsourcing thereof.
|
• |
a dealer in securities,
|
• |
a trader in securities that elects to use a
mark-to-market
|
• |
a
tax-exempt
organization,
|
• |
a life insurance company,
|
• |
a person liable for alternative minimum tax,
|
• |
a person that actually or constructively owns 10% or more of the combined voting power of our voting stock or of the total value of our stock,
|
• |
a person that holds shares or ADSs as part of a straddle or a hedging, conversion, integrated or constructive sale transaction,
|
• |
a person that purchases or sells shares or ADSs as part of a wash sale for tax purposes, or
|
• |
a person whose functional currency is not the U.S. dollar.
|
• |
a citizen or resident of the U.S.,
|
• |
a corporation created or organized in or under the laws of the U.S. or any political subdivision thereof,
|
• |
an estate whose income is subject to U.S. federal income tax regardless of its source, or
|
• |
a trust if a U.S. court can exercise primary supervision over the trust’s administration and one or more U.S. persons are authorized to control all substantial decisions of the trust.
|
• |
at least 75% of our gross income for the taxable year is passive income, or
|
• |
at least 50% of the value, determined on the basis of a quarterly average, of our assets is attributable to assets that produce or are held for the production of passive income.
|
• |
any gain you realize on the sale or other disposition of your shares or ADSs, and
|
• |
any excess distribution that we make to you (generally, any distributions to you during a single taxable year that are greater than 125% of the average annual distributions received by you in respect of the shares or ADSs during the three preceding taxable years or, if shorter, your holding period for the shares or ADSs).
|
• |
the gain or excess distribution will be allocated ratably over your holding period for the shares or ADSs,
|
• |
the amount allocated to the taxable year in which you realized the gain or excess distribution, or to prior years before the first year in which we were a PFIC with respect to you, will be taxed as ordinary income,
|
• |
the amount allocated to each other previous year will be taxed at the highest tax rate in effect for that year, and
|
• |
the interest charge generally applicable to underpayments of tax will be imposed in respect of the tax attributable to each such year.
|
• |
the overall tax consequences of the acquisition, ownership and disposition of shares or ADSs, including specifically the tax consequences under Japanese law,
|
• |
the laws of the jurisdiction of which they are resident, and
|
• |
any tax treaty between Japan and their country of residence.
|
• |
Resource Allocation—At the beginning of each financial year, the EMB determines the allocation of management resources and financial resources such as risk-weighted asset and unsecured funding to business units and establishes usage limits for these resources;
|
• |
Business Plan—At the beginning of each financial year, the EMB approves the business plan and budget of Nomura. Introduction of significant new businesses, changes to business plans, the budget and the allocation of management resources during the year are also approved by the EMB; and
|
• |
Reporting—The EMB reports the status of its deliberations to the BoD.
|
Risk Category
|
Definition
|
|
Financial Risk
|
||
Market risk
|
Risk of loss arising from fluctuations in values of financial assets or debts (including
off-balance
sheet items) due to fluctuations in market risk factors (interest rates, foreign exchange rates, prices of securities and others).
|
|
Credit risk
|
Risk of loss arising from an obligor’s default, insolvency or administrative proceeding which results in the obligor’s failure to meet its contractual obligations in accordance with agreed terms. It is also the risk of loss arising through a credit valuation adjustment (“CVA”) associated with deterioration in the creditworthiness of a counterparty. | |
Model risk
|
Risk of financial loss, incorrect decision making, or damage to the firm’s credibility arising from model errors or incorrect or inappropriate model application. | |
Liquidity risk
|
Risk of loss arising from difficulty in securing the necessary funding or from a significantly higher cost of funding than normal levels due to deterioration of the Nomura Group’s creditworthiness or deterioration in market conditions. | |
Non-financial
Risk
|
||
Operational risk
|
Risk of financial loss or
non-financial
impact arising from inadequate or failed internal processes, people and systems, or from external events. Operational risk includes in its definition Compliance, Legal, IT and Cyber Security, Fraud, Third Party and other
non-financial
risks.
|
|
Reputational risk
|
Possible damage to Nomura’s reputation and associated risk to earnings, capital or liquidity arising from any association, action or inaction which could be perceived by stakeholders to be inappropriate, unethical or inconsistent with Nomura Group’s values and corporate philosophy. | |
Other Risks
|
||
ESG: Environmental,
Social and
Governance
(*)
|
ESG is a collective term for Environmental (E), Social (S) and Governance (G) factors. “Environmental” includes issues related to impacts on the natural environment, including climate change. “Social” includes interactions with stakeholders and communities, for example the approach to human rights, workplace related issues and engagement on social issues. Governance includes issues related to corporate governance, corporate behaviour and the approach to transparent reporting. | |
Strategic risk
|
Risk to current or anticipated earning, capital, liquidity, enterprise value, or the Nomura Group’s reputation arising from adverse business decisions, poor implementation of business decisions, or lack of responsiveness to change in the industry or external environment. |
(*) |
Added as of April 1, 2021
|
Billions of yen
|
||||||||||||
As of
|
||||||||||||
March 31,
2019
|
March 31,
2020
|
March 31,
2021
|
||||||||||
Equity
|
¥ | 1.07 | ¥ | 8.88 | ¥ | 93.43 | ||||||
Interest rate
|
2.85 | 22.35 | 8.56 | |||||||||
Foreign exchange
|
1.88 | 5.08 | 4.17 | |||||||||
|
|
|
|
|
|
|||||||
Subtotal
|
5.79 | 36.31 | 106.16 | |||||||||
Less: Diversification Benefit
|
(1.30 | ) | (11.00 | ) | (12.77 | ) | ||||||
|
|
|
|
|
|
|||||||
VaR
|
¥ | 4.49 | ¥ | 25.31 | ¥ | 93.39 | ||||||
|
|
|
|
|
|
|||||||
Billions of yen
|
||||||||||||
For the twelve months ended
|
||||||||||||
March 31,
2019
|
March 31,
2020
|
March 31,
2021
|
||||||||||
Maximum daily VaR
(1)
|
¥ | 10.61 | ¥ | 32.89 | ¥ | 93.39 | ||||||
Average daily VaR
(1)
|
4.58 | 6.67 | 13.58 | |||||||||
Minimum daily VaR
(1)
|
3.05 | 3.62 | 7.14 |
(1) |
Represents the maximum, average and minimum VaR based on all daily calculations for the twelve months ended March 31, 2019, March 31, 2020, and March 31, 2021.
|
• |
Evaluation of likelihood that a counterparty defaults on its payments and obligations;
|
• |
Assignment of internal ratings to all active counterparties;
|
• |
Approval of extensions of credit and establishment of credit limits;
|
• |
Measurement, monitoring and management of Nomura’s current and potential future credit exposures;
|
• |
Setting credit terms in legal documentation; and
|
• |
Use of appropriate credit risk mitigants including netting, collateral and hedging.
|
• |
Establishing the amount of counterparty credit risk that Nomura is willing to take to an individual counterparty or counterparty group (setting of credit limits);
|
• |
Determining the level of delegated authority for setting credit limits (including tenor);
|
• |
The frequency of credit reviews (renewal of credit limits);
|
• |
Reporting counterparty credit risk to senior management within Nomura; and
|
• |
Reporting counterparty credit risk to stakeholders outside of Nomura.
|
Billions of yen
|
||||||||||||||||||||||||||||||||||||
Years to Maturity
|
Cross-
Maturity
Netting
(1)
|
Total
Fair Value
|
Collateral
obtained
|
Replacement
cost
(3)
|
||||||||||||||||||||||||||||||||
Credit Rating
|
Less than
1 year
|
1 to 3
years
|
3 to 5
years
|
5 to 7
years
|
More than
7 years
|
|||||||||||||||||||||||||||||||
(a)
|
(b)
|
(a)-(b)
|
||||||||||||||||||||||||||||||||||
AAA
|
¥ | 25 | ¥ | 32 | ¥ | 1 | ¥ | 3 | ¥ | 50 | ¥ | (99 | ) | ¥ | 12 | ¥ | 0 | ¥ | 12 | |||||||||||||||||
AA
|
350 | 310 | 126 | 94 | 442 | (1,034 | ) | 288 | 73 | 215 | ||||||||||||||||||||||||||
A
|
829 | 465 | 347 | 164 | 948 | (2,433 | ) | 320 | 204 | 116 | ||||||||||||||||||||||||||
BBB
|
245 | 197 | 118 | 93 | 608 | (961 | ) | 300 | 106 | 194 | ||||||||||||||||||||||||||
BB and lower
|
73 | 61 | 42 | 44 | 57 | (117 | ) | 160 | 255 | 0 | ||||||||||||||||||||||||||
Other
(2)
|
50 | 73 | 169 | 90 | 594 | (1,015 | ) | (39 | ) | 94 | 0 | |||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Sub-total
|
¥ | 1,572 | ¥ | 1,138 | ¥ | 803 | ¥ | 488 | ¥ | 2,699 | ¥ | (5,659 | ) | ¥ | 1,041 | ¥ | 732 | ¥ | 537 | |||||||||||||||||
Listed
|
453 | 74 | 7 | — | — | (355 | ) | 179 | 187 | 0 | ||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Total
|
¥ | 2,025 | ¥ | 1,212 | ¥ | 810 | ¥ | 488 | ¥ | 2,699 | ¥ | (6,014 | ) | ¥ | 1,220 | ¥ | 919 | ¥ | 537 | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
Represents netting of derivative liabilities against derivatives assets entered into with the same counterparty across different maturity bands. Derivative assets and derivative liabilities with the same counterparty in the same maturity band are net within the relevant maturity band. Cash collateral netting against net derivative assets in accordance with ASC
210-20
“
Balance Sheet—Offsetting
Derivatives and Hedging
|
(2) |
“Other” comprises unrated counterparties and certain portfolio level valuation adjustments not allocated to specific counterparties.
|
(3) |
Zero balances represent instances where total collateral received is in excess of the total fair value; therefore, Nomura’s credit exposure is zero.
|
Billions of Yen
|
||||
Top 10 Country Exposures
(1)
|
(As of March 31, 2021)
|
|||
United States
|
3,450 | |||
Japan
|
2,598 | |||
United Kingdom
|
747 | |||
Germany
|
394 | |||
France
|
252 | |||
China
|
250 | |||
Singapore
|
194 | |||
Canada
|
178 | |||
Luxembourg
|
171 | |||
India
|
153 |
(1) |
The table represents the Top 10 country exposures as of March 31, 2021 based on country of risk, combining counterparty and inventory exposures
|
- |
Counterparty exposures include cash and cash equivalents held at banks; the outstanding default fund and initial margin balances posted by Nomura to central clearing counterparties as legally required under its direct and affiliate clearing memberships; the aggregate
marked-to-market
|
- |
Inventory exposures are the market value of debt and equity securities, and equity and credit derivatives, using the net of long versus short positions.
|
1) |
1st Line of Defense: The business which owns and manages its risks
|
2) |
2nd Line of Defense: The Operational Risk Management (“ORM”) function, which
co-ordinates
the Operational Risk Management Framework and its implementation
|
3) |
3rd Line of Defense: Internal Audit, who provide independent assurance
|
• |
Policy framework: Sets standards for managing operational risk and details how to monitor adherence to these standards.
|
• |
Training and awareness: Action taken by ORM to improve business understanding of operational risk.
|
• |
Event Reporting: This process is used to identify and report any event which resulted in or had the potential to result in a loss or gain or other impact associated with inadequate or failed internal processes, people and systems, or from external events.
|
• |
Risk and Control Self-Assessment (“RCSA”): This process is used to identify the inherent risks the business faces, the key controls associated with those risks and relevant actions to mitigate the residual risks. Global ORM are responsible for developing the RCSA process and supporting the business in its implementation.
|
• |
Key Risk Indicators (“KRI”): KRIs are metrics used to monitor the business’ exposure to operational risk and trigger appropriate responses as thresholds are breached.
|
• |
Scenario Analysis: The process used to assess and quantify potential high impact, low likelihood operational risk events. During the process actions may be identified to enhance the control environment which are then tracked via the Operational Risk Management Framework.
|
• |
Analysis and reporting: A key aspect of ORM’s role is to analyze, report, and challenge operational risk information provided by business units, and work with business units to develop action plans to mitigate risks.
|
• |
Operational risk capital calculation: Calculate operational risk capital as required under applicable Basel standards and local regulatory requirements.
|
Business Line
|
Description
|
Beta Factor
|
||||
Retail Banking
|
Retail deposit and loan-related services | 12% | ||||
Commercial Banking
|
Deposit and loan-related services except for Retail Banking business | 15% | ||||
Payment and Settlement
|
Payment and settlement services for clients’ transactions | 18% | ||||
Retail Brokerage
|
Securities-related services mainly for individuals | 12% | ||||
Trading and Sales
|
Market-related business | 18% | ||||
Corporate Finance
|
M&A, underwriting, secondary and private offerings, and other funding services for clients | 18% | ||||
Agency Services
|
Agency services for clients such as custody | 15% | ||||
Asset Management
|
Fund management services for clients | 12% |
1) |
Transaction committees are in place to provide formal governance over the review and decision-making process for individual transactions.
|
2) |
The new product approval process allows business unit sponsors to submit applications for new products and obtain approval from relevant departments prior to execution of the new products. The process is designed to capture and assess risks across various risk classes as a result of the new product or business.
|
• |
Sensitivity analysis is used to quantify the impact of a market move in one or two associated risk factors (for example, equity prices, equity volatilities) in order primarily to capture those risks which may not be readily identified by other risk models;
|
• |
Scenario analysis is used to quantify the impact of a specified event across multiple asset classes and risk classes. This is a primary approach used in performing stress testing at the different hierarchical levels of the Nomura Group;
|
• |
Nomura Group establishes several stress scenarios to validate risk appetite for capital and liquidity soundness, taking into account the business environment, business’s risk profile, economic environment and forecasts.
|
• |
Group-wide stress to assess the capital adequacy of the Nomura Group under severe but plausible market scenarios is conducted on a quarterly basis at a minimum; and
|
• |
Reverse stress testing, a process of considering the vulnerabilities of the firm and hence how it may react to situations where it becomes difficult to continue its business, and reviewing the results of that analysis, is conducted on an annual basis at a minimum.
|
Type of Services:
|
Amount of Fee (U.S. Dollars)
|
|
Taxes and other governmental charges | As applicable. The depositary may offset any taxes or governmental charges it is obligated to withhold, if applicable, against the proceeds from sale of the property received. | |
Transfers of the Company’s shares to or from the name of the depositary (or its nominee) or the Custodian (or its nominee) in connection with deposits or withdrawals
|
Such registration fees as may be in effect for the registration of transfers of the Company’s shares on the Company’s share register (or any entity that presently carries out the duties of registrar). | |
Cable, telex and facsimile transmission expenses | As applicable. | |
Expenses incurred by the depositary in the conversion of foreign currency
|
As applicable. | |
Execution and delivery of Receipts in connection with deposits, stock splits or exercise of subscription rights
|
$5.00 or less per 100 ADSs (or portion thereof). | |
Surrender of Receipts in connection with a withdrawal or termination of the Deposit Agreement
|
$5.00 or less per 100 ADSs (or portion thereof). | |
Any cash distribution pursuant to the Deposit Agreement, including, but not limited to, cash distribution(s) made in connection with cash dividends; distributions in securities, property or subscription rights; and stock splits.
|
$.02 or less per ADS (or portion thereof). Only the cash amounts net of this fee, if applicable, are distributed. | |
Distribution by the depositary of securities (other than common shares of the Company) that accrued on the underlying shares to owners of the Receipts
|
Treating for the purpose of this fee all such securities as if they were common shares of the Company, $5.00 or less per 100 ADSs (or portion thereof). | |
General depositary services | $.02 or less per ADS (or portion thereof), accruing on the last day of each calendar year, except where the fee for cash distribution described above was assessed during that calendar year. | |
Any other charge payable by the depositary, any of the depositary’s agents, including the Custodian, or the agents of the depositary’s agents in connection with the servicing of the Company’s shares or other deposited securities
|
As applicable. |
Millions of yen
|
||||||||
Year ended March 31
|
||||||||
2020
|
2021
|
|||||||
Audit Fees
|
¥ | 3,409 | ¥ | 3,532 | ||||
Audit-Related Fees
|
136 | 144 | ||||||
Tax Fees
|
113 | 137 | ||||||
All Other Fees
|
7 | 26 | ||||||
|
|
|
|
|||||
Total
|
¥ | 3,665 | ¥ | 3,839 | ||||
|
|
|
|
Month
|
Total
Number of
Shares
Purchased
|
Average Price
Paid per
Share
(in yen)
|
Total
Number of
Shares
Purchased
as Part of
Publicly
Announced
Program
|
Maximum
Number of
Shares that
May Yet Be
Purchased
Under the
Program
|
||||||||||||
April 1 to 30, 2020
|
746 | ¥ | 424 | — | — | |||||||||||
May 1 to 31, 2020
|
403 | 428 | — | — | ||||||||||||
June 1 to 30, 2020
|
1,292 | 488 | — | — | ||||||||||||
July 1 to 31, 2020
|
1,847 | 488 | — | — | ||||||||||||
August 1 to 31, 2020
|
1,628 | 517 | — | — | ||||||||||||
September 1 to 30, 2020
|
1,147 | 537 | — | — | ||||||||||||
October 1 to 31, 2020
|
2,065 | 487 | — | — | ||||||||||||
November 1 to 30, 2020
|
1,114 | 500 | — | — | ||||||||||||
December 1 to 31, 2020
|
3,644 | 540 | — | — | ||||||||||||
January 1 to 31, 2021
|
2,418 | 566 | — | — | ||||||||||||
February 1 to 28, 2021
|
1,896 | 593 | — | — | ||||||||||||
March 1 to 31, 2021
|
1,929 | 660 | — | — | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total
|
20,129 | ¥ | 535 | — | — | |||||||||||
|
|
|
|
|
|
|
|
Corporate Governance Practices Followed
by NYSE-listed U.S. Companies
|
Corporate Governance Practices Followed by the Company
|
|
A NYSE-listed U.S. company must have a majority of Directors meeting the independence requirements under Section 303A of the NYSE Listed Company Manual. |
Under the Companies Act, a company which adopts the Company with Three Board Committees structure is not required to have a majority of outside directors, but is required to have a majority of outside directors on each of the audit, nomination and compensation committees.
The Company currently has eight outside directors among its twelve Directors.
|
|
A NYSE-listed U.S. company must have an audit committee that satisfies the requirements under Section 303A of the NYSE Listed Company Manual, including those imposed by Rule
10A-3
under the U.S. Securities Exchange Act of 1934. The audit committee must be composed entirely of independent directors and have at least three members.
|
The Company has an Audit Committee consisting of three Directors, two of whom are outside directors in compliance with the requirements under the Companies Act. All three Audit Committee members are independent directors under Rule
10A-3
under the U.S. Securities Exchange Act of 1934 with one member qualified as audit committee financial expert.
|
|
A NYSE-listed U.S. company must have a nominating/corporate governance committee with responsibilities described under Section 303A of the NYSE Listed Company Manual. The nominating/corporate governance committee must be composed entirely of independent directors. | The Company has a Nomination Committee consisting of three Directors, two of whom are outside directors and the chairman is an outside director in compliance with the requirements under the Companies Act. | |
A NYSE-listed U.S. company must have a compensation committee composed entirely of independent directors. Compensation committee members must satisfy the additional independence requirements under Section 303A.02(a)(ii) of the NYSE Listed Company Manual. A compensation committee must also have authority to retain or obtain the advice of compensation and other advisers, subject to prescribed independence criteria that the committee must consider prior to engaging any such adviser. | The Company has a Compensation Committee consisting of three Directors, two of whom are outside directors and the chairman is an outside director in compliance with the requirements under the Companies Act. | |
A NYSE-listed U.S. company must generally obtain shareholder approval with respect to any equity compensation plan. | Under the Companies Act, Restricted Stock Unit (“RSU”) and Stock Acquisition Right (“SAR”) awards are deemed to be compensation for the services performed by the Company’s Directors and Executive Officers and do not require shareholders’ approval. The Compensation Committee establishes the policy with respect to the determination of the individual compensation of each of the Company’s Directors and Executive Officers (including RSU and SAR awards as equity compensation) and makes determinations in accordance with that compensation policy. |
Corporate Governance Practices Followed
by NYSE-listed U.S. Companies
|
Corporate Governance Practices Followed by the Company
|
|
A NYSE-listed U.S. company must adopt and disclose corporate governance guidelines. | Under the Companies Act, the Company is not required to adopt and disclose corporate governance guidelines. However, in response to Japan’s Corporate Governance Code, which was incorporated into the Tokyo Stock Exchange’s Securities Listing Regulations, the Company has established and publicly disclosed the “Nomura Holdings Corporate Governance Guidelines.” | |
The
non-management
directors of a NYSE-listed U.S. company must meet at regularly scheduled executive sessions without management.
|
Under the Companies Act, outside directors of the Company are not required to meet at regularly scheduled executive sessions without management. However, in accordance with the “Nomura Holdings Corporate Governance Guidelines,” outside directors hold meetings consisting solely of outside directors in order to discuss matters such as the business and corporate governance of the Company. | |
A NYSE-listed U.S. company must adopt and disclose a code of business conduct and ethics for directors, officers and employees, and promptly disclose any waivers of the code for directors or executive officers. | Under the Companies Act, the Company is not required to adopt and disclose a code of business conduct and ethics for directors, officers or employees. However, the Company has adopted the “Nomura Group Code of Conduct” Please see Item 16B of this annual report for further information regarding the “Nomura Group Code of Conduct.” |
Exhibit
Number |
Description
|
|
1.1 |
Articles of Incorporation of Nomura Holdings, Inc. (English translation) (filed on June 25, 2015 as an exhibit to the Annual Report on Form
20-F
(File
No. 001-15270)
and incorporated herein by reference)
|
|
1.2 |
Share Handling Regulations of Nomura Holdings, Inc. (English translation) (filed on June 25, 2015 as an exhibit to the Annual Report on Form
20-F
(File
No. 001-15270)
and incorporated herein by reference)
|
|
1.3 |
Regulations of the Board of Directors of Nomura Holdings, Inc. (English translation)
|
|
1.4 |
Regulations of the Nomination Committee of Nomura Holdings, Inc. (English translation) (filed on June 23, 2016 as an exhibit to the Annual Report on Form
20-F
(File
No. 001-15270)
and incorporated herein by reference)
|
|
1.5 |
Regulations of the Audit Committee of Nomura Holdings, Inc. (English translation)
|
|
1.6 |
Regulations of the Compensation Committee of Nomura Holdings, Inc. (English translation) (filed on June 27, 2012 as an exhibit to the Annual Report on Form
20-F
(File
No. 001-15270)
and incorporated herein by reference)
|
|
2.1 |
Form of Deposit Agreement among Nomura Holdings, Inc., The Bank of New York Mellon as depositary and all owners and holders from time to time of American Depositary Receipts, including the form of American Depositary Receipt (filed on April 28, 2010 as an exhibit to the Registration Statement on
Form F-6
(File No. 333-166346)
and incorporated herein by reference)
|
|
2.2 |
Description of rights of each class of securities registered under Section 12 of the Securities Exchange Act of 1934 (filed on June 25, 2019 as an exhibit to the Annual Report on Form
20-F
(File
No. 001-15270)
and incorporated herein by reference)
|
|
4.1 |
Form of Limitation of Liability Agreement
(1)
|
|
8.1 |
Subsidiaries of Nomura Holdings, Inc.—See Item 4.C. “
Organizational Structure
|
|
11.1 |
Nomura Group Code of Conduct 2021 (English translation)
|
|
11.2 |
Nomura Group Code of Ethics for Financial Professionals (English translation) (filed on June 30, 2020 as an exhibit to the Annual Report on Form
20-F
(File
No. 001-15270)
and incorporated herein by reference)
|
|
12.1 |
Certification of the principal executive officer required by 17 C.F.R. 240.
13a-14(a)
|
|
12.2 |
Certification of the principal financial officer required by 17 C.F.R. 240.
13a-14(a)
|
|
13.1 |
Certification of the chief executive officer required by 18 U.S.C. Section 1350
|
|
13.2 |
Certification of the chief financial officer required by 18 U.S.C. Section 1350
|
|
15.1 |
Consent of Ernst & Young ShinNihon LLC with respect to its report on the audit of the financial statements included in this annual report
|
|
17.1 |
Subsidiary Issuer of Registered Guaranteed Securities
|
|
101.INS |
Inline XBRL Instance Document—the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document
|
|
101.SCH |
Inline XBRL Taxonomy Extension Schema Document
|
|
101.CAL |
Inline XBRL Taxonomy Extension Calculation Linkbase Document
|
|
101.DEF |
Inline XBRL Taxonomy Extension Definition Linkbase Document
|
|
101.LAB |
Inline XBRL Taxonomy Extension Label Linkbase Document
|
|
101.PRE |
Inline XBRL Taxonomy Extension Presentation Linkbase Document
|
|
104 |
The cover page for the Company’s Annual Report on Form 20-F for the year ended March 31, 2021, has been formatted in Inline XBRL
|
(1) |
The Company has entered into Limitation of Liability Agreements substantially in the form of this exhibit with all of its directors and director Shoji Ogawa.
|
Page
|
||||
Consolidated Financial Statements of Nomura Holdings, Inc.:
|
||||
F-2
|
||||
F-6
|
||||
F-9
|
||||
F-10
|
||||
F-11
|
||||
F-13
|
||||
F-15
|
Fair value of less liquid financial instruments
|
||
Description of the Matter
|
The Company holds investment positions in the fixed income and equity markets both for trading and customer facilitation. The Company had JPY 835 billion and JPY 963 billion of financial instruments assets and liabilities, respectively, categorized within Level 3 of the fair value hierarchy. In determining the fair value of these financial instruments, the Company used unobservable valuation inputs which reflect their assumptions and specific data. These inputs are significant to the fair value of the financial instruments and are supported by little or no market activity as of March 31, 2021. The methodologies applied by management to determine the fair value of such instruments are described in Note 2 to the consolidated financial statements.
Auditing the fair value of the Company’s Level 3 financial instruments was complex and highly judgmental due to the subjectivity of the judgments used and estimations made by management in determining the fair value for these financial instruments especially considering the impact of
COVID-19
on global financial markets. In particular, to value certain financial instruments, management used a variety of valuation techniques which involved certain underlying assumptions and significant unobservable valuation inputs, including WACC, growth rates, liquidity discounts, market multiples including EV/ EBITDA ratios, volatilities and correlations which are significant to the value of these investments.
|
|
How We Addressed the Matter in Our Audit
|
We obtained an understanding, evaluated the design and tested the operating effectiveness of controls that address the risk of material misstatement relating to management’s assessment of the significant inputs and estimates included in fair value measurement. This included the testing of model validation controls by various departments within the Company.
Our audit procedures to evaluate the valuation methodologies used by the Company included, among others, testing significant unobservable inputs, estimates and the mathematical accuracy of the Company’s valuation models. We independently developed fair value estimates and compared them to the Company’s results, and involved our valuation specialists to assist with the application of these procedures, on a sample basis. We also agreed significant inputs and underlying data used in the Company’s valuations to agreements, information available from third party sources and market data, where available. We evaluated subsequent transactions and considered whether they corroborate or contradict the Company’s
year-end
valuations.
|
|
Provisions for investigations, lawsuits and other legal proceedings
|
||
Description of the Matter
|
As disclosed in Note 21 to the consolidated financial statements, the Company is involved in investigations, lawsuits and other legal proceedings. As of March 31, 2021, the Company has recorded litigation provision of JPY 62,889 million and for those cases where an estimate of the range of reasonably possible losses can be made, the Company estimates that the total aggregate reasonably possible maximum loss in excess of amounts recognized as a liability (if any) against these cases is approximately JPY 48 billion. Legal expenses of JPY 41,131 million were recorded for the year ended March 31, 2021.
The Company recognizes a liability for those contingencies for which it is probable that a liability has been incurred at the date of the consolidated financial statements and the amount is reasonably estimable. As part of this, management performs an assessment of the materiality of contingencies where a loss is either reasonably possible or it is reasonably possible that an exposure to loss exists in excess of the amount accrued. If it is reasonably possible that such a loss or an additional loss may have been incurred and the effect on the consolidated financial statements is material, the Company discloses the nature of the loss contingency and an estimate of the possible loss or range of loss or a statement that such an estimate cannot be made within the notes to the consolidated financial statements.
|
|
Auditing management’s determination of whether a loss contingency is probable and reasonably estimable, reasonably possible or remote, and the related disclosures, is highly subjective, complex and requires significant judgment. Management judgment is needed to determine whether an obligation exists and a loss contingency should be recorded at March 31, 2021. This includes judgment in the determination of whether an outflow in respect of identified loss contingency is probable and can be estimated reliably. In addition, management judgment is needed to determine if an estimated loss is only reasonably possible rather than probable.
|
|
How We Addressed the Matter in Our Audit
|
We obtained an understanding, evaluated the design and tested the operating effectiveness of controls that address the risks of material misstatement relating to management’s assessment for timely identification of contingencies that may arise out of lawsuits and regulatory investigations including the Company’s assessment of whether they are probable or reasonably possible and the associated measurement of the best estimate.
Our audit procedures to test the assessment of the probability of incurrence of a loss and whether the loss was reasonably estimable included, among others, reading the minutes of the meetings of the Board of Directors and Executive Management Board, and reading relevant regulatory and legal correspondence to assess developments in significant matters, requesting and receiving external legal counsel confirmation letters, meeting with internal and external legal counsel to discuss the allegations, and obtaining a representation letter from the Company’s management. In addition, our audit procedures to test the measurement of the loss contingency and the disclosure of the reasonably possible additional loss in excess of amounts recognized as a liability included, among others, evaluating the method of measuring the contingency, testing the accuracy and completeness of the underlying data, reading correspondence received from internal and external counsel used to determine a range of reasonably possible loss and performing a search for new or contrary evidence affecting the estimate.
|
Millions of yen
|
||||||||
March 31
|
||||||||
2020
|
2021
|
|||||||
ASSETS
|
||||||||
Cash and cash deposits:
|
||||||||
Cash and cash equivalents
|
¥ |
|
¥ |
|
||||
Time deposits
|
|
|
||||||
Deposits with stock exchanges and other segregated cash
|
|
|
||||||
|
|
|
|
|||||
Total cash and cash deposits
|
|
|
||||||
|
|
|
|
|||||
Loans and receivables:
|
||||||||
Loans receivable (including ¥
|
|
|
||||||
Receivables from customers (including ¥
|
|
|
||||||
Receivables from other than customers
|
|
|
||||||
Allowance for doubtful accounts
|
(
|
) |
(
|
) | ||||
|
|
|
|
|||||
Total loans and receivables
|
|
|
||||||
|
|
|
|
|||||
Collateralized agreements:
|
||||||||
Securities purchased under agreements to resell (including ¥
|
|
|
||||||
Securities borrowed
|
|
|
||||||
|
|
|
|
|||||
Total collateralized agreements
|
|
|
||||||
|
|
|
|
|||||
Trading assets and private equity and debt investments:
|
||||||||
Trading assets (including securities pledged as collateral of ¥
|
|
|
||||||
Private equity and debt investments (including ¥
|
|
|
||||||
|
|
|
|
|||||
Total trading assets and private equity and debt investments
|
|
|
||||||
|
|
|
|
|||||
Other assets:
|
||||||||
Office buildings, land, equipment and facilities (net of accumulated depreciation and amortization of ¥
|
|
|
||||||
Non-trading
debt securities (including securities pledged as collateral
of ¥
¥
million as of March 31, 2020 and March 31, 2021, respectively)
|
|
|
||||||
Investments in equity securities
|
|
|
||||||
Investments in and advances to affiliated companies
|
|
|
||||||
Other (including ¥
|
|
|
||||||
|
|
|
|
|||||
Total other assets
|
|
|
||||||
|
|
|
|
|||||
Total assets
|
¥ |
|
¥ |
|
||||
|
|
|
|
Millions of yen
|
||||||||
March 31
|
||||||||
2020
|
2021
|
|||||||
LIABILITIES AND EQUITY
|
||||||||
Short-term borrowings (including ¥
|
¥ |
|
¥ |
|
||||
Payables and deposits:
|
||||||||
Payables to customers
|
|
|
||||||
Payables to other than customers
|
|
|
||||||
Deposits received at banks (including ¥
|
|
|
||||||
|
|
|
|
|||||
Total payables and deposits
|
|
|
||||||
|
|
|
|
|||||
Collateralized financing:
|
||||||||
Securities sold under agreements to repurchase (including ¥
|
|
|
||||||
Securities loaned (including ¥
|
|
|
||||||
Other secured borrowings
|
|
|
||||||
|
|
|
|
|||||
Total collateralized financing
|
|
|
||||||
|
|
|
|
|||||
Trading liabilities
|
|
|
||||||
Other liabilities (including ¥
|
|
|
||||||
Long-term borrowings (including ¥
|
|
|
||||||
|
|
|
|
|||||
Total liabilities
|
|
|
||||||
|
|
|
|
|||||
Commitments and contingencies (Note 21)
|
|
|
||||||
Equity:
|
||||||||
Nomura Holdings, Inc. (“NHI”) shareholders’ equity:
|
||||||||
Common stock
|
||||||||
No par value shares;
Authorized— Issued— Outstanding— |
|
|
||||||
Additional
paid-in
capital
|
|
|
||||||
Retained earnings
|
|
|
||||||
Accumulated other comprehensive income
|
(
|
) |
(
|
) | ||||
|
|
|
|
|||||
Total NHI shareholders’ equity before treasury stock
|
|
|
||||||
Common stock held in treasury, at cost—
|
(
|
) |
(
|
) | ||||
|
|
|
|
|||||
Total NHI shareholders’ equity
|
|
|
||||||
|
|
|
|
|||||
Noncontrolling interests
|
|
|
||||||
Total equity
|
|
|
||||||
|
|
|
|
|||||
Total liabilities and equity
|
¥ |
|
¥ |
|
||||
|
|
|
|
Billions of yen
|
||||||||
March 31
|
||||||||
2020
|
2021
|
|||||||
Cash and cash deposits
|
¥ |
|
¥ |
|
||||
Trading assets and private equity and debt investments
|
|
|
||||||
Other assets
|
|
|
||||||
|
|
|
|
|||||
Total assets
|
¥ |
|
¥ |
|
||||
|
|
|
|
|||||
Trading liabilities
|
¥ |
|
¥ |
|
||||
Other liabilities
|
|
|
||||||
Borrowings
|
|
|
||||||
|
|
|
|
|||||
Total liabilities
|
¥ |
|
¥ |
|
||||
|
|
|
|
Millions of yen
|
||||||||||||
Year ended March 31
|
||||||||||||
2019
|
2020
|
2021
|
||||||||||
Revenue:
|
||||||||||||
Commissions
|
¥
|
|
|
¥
|
|
|
¥
|
|
|
|||
Fees from investment banking
|
|
|
|
|
|
|
|
|
|
|||
Asset management and portfolio service fees
|
|
|
|
|
|
|
|
|
|
|||
Net gain on trading
|
|
|
|
|
|
|
|
|
|
|||
Gain (loss) on private equity and debt investments
|
|
|
|
|
(
|
)
|
|
|
|
|||
Interest and dividends
|
|
|
|
|
|
|
|
|
|
|||
Gain (loss) on investments in equity securities
|
|
(
|
)
|
|
(
|
)
|
|
|
|
|||
Other
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|||||||
Total revenue
|
|
|
|
|
|
|
|
|
|
|||
Interest expense
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|||||||
Net revenue
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|||||||
Non-interest
expenses:
|
||||||||||||
Compensation and benefits
|
|
|
|
|
|
|
|
|
|
|||
Commissions and floor brokerage
|
|
|
|
|
|
|
|
|
|
|||
Information processing and communications
|
|
|
|
|
|
|
|
|
|
|||
Occupancy and related depreciation
|
|
|
|
|
|
|
|
|
|
|||
Business development expenses
|
|
|
|
|
|
|
|
|
|
|||
Other
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|||||||
Total
non-interest
expenses
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|||||||
Income (loss) before income taxes
|
|
(
|
)
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|||||||
Income tax expense
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|||||||
Net income (loss)
|
¥
|
(
|
)
|
¥
|
|
|
¥
|
|
|
|||
|
|
|
|
|
|
|||||||
Less: Net income attributable to noncontrolling interests
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|||||||
Net income (loss) attributable to NHI shareholders
|
¥
|
(
|
)
|
¥
|
|
|
¥
|
|
|
|||
|
|
|
|
|
|
|||||||
Yen
|
||||||||||||
Per share of common stock:
|
||||||||||||
Basic
—
|
||||||||||||
Net income (loss) attributable to NHI shareholders per share
|
¥
|
(
|
)
|
¥
|
|
|
¥
|
|
|
|||
|
|
|
|
|
|
|||||||
Diluted
—
|
||||||||||||
Net income (loss) attributable to NHI shareholders per share
|
¥
|
(
|
)
|
¥
|
|
|
¥
|
|
|
|||
|
|
|
|
|
|
Millions of yen
|
||||||||||||
Year ended March 31
|
||||||||||||
2019
|
2020
|
2021
|
||||||||||
Net income (loss)
|
¥
|
(
|
)
|
¥
|
|
|
¥
|
|
|
|||
Other comprehensive income (loss):
|
||||||||||||
Change in cumulative translation adjustments:
|
||||||||||||
Change in cumulative translation adjustments
|
|
|
|
|
(
|
)
|
|
|
|
|||
Deferred income taxes
|
|
(
|
)
|
|
|
|
|
(
|
)
|
|||
|
|
|
|
|
|
|||||||
Total
|
|
|
|
|
(
|
)
|
|
|
|
|||
|
|
|
|
|
|
|||||||
Defined benefit pension plans:
|
||||||||||||
Pension liability adjustment
|
|
(
|
)
|
|
|
|
|
|
|
|||
Deferred income taxes
|
|
|
|
|
|
|
|
(
|
)
|
|||
|
|
|
|
|
|
|||||||
Total
|
|
(
|
)
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|||||||
Own credit adjustments:
|
||||||||||||
Own credit adjustments
|
|
|
|
|
|
|
|
(
|
)
|
|||
Deferred income taxes
|
|
(
|
)
|
|
(
|
)
|
|
|
|
|||
|
|
|
|
|
|
|||||||
Total
|
|
|
|
|
|
|
|
(
|
)
|
|||
|
|
|
|
|
|
|||||||
Total other comprehensive income (loss)
|
|
|
|
|
|
|
|
(
|
)
|
|||
|
|
|
|
|
|
|||||||
Comprehensive income (loss)
|
|
(
|
)
|
|
|
|
|
|
|
|||
Less: Comprehensive income attributable to noncontrolling interests
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|||||||
Comprehensive income (loss) attributable to NHI shareholders
|
¥
|
(
|
)
|
¥
|
|
|
¥
|
|
|
|||
|
|
|
|
|
|
Millions of yen
|
||||||||||||
Year ended March 31
|
||||||||||||
2019
|
2020
|
2021
|
||||||||||
Common stock
|
||||||||||||
Balance at beginning of year
|
¥
|
|
|
¥
|
|
|
¥
|
|
|
|||
|
|
|
|
|
|
|||||||
Balance at end of year
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|||||||
Additional
paid-in
capital
|
||||||||||||
Balance at beginning of year
|
|
|
|
|
|
|
|
|
|
|||
Stock-based compensation awards
|
|
|
|
|
(
|
)
|
|
|
|
|||
Changes in ownership interests in subsidiaries
|
|
|
|
|
(
|
)
|
|
|
|
|||
Changes in an affiliated company’s interests in its subsidiary
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|||||||
Balance at end of year
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|||||||
Retained earnings
|
||||||||||||
Balance at beginning of year
|
|
|
|
|
|
|
|
|
|
|||
Cumulative effect of change in accounting principle
(1)
|
|
|
|
|
|
|
|
(
|
)
|
|||
Net income (loss) attributable to NHI shareholders
|
|
(
|
)
|
|
|
|
|
|
|
|||
Cash dividends
|
|
(
|
)
|
|
(
|
)
|
|
(
|
)
|
|||
Gain (loss) on sales of treasury stock
|
|
(
|
)
|
|
(
|
)
|
|
(
|
)
|
|||
Cancellation of treasury stock
|
|
(
|
)
|
|
|
|
|
(
|
)
|
|||
|
|
|
|
|
|
|||||||
Balance at end of year
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|||||||
Accumulated other comprehensive income (loss)
|
||||||||||||
Cumulative translation adjustments
|
||||||||||||
Balance at beginning of year
|
|
(
|
)
|
|
|
|
|
(
|
)
|
|||
Net change during the year
|
|
|
|
|
(
|
)
|
|
|
|
|||
|
|
|
|
|
|
|||||||
Balance at end of year
|
|
|
|
|
(
|
)
|
|
|
|
|||
|
|
|
|
|
|
|||||||
Defined benefit pension plans
|
||||||||||||
Balance at beginning of year
|
|
(
|
)
|
|
(
|
)
|
|
(
|
)
|
|||
Pension liability adjustment
|
|
(
|
)
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|||||||
Balance at end of year
|
|
(
|
)
|
|
(
|
)
|
|
(
|
)
|
|||
|
|
|
|
|
|
|||||||
Own credit adjustments
|
||||||||||||
Balance at beginning of year
|
|
|
|
|
|
|
|
|
|
|||
Own credit adjustments
|
|
|
|
|
|
|
|
(
|
)
|
|||
|
|
|
|
|
|
|||||||
Balance at end of year
|
|
|
|
|
|
|
|
(
|
)
|
|||
|
|
|
|
|
|
|||||||
Balance at end of year
|
|
(
|
)
|
|
(
|
)
|
|
(
|
)
|
|||
|
|
|
|
|
|
(1) |
Represents the adjustment to initially apply Accounting Standards Update (“ASU”)
2014-09,
“
Revenue from Contracts with Customers
2016-02,
“
Leases
2016-13,
“
Measurement of Credit Losses on Financial Instruments
|
Millions of yen
|
||||||||||||
Year ended March 31
|
||||||||||||
2019
|
2020
|
2021
|
||||||||||
Common stock held in treasury
|
||||||||||||
Balance at beginning of year
|
|
(
|
)
|
|
(
|
)
|
|
(
|
)
|
|||
Repurchases of common stock
|
|
(
|
)
|
|
(
|
)
|
|
(
|
)
|
|||
Sales of common stock
|
|
|
|
|
|
|
|
|
|
|||
Common stock issued to employees
|
|
|
|
|
|
|
|
|
|
|||
Cancellation of treasury stock
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|||||||
Balance at end of year
|
|
(
|
)
|
|
(
|
)
|
|
(
|
)
|
|||
|
|
|
|
|
|
|||||||
Total NHI shareholders’ equity
|
||||||||||||
Balance at end of year
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|||||||
Noncontrolling interests
|
||||||||||||
Balance at beginning of year
|
|
|
|
|
|
|
|
|
|
|||
Cash dividends
|
|
(
|
)
|
|
(
|
)
|
|
(
|
)
|
|||
Net income attributable to noncontrolling interests
|
|
|
|
|
|
|
|
|
|
|||
Accumulated other comprehensive income (loss) attributable to noncontrolling interests
|
||||||||||||
Cumulative translation adjustments
|
|
|
|
|
(
|
)
|
|
|
|
|||
Purchase/sale (disposition) of subsidiary shares, etc., net
|
|
|
|
|
|
|
|
|
|
|||
Other net change in noncontrolling interests
|
|
(
|
)
|
|
|
|
|
(
|
)
|
|||
|
|
|
|
|
|
|||||||
Balance at end of year
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|||||||
Total equity
|
||||||||||||
Balance at end of year
|
¥
|
|
|
¥
|
|
|
¥
|
|
|
|||
|
|
|
|
|
|
Millions of yen
|
||||||||||||
Year ended March 31
|
||||||||||||
2019
|
2020
|
2021
|
||||||||||
Cash flows from operating activities:
|
||||||||||||
Net income (loss)
|
¥
|
(
|
)
|
¥
|
|
|
¥
|
|
|
|||
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
|
||||||||||||
Depreciation and amortization
|
|
|
|
|
|
|
|
|
|
|||
Impairment of goodwill
|
|
|
|
|
|
|
|
—
|
|
|||
Stock-based compensation
|
|
|
|
|
|
|
|
|
|
|||
(Gain) loss on investments in equity securities
|
|
|
|
|
|
|
|
(
|
)
|
|||
(Gain) loss on investments in subsidiaries and affiliates
|
|
|
|
|
(
|
)
|
|
|
|
|||
Equity in earnings of affiliates, net of dividends received
|
|
(
|
)
|
|
(
|
)
|
|
(
|
)
|
|||
(
Loss on disposal of office buildings, land, equipment and facilities
Gain)
|
|
|
|
|
(
|
)
|
|
(
|
)
|
|||
Deferred income taxes
|
|
|
|
|
(
|
)
|
|
(
|
)
|
|||
Changes in operating assets and liabilities:
|
||||||||||||
Time deposits
|
|
|
|
|
(
|
)
|
|
|
|
|||
Deposits with stock exchanges and other segregated cash
|
|
|
|
|
(
|
)
|
|
|
|
|||
Trading assets and private equity and debt investments
|
|
|
|
|
(
|
)
|
|
|
|
|||
Trading liabilities
|
|
(
|
)
|
|
|
|
|
|
|
|||
Securities purchased under agreements to resell, net of securities sold under agreements to repurchase
|
|
(
|
)
|
|
|
|
|
(
|
)
|
|||
Securities borrowed, net of securities loaned
|
|
|
|
|
|
|
|
(
|
)
|
|||
Other secured borrowings
|
|
|
|
|
|
|
|
(
|
)
|
|||
Loans and receivables, net of allowance for doubtful accounts
|
|
|
|
|
(
|
)
|
|
|
|
|||
Payables
|
|
(
|
)
|
|
|
|
|
(
|
)
|
|||
Bonus accrual
|
|
(
|
)
|
|
|
|
|
|
|
|||
Accrued income taxes, net
|
|
|
|
|
(
|
)
|
|
|
|
|||
Other, net
|
|
(
|
)
|
|
(
|
)
|
|
|
|
|||
|
|
|
|
|
|
|||||||
Net cash provided by (used in) operating activities
|
|
(
|
)
|
|
(
|
)
|
|
|
|
|||
|
|
|
|
|
|
|||||||
Cash flows from investing activities:
|
||||||||||||
Payments for purchases of office buildings, land, equipment and facilities
|
|
(
|
)
|
|
(
|
)
|
|
(
|
)
|
|||
Proceeds from sales of office buildings, land, equipment and facilities
|
|
|
|
|
|
|
|
|
|
|||
Proceeds from sales of investments in equity securities
|
|
|
|
|
|
|
|
|
|
|||
Decrease (increase) in loans receivable at banks, net
|
|
(
|
)
|
|
|
|
|
(
|
)
|
|||
Decrease (increase) in
non-trading
debt securities, net
|
|
|
|
|
(
|
)
|
|
|
|
|||
Business combinations or disposals, net
|
|
|
|
|
(
|
)
|
|
(
|
)
|
|||
Decrease (increase) in investments in affiliated companies, net
|
|
(
|
)
|
|
|
|
|
(
|
)
|
|||
Other, net
|
|
(
|
)
|
|
|
|
|
(
|
)
|
|||
|
|
|
|
|
|
|||||||
Net cash provided by (used in) investing activities
|
|
(
|
)
|
|
|
|
|
(
|
)
|
|||
|
|
|
|
|
|
|||||||
Cash flows from financing activities:
|
||||||||||||
Increase in long-term borrowings
|
|
|
|
|
|
|
|
|
|
|||
Decrease in long-term borrowings
|
|
(
|
)
|
|
(
|
)
|
|
(
|
)
|
|||
Increase (decrease) in short-term borrowings, net
|
|
|
|
|
|
|
|
(
|
)
|
|||
Increase (decrease) in deposits received at banks, net
|
|
|
|
|
(
|
)
|
|
|
|
|||
Proceeds from sales of common stock held in treasury
|
|
|
|
|
|
|
|
|
|
|||
Payments for repurchases of common stock held in treasury
|
|
(
|
)
|
|
(
|
)
|
|
(
|
)
|
|||
Payments for cash dividends
|
|
(
|
)
|
|
(
|
)
|
|
(
|
)
|
|||
Contribution from noncontrolling interests
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|||||||
Net cash provided by (used in) financing activities
|
|
|
|
|
|
|
|
(
|
)
|
|||
|
|
|
|
|
|
|||||||
Effect of exchange rate changes on cash, cash equivalents, restricted cash and restricted cash equivalents
|
|
|
|
|
(
|
)
|
|
|
|
|||
|
|
|
|
|
|
|||||||
Net increase in cash, cash equivalents, restricted cash and restricted cash equivalents
|
|
|
|
|
|
|
|
|
|
|||
Cash, cash equivalents, restricted cash and restricted cash equivalents at beginning of year
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|||||||
Cash, cash equivalents, restricted cash and restricted cash equivalents at end of year
|
¥
|
|
|
¥
|
|
|
¥
|
|
|
|||
|
|
|
|
|
|
|||||||
Supplemental information:
|
||||||||||||
Cash paid during the year for
—
|
||||||||||||
Interest
|
¥
|
|
|
¥
|
|
|
¥
|
|
|
|||
|
|
|
|
|
|
|||||||
Income tax payments, net
|
¥
|
|
|
¥
|
|
|
¥
|
|
|
|||
|
|
|
|
|
|
Millions of yen
|
||||||||||||
Year ended March 31
|
||||||||||||
2019
|
2020
|
2021
|
||||||||||
Cash and cash equivalents reported in
Cash and cash equivalents
|
¥
|
|
|
¥
|
|
|
¥
|
|
|
|||
Restricted cash and restricted cash equivalents reported in
Deposits with stock exchanges and other segregated cash
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|||||||
Total cash, cash equivalent, restricted cash and restricted cash equivalents
|
¥
|
|
|
¥
|
|
|
¥
|
|
|
|||
|
|
|
|
|
|
Millions of yen
|
||||||||
March 31
|
||||||||
2020
|
2021
|
|||||||
Land
|
¥ |
|
¥ |
|
||||
Office buildings
|
|
|
||||||
Equipment and facilities
|
|
|
||||||
Software
|
|
|
||||||
Construction in progress
|
|
|
||||||
Operating lease ROU assets
|
|
|
||||||
|
|
|
|
|||||
Total
|
¥ |
|
¥ |
|
||||
|
|
|
|
Office buildings
|
|
|||
Equipment and facilities
|
|
|||
Software
|
|
Pronouncement
|
|
Summary of new guidance
|
|
Adoption
date and method of adoption |
|
Effect on these
consolidated statements |
ASU 2016-13, “
Measurement of Credit Losses on Financial Instruments
(1)
|
|
• Introduces a new model for recognition and measurement of credit losses against certain financial instruments such as loans, debt securities and receivables which are not carried at fair value with changes in fair value recognized through earnings. The model also applies to off balance sheet credit exposures such as written loan commitments, standby letters of credit and issued financial guarantees not accounted for as insurance, which are not carried at fair value through earnings.
• The new model based on lifetime current expected credit losses (CECL) measurement, to be recognized at the time an in-scope instrument is originated, acquired or issued.
• Replaces existing incurred credit losses model under current GAAP.
• Permits electing the fair value option for certain financial instruments on adoption date.
• Requires enhanced qualitative and quantitative disclosures around credit risk, the methodology used to estimate and monitor expected credit losses and changes in estimates of expected credit losses.
|
|
Modified retrospective adoption from April 1, 2020.
|
|
For financial instruments subject to CECL, ¥
Allowance for doubtful accounts
Other liabilities
Deferred tax assets
Retained earnings
For financial instruments elected for the FVO, ¥
Loans receivable
Other liabilities
Retained earnings
(2)
Allowances for credit losses as determined on adoption date under the new model increased as a result of the COVID-19 pandemic because of the increased credit risk caused by the impact of the pandemic on borrowers.
See Note 7 “
Financing receivables
|
Pronouncement
|
Summary of new guidance
|
Adoption date and
method of adoption |
Effect on these
consolidated statements |
|||
ASU
2019-12,
“
Simplifying the Accounting for Income Taxes
|
• Simplifies the accounting for income taxes by removing certain exceptions to the general principles in ASC 740
“Income Taxes”
• Requires an entity to recognize a franchise tax (or similar tax) that is partially based on income as an income-based tax and account for any incremental amount incurred as a
non-income—based
tax.
• Makes other minor amendments for simplification and clarification of income taxes accounting.
|
Modified retrospective adoption from April 1, 2020. | No material impact on adoption and no material impact expected in future reporting periods. | |||
ASU 2017- 04
“
Goodwill
|
• Simplifies the test for goodwill impairment by eliminating the existing requirement to measure an impairment loss by comparing the implied fair value of goodwill in a reporting unit to the actual carrying value of goodwill.
• An impairment loss will be recognized if the carrying value of the reporting unit exceeds the estimated fair value of the reporting unit.
|
Prospective adoption to goodwill tests performed from April 1, 2020. | No material impact expected on future goodwill impairment tests. |
Pronouncement
|
Summary of new guidance
|
Adoption date and
method of adoption |
Effect on these
consolidated statements |
|||
• Requires to consider income tax effects from any tax deductible goodwill on the carrying value of the reporting unit when measuring an impairment loss.
• Does not impact when goodwill is tested for impairment or level at which goodwill is tested.
|
||||||
ASU
2020-04
“
Reference rate reform
|
• Provides temporary optional expedients and exceptions to the application of generally accepted accounting principles to certain contract and hedge relationships affected by reference rate reform.
• Contract modifications solely related to the replacement of reference rate are eligible for relief from modification accounting requirements and accounted for as a continuation of the existing contract.
• Allows various optional expedients and elections to allow hedging relationships affected by reference rate reform would continue uninterrupted during the reference rate transition if certain criteria are met.
|
The expedients and exceptions provided by the ASU are permitted to be adopted any time until December 31, 2022. |
No material expedients have been applied for the year ended March 31, 2021.
Nomura may apply certain of the optional expedients to relevant contract modification and hedge accounting relationship during the reference rate transition period and does not expect a material impact in future reporting periods.
|
(1) |
As subsequently amended by ASU
2018-19
“
Codification Improvements to Topic 326, Financial Instruments—Credit Losses
2019-04
“
Codification Improvements to Topic 326, Financial Instruments—Credit Losses, Topic 815, Derivatives and Hedging, and Topic 825, Financial Instruments
2019-05
“
Financial Instruments—Credit Losses (Topic 326): Targeted Transition Relief
ASU 2019-09
“
Codification Improvements to Topic 326, Financial Instruments—Credit Losses
ASU 2019-10
“
Financial Instruments—Credit Losses (Topic 326), Derivatives and Hedging (Topic 815), and Leases (Topic 842): Effective Dates.
|
(2) |
Nomura elected the FVO for certain loans and loan commitments originated and acquired by the Wholesale division on April 1, 2020 as part of adoption of ASC 326 and as permitted by ASC 326. These loans and loan commitments were primarily elected for the FVO in order to actively risk manage them on a prospective basis through the
COVID-19
global pandemic. Active risk management for this purpose has consisted of hedging these financial instruments and also potentially selling certain positions within the
|
portfolio if and when active markets and buyers return. The financial instruments elected for the FVO were selected primarily based on the activity of the borrower, internal credit rating and from a credit and market risk perspective. The cumulative effect adjustment to decrease
retained earnings
COVID-19
global pandemic. See Note 2,
“Fair Value of Financial Instruments”
|
Billions of yen
|
||||||||||||||||||||
March 31, 2020
|
||||||||||||||||||||
Level 1
|
Level 2
|
Level 3
|
Counterparty
and
Cash Collateral
Netting
(1)
|
Balance as of
March 31, 2020
|
||||||||||||||||
Assets:
|
||||||||||||||||||||
Trading assets and private equity and debt investments
(2)
|
||||||||||||||||||||
Equities
(3)
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||
Private equity and debt investments
(4)
|
|
|
|
|
|
|||||||||||||||
Japanese government securities
|
|
|
|
|
|
|||||||||||||||
Japanese agency and municipal securities
|
|
|
|
|
|
|||||||||||||||
Foreign government, agency and municipal securities
|
|
|
|
|
|
|||||||||||||||
Bank and corporate debt securities and loans for trading purposes
|
|
|
|
|
|
|||||||||||||||
Commercial mortgage-backed securities (“CMBS”)
|
|
|
|
|
|
|||||||||||||||
Residential mortgage-backed securities (“RMBS”)
|
|
|
|
|
|
|||||||||||||||
Issued/Guaranteed by government sponsored entity
|
|
|
|
|
|
|||||||||||||||
Other
|
|
|
|
|
|
|||||||||||||||
Real estate-backed securities
|
|
|
|
|
|
|||||||||||||||
Collateralized debt obligations (“CDOs”) and other
(5)
|
|
|
|
|
|
|||||||||||||||
Investment trust funds and other
|
|
|
|
|
|
|||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total trading assets and private equity and debt investments
|
|
|
|
|
|
|||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Derivative assets
(6)
|
||||||||||||||||||||
Equity contracts
|
|
|
|
|
|
|||||||||||||||
Interest rate contracts
|
|
|
|
|
|
|||||||||||||||
Credit contracts
|
|
|
|
|
|
|||||||||||||||
Foreign exchange contracts
|
|
|
|
|
|
|||||||||||||||
Commodity contracts
|
|
|
|
|
|
|||||||||||||||
Netting
|
|
|
|
(
|
) |
(
|
) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total derivative assets
|
|
|
|
(
|
) |
|
||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Subtotal
|
¥ |
|
¥ |
|
¥ |
|
¥ |
(
|
) | ¥ |
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Loans and receivables
(7)
|
|
|
|
|
|
|||||||||||||||
Collateralized agreements
(8)
|
|
|
|
|
|
|||||||||||||||
Other assets
|
||||||||||||||||||||
Non-trading
debt securities
|
|
|
|
|
|
|||||||||||||||
Other
(2)(3)
|
|
|
|
|
|
|||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total
|
¥ |
|
¥ |
|
¥ |
|
¥ |
(
|
) | ¥ |
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Liabilities:
|
||||||||||||||||||||
Trading liabilities
|
||||||||||||||||||||
Equities
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||
Japanese government securities
|
|
|
|
|
|
|||||||||||||||
Japanese agency and municipal securities
|
|
|
|
|
|
|||||||||||||||
Foreign government, agency and municipal securities
|
|
|
|
|
|
|||||||||||||||
Bank and corporate debt securities
|
|
|
|
|
|
|||||||||||||||
Residential mortgage-backed securities (“RMBS”)
|
|
|
|
|
|
|||||||||||||||
Collateralized debt obligations (“CDOs”) and other
(5)
|
|
|
|
|
|
|||||||||||||||
Investment trust funds and other
|
|
|
|
|
|
|||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total trading liabilities
|
|
|
|
|
|
|||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Derivative liabilities
(6)
|
||||||||||||||||||||
Equity contracts
|
|
|
|
|
|
|||||||||||||||
Interest rate contracts
|
|
|
|
|
|
|||||||||||||||
Credit contracts
|
|
|
|
|
|
|||||||||||||||
Foreign exchange contracts
|
|
|
|
|
|
|||||||||||||||
Commodity contracts
|
|
|
|
|
|
|||||||||||||||
Netting
|
|
|
|
(
|
) |
(
|
) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total derivative liabilities
|
|
|
|
(
|
) |
|
||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Subtotal
|
¥ |
|
¥ |
|
¥ |
|
¥ |
(
|
) | ¥ |
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Short-term borrowings
(9)
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||
Payables and deposits
(10)
|
|
|
|
|
|
|||||||||||||||
Collateralized financing
(8)
|
|
|
|
|
|
|||||||||||||||
Long-term borrowings
(9)(11)(12)
|
|
|
|
|
|
|||||||||||||||
Other liabilities
(13)
|
|
|
|
|
|
|||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total
|
¥ |
|
¥ |
|
¥ |
|
¥ |
(
|
) | ¥ |
|
|||||||||
|
|
|
|
|
|
|
|
|
|
Billions of yen
|
||||||||||||||||||||
March 31, 2021
|
||||||||||||||||||||
Level 1
|
Level 2
|
Level 3
|
Counterparty
and
Cash Collateral
Netting
(1)
|
Balance as of
March 31, 2021
|
||||||||||||||||
Assets:
|
||||||||||||||||||||
Trading assets and private equity and debt investments
(2)
|
||||||||||||||||||||
Equities
(3)
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||
Private equity and debt investments
(4)
|
|
|
|
|
|
|||||||||||||||
Japanese government securities
|
|
|
|
|
|
|||||||||||||||
Japanese agency and municipal securities
|
|
|
|
|
|
|||||||||||||||
Foreign government, agency and municipal securities
|
|
|
|
|
|
|||||||||||||||
Bank and corporate debt securities and loans for trading purposes
|
|
|
|
|
|
|||||||||||||||
Commercial mortgage-backed securities (“CMBS”)
|
|
|
|
|
|
|||||||||||||||
Residential mortgage-backed securities (“RMBS”)
|
|
|
|
|
|
|||||||||||||||
Issued/Guaranteed by government sponsored entity
|
|
|
|
|
|
|||||||||||||||
Other
|
|
|
|
|
|
|||||||||||||||
Real estate-backed securities
|
|
|
|
|
|
|||||||||||||||
Collateralized debt obligations (“CDOs”) and other
(5)
|
|
|
|
|
|
|||||||||||||||
Investment trust funds and other
|
|
|
|
|
|
|||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total trading assets and private equity and debt investments
|
|
|
|
|
|
|||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Derivative assets
(6)
|
||||||||||||||||||||
Equity contracts
|
|
|
|
|
|
|||||||||||||||
Interest rate contracts
|
|
|
|
|
|
|||||||||||||||
Credit contracts
|
|
|
|
|
|
|||||||||||||||
Foreign exchange contracts
|
|
|
|
|
|
|||||||||||||||
Commodity contracts
|
|
|
|
|
|
|||||||||||||||
Netting
|
|
|
|
(
|
) |
(
|
) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total derivative assets
|
|
|
|
(
|
) |
|
||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Subtotal
|
¥ |
|
¥ |
|
¥ |
|
¥ |
(
|
) | ¥ |
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Loans and receivables
(7)
|
|
|
|
|
|
|||||||||||||||
Collateralized agreements
(8)
|
|
|
|
|
|
|||||||||||||||
Other assets
|
||||||||||||||||||||
Non-trading
debt securities
|
|
|
|
|
|
|||||||||||||||
Other
(2)(3)
|
|
|
|
|
|
|||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total
|
¥ |
|
¥ |
|
¥ |
|
¥ |
(
|
) | ¥ |
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Liabilities:
|
||||||||||||||||||||
Trading liabilities
|
||||||||||||||||||||
Equities
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||
Japanese government securities
|
|
|
|
|
|
|||||||||||||||
Japanese agency and municipal securities
|
|
|
|
|
|
|||||||||||||||
Foreign government, agency and municipal securities
|
|
|
|
|
|
|||||||||||||||
Bank and corporate debt securities
|
|
|
|
|
|
|||||||||||||||
Residential mortgage-backed securities (“RMBS”)
|
|
|
|
|
|
|||||||||||||||
Collateralized debt obligations (“CDOs”) and other
(5)
|
|
|
|
|
|
|||||||||||||||
Investment trust funds and other
|
|
|
|
|
|
|||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total trading liabilities
|
|
|
|
|
|
|||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Derivative liabilities
(6)
|
||||||||||||||||||||
Equity contracts
|
|
|
|
|
|
|||||||||||||||
Interest rate contracts
|
|
|
|
|
|
|||||||||||||||
Credit contracts
|
|
|
|
|
|
|||||||||||||||
Foreign exchange contracts
|
|
|
|
|
|
|||||||||||||||
Commodity contracts
|
|
|
|
|
|
|||||||||||||||
Netting
|
|
|
|
(
|
) |
(
|
) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total derivative liabilities
|
|
|
|
(
|
) |
|
||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Subtotal
|
¥ |
|
¥ |
|
¥ |
|
¥ |
(
|
) | ¥ |
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Short-term borrowings
(9)
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||
Payables and deposits
(10)
|
|
|
|
|
|
|||||||||||||||
Collateralized financing
(8)
|
|
|
|
|
|
|||||||||||||||
Long-term borrowings
(9)(11)(12)
|
|
|
|
|
|
|||||||||||||||
Other liabilities
(13)
|
|
|
|
|
|
|||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total
|
¥ |
|
¥ |
|
¥ |
|
¥ |
(
|
) | ¥ |
|
|||||||||
|
|
|
|
|
|
|
|
|
|
(1) |
Represents the amount offset under counterparty netting of derivative assets and liabilities as well as cash collateral netting against net derivatives.
|
(2) |
Certain investments that are measured at fair value using net asset value per share as a practical expedient have not been classified in the fair value hierarchy. As of March 31, 2020 and March 31, 2021, the fair values of these investments which are included in
¥
Trading assets and private equity and debt investments
were
billion, respectively. As of March 31, 2020 and March 31, 2021, the fair values of these investments which are included in
¥
Other assets—Others
were
|
(3) |
Includes equity investments that would have been accounted for under the equity method had Nomura not chosen to elect the fair value option.
|
(4) |
Private equity and debt investments
non-traded
financial instruments including ownership or other forms of junior capital (such as mezzanine loan). Includes equity investments that would have been accounted for under the equity method had Nomura not chosen to elect the fair value option.
|
(5) |
Includes collateralized loan obligations (“CLOs”) and asset-backed securities (“ABS”) such as those secured on credit card loans, auto loans and student loans.
|
(6) |
Each derivative classification includes derivatives with multiple risk underlyings. For example, interest rate contracts include complex derivatives referencing interest rate risk as well as foreign exchange risk or other factors such as prepayment rates. Credit contracts include credit default swaps as well as derivatives referencing corporate and government debt securities.
|
(7) |
Includes loans for which the fair value option has been elected.
|
(8) |
Includes collateralized agreements or collateralized financing for which the fair value option has been elected.
|
(9) |
Includes structured notes for which the fair value option has been elected.
|
(10) |
Includes embedded derivatives bifurcated from deposits received at banks. If unrealized gains are greater than unrealized losses, deposits are reduced by the excess amount.
|
(11) |
Includes embedded derivatives bifurcated from issued structured notes. If unrealized gains are greater than unrealized losses, borrowings are reduced by the excess amount.
|
(12) |
Includes liabilities recognized from secured financing transactions that are accounted for as financings rather than sales. Nomura elected the fair value option for these liabilities.
|
(13) |
Includes loan commitments for which the fair value option has been elected.
|
March 31, 2020
|
||||||||||||||
Financial Instrument
|
Fair
value in billions of yen |
Valuation
technique
|
Significant
unobservable
valuation input |
Range of
valuation
inputs
(1)
|
Weighted
Average
(2)
|
Impact of
increases in significant unobservable valuation inputs
(3)(4)
|
Interrelationships
between valuation inputs
(5)
|
|||||||
Assets:
|
||||||||||||||
Trading assets and private equity and debt investments
|
||||||||||||||
Equities
|
¥
|
DCF | Liquidity discounts |
|
|
|
|
|||||||
|
|
|
|
|
|
|||||||||
Market multiples | Liquidity discounts |
|
|
|
|
|||||||||
|
|
|
|
|
|
|
||||||||
Private equity and debt investments
|
|
DCF
|
WACC
Growth rates
Liquidity discounts
|
|
|
|
|
|||||||
|
|
|
|
|
|
|||||||||
Market multiples |
EV/EBITDA ratios
PE Ratios
Liquidity discounts
|
|
|
|
|
|||||||||
|
|
|
|
|
|
|
||||||||
Foreign government, agency and municipal securities
|
|
DCF
|
Credit spreads
Recovery rates
|
|
|
|
|
|||||||
|
|
|
|
|
|
|
||||||||
Bank and corporate debt securities and loans for trading purposes
|
|
DCF
|
Credit spreads
Recovery rates
|
|
|
|
|
|||||||
|
|
|
|
|
|
|
||||||||
Residential mortgage backed securities (“RMBS”)
|
|
DCF
|
Yields
Prepayment rates
Loss severities
|
|
|
|
|
|||||||
|
|
|
|
|
|
|
||||||||
Real estate-backed securities
|
|
DCF
|
Loss severities
|
|
|
|
|
|||||||
|
|
|
|
|
|
|
||||||||
Collateralized debt obligations (“CDOs”) and other
|
|
DCF
|
Yields
Prepayment rates
Default probabilities
Loss severities
|
|
|
|
|
|||||||
|
|
|
|
|
|
|
March 31, 2020
|
||||||||||||||
Financial Instrument
|
Fair
value in billions of yen |
Valuation
technique
|
Significant
unobservable
valuation input |
Range of
valuation
inputs
(1)
|
Weighted
Average
(2)
|
Impact of
increases in significant unobservable valuation inputs
(3)(4)
|
Interrelationships
between valuation inputs
(5)
|
|||||||
Derivatives, net:
|
||||||||||||||
Equity contracts
|
¥
|
Option models |
Dividend yield
Volatilities
Correlations
|
(
|
—
—
—
|
|
|
|||||||
|
|
|
|
|
|
|
||||||||
Interest rate contracts
|
(
|
DCF/
Option models
|
Interest rates
Volatilities
Volatilities
Correlations
|
(
24.6
–
119.4
bp
(
|
—
—
—
—
|
|
|
|||||||
|
|
|
|
|
|
|
||||||||
Credit contracts
|
(
|
DCF/
Option models
|
Credit spreads
Recovery rates
Volatilities
Correlations
|
|
—
—
—
—
|
|
|
|||||||
|
|
|
|
|
|
|
||||||||
Foreign exchange contracts
|
|
Option models
|
Interest rates
Volatilities
Volatilities
Correlations
|
(
19.2
–
50.7
bp
(
|
—
—
—
—
|
|
|
|||||||
|
|
|
|
|
|
|
||||||||
Loans and receivables
|
|
DCF |
Credit spreads
Recovery rates
|
|
|
|
|
|||||||
|
|
|
|
|
|
|
||||||||
Collateralized agreements
|
|
DCF | Repo rate |
|
|
|
|
|||||||
|
|
|
|
|
|
|
||||||||
Other assets
|
||||||||||||||
Other
(6)
|
|
DCF |
WACC
Growth rates
Liquidity discounts
|
|
|
|
|
|||||||
|
|
|
|
|
|
|||||||||
Market multiples |
EV/EBITDA ratios
PE Ratios
Price/Book ratios
Liquidity discounts
|
|
|
|
|
|||||||||
|
|
|
|
|
|
|
||||||||
Liabilities:
|
||||||||||||||
Short-term borrowings
|
|
DCF/
Option models
|
Volatilities
Correlations
|
(
|
—
—
|
|
|
|||||||
|
|
|
|
|
|
|
||||||||
Long-term borrowings
|
|
DCF/
Option models
|
Volatilities
Volatilities
Correlations
|
30.0
–
103.2
bp
(
|
—
—
—
|
|
|
|||||||
|
|
|
|
|
|
|
March 31, 202
1
|
||||||||||||||
Financial Instrument
|
Fair
value in billions of yen |
Valuation
technique
|
Significant
unobservable
valuation input |
Range of
valuation
inputs
(1)
|
Weighted
Average
(2)
|
Impact of
increases in significant unobservable valuation inputs
(3)(4)
|
Interrelationships
between valuation inputs
(5)
|
|||||||
Assets:
|
||||||||||||||
Trading assets and private equity and debt investments
|
||||||||||||||
Equities
|
¥
|
DCF | Liquidity discounts |
|
|
|
|
|||||||
|
|
|
|
|
|
|
||||||||
Private equity and debt investments
|
|
DCF
|
WACC
Growth rates
Credit spreads
Liquidity discounts
|
|
|
|
|
|||||||
|
|
|
|
|
|
|||||||||
Market multiples |
EV/EBITDA ratios
PE Ratios
Liquidity discounts
|
|
|
|
|
|||||||||
|
|
|
|
|
|
|
||||||||
Foreign government, agency and municipal securities
|
|
DCF
|
Credit spreads
Recovery rates
|
|
|
|
|
|||||||
|
|
|
|
|
|
|
||||||||
Bank and corporate debt securities and loans for trading purposes
|
|
DCF
|
Credit spreads
Recovery rates
|
|
|
|
|
|||||||
|
|
|
|
|
|
|
||||||||
Commercial mortgage backed securities (“CMBS”)
|
|
DCF
|
Yields
Loss severities
|
|
|
|
|
|||||||
|
|
|
|
|
|
|
||||||||
Residential mortgage backed securities (“RMBS”)
|
|
DCF
|
Yields
Prepayment rates
Loss severities
|
|
|
|
|
|||||||
|
|
|
|
|
|
|
||||||||
Real estate-backed securities
|
|
DCF | Loss severities |
|
|
|
|
|||||||
|
|
|
|
|
|
|
||||||||
Collateralized debt obligations (“CDOs”) and other
|
|
DCF
|
Yields
Prepayment rates
Default probabilities
Loss severities
|
|
|
|
|
|||||||
|
|
|
|
|
|
|
March 31, 202
1
|
||||||||||||||
Financial Instrument
|
Fair
value in billions of yen |
Valuation
technique
|
Significant
unobservable
valuation input |
Range of
valuation
inputs
(1)
|
Weighted
Average
(2)
|
Impact of
increases in significant unobservable valuation inputs
(3)(4)
|
Interrelationships
between valuation inputs
(5)
|
|||||||
Derivatives, net:
|
||||||||||||||
Equity contracts
|
¥ (
|
Option models |
Dividend yield
Volatilities
Correlations
|
(
|
—
—
—
|
|
|
|||||||
|
|
|
|
|
|
|
||||||||
Interest rate contracts
|
(
|
DCF/
Option models
|
Interest rates
Volatilities
Volatilities
Correlations
|
24.9
–
94.0
bp
(
|
—
—
—
—
|
|
|
|||||||
|
|
|
|
|
|
|
||||||||
Credit contracts
|
(
|
DCF/
Option models
|
Credit spreads
Recovery rates
Volatilities
Correlations
|
|
—
—
—
—
|
|
|
|||||||
|
|
|
|
|
|
|
||||||||
Foreign exchange contracts
|
|
Option models
|
Interest rates
Volatilities
Volatilities
Correlations
|
16.2
–
25.5
bp
(
|
—
—
—
—
|
|
|
|||||||
|
|
|
|
|
|
|
||||||||
Loans and receivables
|
|
DCF |
Credit spreads
Recovery rates
|
|
|
|
|
|||||||
|
|
|
|
|
|
|
||||||||
Collateralized agreements
|
|
DCF
|
Repo rate
|
|
|
|
|
|||||||
|
|
|
|
|
|
|
||||||||
Other assets
|
||||||||||||||
Other
(6)
|
|
DCF |
WACC
Growth rates
Liquidity discounts
|
|
|
|
|
|||||||
|
|
|
|
|
|
|||||||||
Market multiples |
EV/EBITDA ratios
PE Ratios
Price/Book ratios
Liquidity discounts
|
|
|
|
|
|||||||||
|
|
|
|
|
|
|
||||||||
Liabilities:
|
||||||||||||||
Trading Liabilities Bank and corporate debt sec
|
|
DCF
|
Recovery rates
|
|
|
|
|
|||||||
|
|
|
|
|
|
|
||||||||
Short-term borrowings
|
|
DCF/
Option models
|
Volatilities
Correlations
|
(
|
—
—
|
|
|
|||||||
|
|
|
|
|
|
|
||||||||
Long-term borrowings
|
|
DCF/
Option models
|
Volatilities
Volatilities
Correlations
|
29.6
–
77.0
bp
(
|
—
—
—
|
|
|
|||||||
|
|
|
|
|
|
|
(1) |
Range information is provided in percentages, coefficients and multiples and represents the highest and lowest level significant unobservable valuation input used to value that type of financial instrument. A wide dispersion in the range does not necessarily reflect increased uncertainty or subjectivity in the valuation input and is typically just a consequence of the different characteristics of the financial instruments themselves.
|
(2) |
Weighted average information for
non-derivative
instruments is calculated by weighting each valuation input by the fair value of the financial instrument.
|
(3) |
The above table only considers the impact of an increase in each significant unobservable valuation input on the fair value measurement of the financial instrument. However, a decrease in the significant unobservable valuation input would have the opposite effect on the fair value measurement of the financial instrument. For example, if an increase in a significant unobservable valuation input would result in a lower fair value measurement, a decrease in the significant unobservable valuation input would result in a higher fair value measurement.
|
(4) |
The impact of an increase in the significant unobservable input on the fair value measurement for a derivative assumes Nomura is long risk to the input e.g., long volatility. Where Nomura is short such risk, the impact of an increase would have a converse effect on the fair value measurement of the derivative.
|
(5) |
Consideration of the interrelationships between significant unobservable inputs is only relevant where more than one unobservable valuation input is used to determine the fair value measurement of the financial instrument.
|
(6) |
Valuation technique(s) and unobservable valuation inputs in respect of equity securities reported within
Other assets
|
Billions of yen
|
||||||||||||||||||||||||||||||||||||||||
Year ended March 31, 2020
|
||||||||||||||||||||||||||||||||||||||||
Balance
as of
April 1,
2019
|
Total gains
(losses)
recognized
in net
revenue
(1)
|
Total gains
(losses)
recognized in
other
comprehensive
income
|
Purchases
/ issues
(2)
|
Sales /
redemptions
(2)
|
Settlements
|
Foreign
exchange
movements
|
Transfers
into
Level 3
(4)(5)
|
Transfers
out of
Level 3
(5)
|
Balance
as of
March 31,
2020
|
|||||||||||||||||||||||||||||||
Assets:
|
||||||||||||||||||||||||||||||||||||||||
Trading assets and private equity and debt investments
|
||||||||||||||||||||||||||||||||||||||||
Equities
|
¥ |
|
¥ |
(
|
) | ¥ |
|
¥ |
|
¥ |
(
|
) | ¥ |
|
¥ |
|
¥ |
|
¥ |
(
|
) | ¥ |
|
|||||||||||||||||
Private equity and debt investments
|
|
|
|
|
(
|
) |
|
(
|
) |
|
|
|
||||||||||||||||||||||||||||
Japanese agency and municipal securities
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||
Foreign government, agency and municipal securities
|
|
|
|
|
(
|
) |
|
|
|
(
|
) |
|
||||||||||||||||||||||||||||
Bank and corporate debt securities and loans for trading purposes
|
|
(
|
) |
|
|
(
|
) |
|
(
|
) |
|
(
|
) |
|
||||||||||||||||||||||||||
Commercial mortgage-backed securities (“CMBS”)
|
|
(
|
) |
|
|
(
|
) |
|
|
|
|
|
||||||||||||||||||||||||||||
Residential mortgage-backed securities (“RMBS”)
|
|
(
|
) |
|
|
(
|
) |
|
|
|
(
|
) |
|
|||||||||||||||||||||||||||
Real estate-backed securities
|
|
|
|
|
(
|
) |
|
(
|
) |
|
|
|
||||||||||||||||||||||||||||
Collateralized debt obligations (“CDOs”) and other
|
|
(
|
) |
|
|
(
|
) |
|
(
|
) |
|
(
|
) |
|
||||||||||||||||||||||||||
Investment trust funds and other
|
|
|
|
|
(
|
) |
|
|
|
|
|
|||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Total trading assets and private equity and debt investments
|
|
(
|
) |
|
|
(
|
) |
|
(
|
) |
|
(
|
) |
|
||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Derivatives, net
(3)
|
||||||||||||||||||||||||||||||||||||||||
Equity contracts
|
(
|
) |
|
|
|
|
(
|
) |
|
|
(
|
) |
|
|||||||||||||||||||||||||||
Interest rate contracts
|
(
|
) |
|
|
|
|
(
|
) |
|
(
|
) |
|
(
|
) | ||||||||||||||||||||||||||
Credit contracts
|
(
|
) |
|
|
|
|
|
|
(
|
) |
|
(
|
) | |||||||||||||||||||||||||||
Foreign exchange contracts
|
|
(
|
) |
|
|
|
|
(
|
) |
|
|
|
||||||||||||||||||||||||||||
Commodity contracts
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Total derivatives, net
|
(
|
) |
|
|
|
|
(
|
) |
(
|
) |
|
|
(
|
) | ||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Subtotal
|
¥ |
|
¥ |
(
|
) | ¥ |
|
¥ |
|
¥ |
(
|
) | ¥ |
(
|
) | ¥ |
(
|
) | ¥ |
|
¥ |
(
|
) | ¥ |
|
|||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Loans and receivables
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
(
|
) | ¥ |
|
¥ |
(
|
) | ¥ |
|
¥ |
(
|
) | ¥ |
|
|||||||||||||||||
Collateralized agreements
|
|
|
|
|
(
|
) |
|
(
|
) |
|
|
|
||||||||||||||||||||||||||||
Other assets
|
||||||||||||||||||||||||||||||||||||||||
Other
|
|
(
|
) |
|
|
(
|
) |
|
(
|
) |
|
|
|
|||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Total
|
¥ |
|
¥ |
(
|
) | ¥ |
|
¥ |
|
¥ |
(
|
) | ¥ |
(
|
) | ¥ |
(
|
) | ¥ |
|
¥ |
(
|
) | ¥ |
|
|||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Liabilities:
|
||||||||||||||||||||||||||||||||||||||||
Trading liabilities
|
||||||||||||||||||||||||||||||||||||||||
Equities
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||||||||||||
Foreign government, agency and municipal securities
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||
Bank and corporate debt securities
|
|
(
|
) |
|
|
(
|
) |
|
|
|
|
|
||||||||||||||||||||||||||||
Collateralized debt obligations (“CDOs”) and other
|
|
|
|
|
(
|
) |
|
|
|
|
|
|||||||||||||||||||||||||||||
Investment trust funds and other
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Total trading liabilities
|
¥ |
|
¥ |
(
|
) | ¥ |
|
¥ |
|
¥ |
(
|
) | ¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Short-term borrowings
|
|
|
|
|
(
|
) |
|
|
|
(
|
) |
|
||||||||||||||||||||||||||||
Payables and deposits
|
|
|
|
|
|
|
|
|
(
|
) |
|
|||||||||||||||||||||||||||||
Long-term borrowings
|
|
|
|
|
(
|
) |
|
(
|
) |
|
(
|
) |
|
|||||||||||||||||||||||||||
Other liabilities
|
|
(
|
) |
|
|
(
|
) |
|
|
|
|
|
||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Total
|
¥ |
|
¥ |
(
|
) | ¥ |
|
¥ |
|
¥ |
(
|
) | ¥ |
|
¥ |
(
|
) | ¥ |
|
¥ |
(
|
) | ¥ |
|
||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Billions of yen
|
||||||||||||||||||||||||||||||||||||||||
Year ended March 31, 2021
|
||||||||||||||||||||||||||||||||||||||||
Balance
as of
April 1,
2020
|
Total gains
(losses)
recognized
in net
revenue
(1)
|
Total gains
(losses)
recognized in
other
comprehensive
income
|
Purchases
/ issues
(2)
|
Sales /
redemptions
(2)
|
Settlements
|
Foreign
exchange
movements
|
Transfers
into
Level 3
(4)(5)
|
Transfers
out of
Level 3
(5)
|
Balance
as of
March 31,
2021
|
|||||||||||||||||||||||||||||||
Assets:
|
||||||||||||||||||||||||||||||||||||||||
Trading assets and private equity and debt investments
|
||||||||||||||||||||||||||||||||||||||||
Equities
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
(
|
) | ¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
|||||||||||||||||||
Private equity and debt investments
|
|
|
|
|
(
|
) |
|
|
|
|
|
|||||||||||||||||||||||||||||
Japanese agency and municipal securities
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||
Foreign government, agency and municipal securities
|
|
|
|
|
(
|
) |
|
|
|
(
|
) |
|
||||||||||||||||||||||||||||
Bank and corporate debt securities and loans for trading purposes
|
|
|
|
|
(
|
) |
|
|
|
(
|
) |
|
||||||||||||||||||||||||||||
Commercial mortgage-backed securities (“CMBS”)
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||
Residential mortgage-backed securities (“RMBS”)
|
|
|
|
|
(
|
) |
|
|
|
(
|
) |
|
||||||||||||||||||||||||||||
Real estate-backed securities
|
|
(
|
) |
|
|
(
|
) |
|
|
|
|
|
||||||||||||||||||||||||||||
Collateralized debt obligations (“CDOs”) and other
|
|
|
|
|
(
|
) |
|
|
|
(
|
) |
|
||||||||||||||||||||||||||||
Investment trust funds and other
|
|
|
|
|
(
|
) |
|
|
|
|
|
|||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Total trading assets and private equity and debt investments
|
|
|
|
|
(
|
) |
|
|
|
(
|
) |
|
||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Derivatives, net
(3)
|
||||||||||||||||||||||||||||||||||||||||
Equity contracts
|
|
(
|
) |
|
|
|
(
|
) |
|
|
(
|
) |
(
|
) | ||||||||||||||||||||||||||
Interest rate contracts
|
(
|
) |
|
|
|
|
(
|
) |
|
(
|
) |
|
(
|
) | ||||||||||||||||||||||||||
Credit contracts
|
(
|
) |
(
|
) |
|
|
|
(
|
) |
(
|
) |
(
|
) |
|
(
|
) | ||||||||||||||||||||||||
Foreign exchange contracts
|
|
|
|
|
|
(
|
) |
|
(
|
) |
|
|
||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Total derivatives, net
|
(
|
) |
(
|
) |
|
|
|
(
|
) |
|
|
(
|
) |
(
|
) | |||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Subtotal
|
¥ |
|
¥ |
(
|
) | ¥ |
|
¥ |
|
¥ |
(
|
) | ¥ |
(
|
) | ¥ |
|
¥ |
|
¥ |
(
|
) | ¥ |
|
||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Loans and receivables
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
(
|
) | ¥ |
|
¥ |
|
¥ |
|
¥ |
(
|
) | ¥ |
|
||||||||||||||||||
Collateralized agreements
|
|
(
|
) |
|
|
(
|
) |
|
|
|
|
|
||||||||||||||||||||||||||||
Other assets
|
||||||||||||||||||||||||||||||||||||||||
Other
|
|
|
|
|
(
|
) |
|
|
|
|
|
|||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Total
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
(
|
) | ¥ |
(
|
) | ¥ |
|
¥ |
|
¥ |
(
|
) | ¥ |
|
|||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Liabilities:
|
||||||||||||||||||||||||||||||||||||||||
Trading liabilities
|
||||||||||||||||||||||||||||||||||||||||
Equities
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
(
|
) | ¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
|||||||||||||||||||
Foreign government, agency and municipal securities
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||
Bank and corporate debt securities
|
|
|
|
|
(
|
) |
|
|
|
(
|
) |
|
||||||||||||||||||||||||||||
Collateralized debt obligations (“CDOs”) and other
|
|
|
|
|
(
|
) |
|
|
|
|
|
|||||||||||||||||||||||||||||
Investment trust funds and other
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Total trading liabilities
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
(
|
) | ¥ |
|
¥ |
|
¥ |
|
¥ |
(
|
) | ¥ |
|
||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Short-term borrowings
|
|
(
|
) |
|
|
(
|
) |
|
|
|
(
|
) |
|
|||||||||||||||||||||||||||
Payables and deposits
|
|
|
|
|
|
|
|
|
(
|
) |
|
|||||||||||||||||||||||||||||
Collateralized financing
|
|
(
|
) |
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||
Long-term borrowings
|
|
(
|
) |
(
|
) |
|
(
|
) |
|
|
|
(
|
) |
|
||||||||||||||||||||||||||
Other liabilities
|
|
(
|
) |
|
|
|
|
|
|
(
|
) |
|
||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Total
|
¥ |
|
¥ |
(
|
) | ¥ |
(
|
) | ¥ |
|
¥ |
(
|
) | ¥ |
|
¥ |
|
¥ |
|
¥ |
(
|
) | ¥ |
|
||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
Includes gains and losses reported primarily within
Net gain on trading, Gain on private equity and debt investments,
Gain (loss) on investments in equity securities, Revenue—Other
Non-interest
expenses
—Other, Interest and dividends
Interest expense
|
(2) |
Amounts reported in
Purchases / issues
Sales / redemptions
|
(3) |
Each derivative classification includes derivatives with multiple risk underlyings. For example, interest rate contracts include complex derivatives referencing interest rate risk as well as foreign exchange risk or other factors such as prepayment rates. Credit contracts include credit default swaps as well as derivatives referencing corporate and government debt securities.
|
(4) |
Amounts of gains and losses on these transfers which were recognized in the period when the
Transfers into Level
3
|
(5) |
Transfers into Level
3
Transfers out of Level
3
Quantitative and qualitative information regarding significant unobservable inputs
|
Billions of yen
|
||||||||
March 31
|
||||||||
2020
|
2021
|
|||||||
Unrealized gains / (losses)
(1)
|
||||||||
Assets:
|
||||||||
Trading assets and private equity and debt investments
|
||||||||
Equities
|
¥ |
(
|
) | ¥ |
|
|||
Private equity and debt investments
|
|
|
||||||
Japanese agency and municipal securities
|
|
|
||||||
Foreign government, agency and municipal securities
|
(
|
) |
|
|||||
Bank and corporate debt securities and loans for trading purposes
|
(
|
) |
(
|
) | ||||
Commercial mortgage-backed securities (“CMBS”)
|
(
|
) |
|
|||||
Residential mortgage-backed securities (“RMBS”)
|
(
|
) |
|
|||||
Real estate-backed securities
|
|
(
|
) | |||||
Collateralized debt obligations (“CDOs”) and other
|
(
|
) |
(
|
) | ||||
Investment trust funds and other
|
|
|
||||||
|
|
|
|
|||||
Total trading assets and private equity and debt investments
|
(
|
) |
|
|||||
|
|
|
|
|||||
Derivatives, net
(2)
|
||||||||
Equity contracts
|
|
(
|
) | |||||
Interest rate contracts
|
(
|
) |
|
|||||
Credit contracts
|
|
(
|
) | |||||
Foreign exchange contracts
|
(
|
) |
|
|||||
|
|
|
|
|||||
Total derivatives, net
|
(
|
) |
(
|
) | ||||
|
|
|
|
|||||
Subtotal
|
¥ |
(
|
) | ¥ |
(
|
) | ||
|
|
|
|
|||||
Loans and receivables
|
(
|
) |
(
|
) | ||||
Collateralized agreements
|
|
(
|
) | |||||
Other assets
|
||||||||
Other
|
(
|
) |
|
|||||
|
|
|
|
|||||
Total
|
¥ |
(
|
) | ¥ |
(
|
) | ||
|
|
|
|
Billions of yen
|
||||||||
March 31
|
||||||||
2020
|
2021
|
|||||||
Unrealized gains / (losses)
(1)
|
||||||||
Liabilities:
|
||||||||
Trading liabilities
|
||||||||
Equities
|
¥ |
|
¥ |
|
||||
Foreign government, agency and municipal securities
|
|
|
||||||
Bank and corporate debt securities
|
(
|
) |
|
|||||
Collateralized debt obligations (“CDOs”) and other
|
|
|
||||||
|
|
|
|
|||||
Total trading liabilities
|
¥ |
(
|
) | ¥ |
|
|||
|
|
|
|
|||||
Short-term borrowings
(3)
|
|
|
||||||
Payables and deposits
(3)
|
|
|
||||||
Collateralized financing
(3)
|
— |
|
||||||
Long-term borrowings
(3)
|
|
(
|
) | |||||
Other liabilities
|
— |
|
||||||
|
|
|
|
|||||
Total
|
¥ |
|
¥ |
(
|
) | |||
|
|
|
|
(1) |
Includes gains and losses reported within
Net gain on trading, Gain on private equity and debt investments
Gain on investments in equity securities, Revenue—Other
Non-interest expenses—Other, Interest and dividends
Interest expense
|
(2) |
Each derivative classification includes derivatives with multiple risk underlyings. For example, interest rate contracts include complex derivatives referencing interest rate risk as well as foreign exchange risk or other factors such as prepayment rates. Credit contracts include credit default swaps as well as derivatives referencing corporate and government debt securities.
|
(3) |
Includes changes in unrealized gains and losses in
Other comprehensive income (loss)
|
Billions of yen
|
||||||||||||||||||||
March 31, 2020
|
||||||||||||||||||||
Fair value
|
Unfunded
commitments
(1)
|
Redemption frequency
(if currently eligible)
(2)
|
Redemption notice
(3)
|
|||||||||||||||||
Hedge funds
|
¥ |
|
¥ |
|
|
Same day-
|
||||||||||||||
Venture capital funds
|
|
|
|
|
||||||||||||||||
Private equity funds
|
|
|
|
|
||||||||||||||||
Real estate funds
|
|
|
|
|
||||||||||||||||
|
|
|
|
|||||||||||||||||
Total
|
¥ |
|
¥ |
|
||||||||||||||||
|
|
|
|
|||||||||||||||||
Billions of yen
|
||||||||||||||||||||
March 31, 2021
|
||||||||||||||||||||
Fair value
|
Unfunded
commitments
(1)
|
Redemption frequency
(if currently eligible)
(2)
|
Redemption notice
(3)
|
|||||||||||||||||
Hedge funds
|
¥ |
|
¥ |
|
|
Same
day
-
days
|
||||||||||||||
Venture capital funds
|
|
|
|
|
||||||||||||||||
Private equity funds
|
|
|
|
|
||||||||||||||||
Real estate funds
|
|
|
|
|
||||||||||||||||
|
|
|
|
|||||||||||||||||
Total
|
¥ |
|
¥ |
|
||||||||||||||||
|
|
|
|
(1) |
The contractual amount of any unfunded commitments Nomura is required to make to the entities in which the investment is held.
|
(2) |
The range in frequency with which Nomura can redeem investments.
|
(3) |
The range in notice period required to be provided before redemption is possible.
|
|
•
|
|
Equity method investments reported within
Trading assets and private equity and debt investments
Other assets
|
|
•
|
|
Loans receivable and Receivables from customers
Loans and receivables
|
|
•
|
|
Reverse repurchase and repurchase agreements reported within
Collateralized agreements
Collateralized financing
|
|
•
|
|
All structured notes issued on or after April 1, 2008 reported within
Short-term borrowings
Long-term borrowings
|
• |
Certain structured deposit issuances reported within
Deposits received at banks.
|
• |
Financial liabilities reported within
Long-term borrowings
|
• |
Financial reinsurance contracts reported within
Other assets
|
Billions of yen
|
||||||||||||
Year ended March 31
|
||||||||||||
2019
|
2020
|
2021
|
||||||||||
Gains/(Losses)
(1)
|
||||||||||||
Assets:
|
||||||||||||
Trading assets and private equity and debt investments
(2)
|
||||||||||||
Trading assets
|
¥ |
|
¥ |
|
¥ |
|
||||||
Private equity and debt investments
|
|
(
|
) |
|
||||||||
Loans and receivables
|
(
|
) |
|
|
||||||||
Collateralized agreements
(3)
|
|
|
|
|||||||||
Other assets
(2)
|
(
|
) |
(
|
) |
|
|||||||
|
|
|
|
|
|
|||||||
Total
|
¥ |
(
|
) | ¥ |
(
|
) | ¥ |
|
||||
|
|
|
|
|
|
|||||||
Liabilities:
|
||||||||||||
Short-term borrowings
(4)
|
¥ |
|
¥ |
|
¥ |
(
|
) | |||||
Payables and deposits
|
— |
|
|
|||||||||
Collateralized financing
(3)
|
|
(
|
) |
|
||||||||
Long-term borrowings
(4)(5)
|
(
|
) |
|
(
|
) | |||||||
Other liabilities
(6)
|
|
|
|
|||||||||
|
|
|
|
|
|
|||||||
Total
|
¥ |
(
|
) | ¥ |
|
¥ |
(
|
) | ||||
|
|
|
|
|
|
(1)
|
Includes gains and losses reported primarily within
Net gain on trading
Revenue—Other
|
(2)
|
Includes equity investments that would have been accounted for under the equity method had Nomura not chosen to elect the fair value option.
|
(3)
|
Includes reverse repurchase and repurchase agreements.
|
(4)
|
Includes structured notes and other financial liabilities.
|
(5)
|
Includes secured financing transactions arising from transfers of financial assets which did not meet the criteria for sales accounting.
|
(6)
|
Includes unfunded written loan commitments.
|
Billions of Yen
|
||||||||
Year ended March 31
|
||||||||
2020
|
2021
|
|||||||
Changes recognized as a credit (debit) to other comprehensive income
|
¥ |
|
¥ |
(
|
) | |||
Credit (debit) amounts reclassified to earnings
|
(
|
) |
(
|
) | ||||
Cumulative credit (debit) balance recognized in accumulated other comprehensive income
|
|
(
|
) |
Billions of yen
|
||||||||||||||||||||
March 31, 2020
|
||||||||||||||||||||
Japan
|
U.S.
|
EU & U.K.
|
Other
|
Total
(1)
|
||||||||||||||||
Government, agency and municipal securities
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
Billions of yen
|
||||||||||||||||||||
March 31, 2021
|
||||||||||||||||||||
Japan
|
U.S.
|
EU & U.K.
|
Other
|
Total
(1)
|
||||||||||||||||
Government, agency and municipal securities
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
(1) |
Other than above, there were ¥
Other
assets—Non-trading
debt securities
|
Billions of yen
|
||||||||||||||||||||
March 31, 2020
(1)
|
||||||||||||||||||||
Fair value by level
|
||||||||||||||||||||
Carrying
value
|
Fair
value |
Level 1
|
Level 2
|
Level 3
|
||||||||||||||||
Assets:
|
||||||||||||||||||||
Cash and cash equivalents
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||
Time deposits
|
|
|
|
|
|
|||||||||||||||
Deposits with stock exchanges and other segregated cash
|
|
|
|
|
|
|||||||||||||||
Loans receivable
(2)
|
|
|
|
|
|
|||||||||||||||
Securities purchased under agreements to resell
|
|
|
|
|
|
|||||||||||||||
Securities borrowed
|
|
|
|
|
|
|||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Liabilities:
|
||||||||||||||||||||
Short-term borrowings
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||
Deposits received at banks
|
|
|
|
|
|
|||||||||||||||
Securities sold under agreements to repurchase
|
|
|
|
|
|
|||||||||||||||
Securities loaned
|
|
|
|
|
|
|||||||||||||||
Other secured borrowings
|
|
|
|
|
|
|||||||||||||||
Long-term borrowings
|
|
|
|
|
|
|||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Billions of yen
|
||||||||||||||||||||
March 31, 2021
(1)
|
||||||||||||||||||||
Fair value by level
|
||||||||||||||||||||
Carrying
value
|
Fair
value |
Level 1
|
Level 2
|
Level 3
|
||||||||||||||||
Assets:
|
||||||||||||||||||||
Cash and cash equivalents
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||
Time deposits
|
|
|
|
|
|
|||||||||||||||
Deposits with stock exchanges and other segregated cash
|
|
|
|
|
|
|||||||||||||||
Loans receivable
(2)
|
|
|
|
|
|
|||||||||||||||
Securities purchased under agreements to resell
|
|
|
|
|
|
|||||||||||||||
Securities borrowed
|
|
|
|
|
|
|||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||
|
|
|
|
|
|
|
|
|
|
Billions of yen
|
||||||||||||||||||||
March 31, 2021
(1)
|
||||||||||||||||||||
Fair value by level
|
||||||||||||||||||||
Carrying
value
|
Fair
value |
Level 1
|
Level 2
|
Level 3
|
||||||||||||||||
Liabilities:
|
||||||||||||||||||||
Short-term borrowings
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||
Deposits received at banks
|
|
|
|
|
|
|||||||||||||||
Securities sold under agreements to repurchase
|
|
|
|
|
|
|||||||||||||||
Securities loaned
|
|
|
|
|
|
|||||||||||||||
Other secured borrowings
|
|
|
|
|
|
|||||||||||||||
Long-term borrowings
|
|
|
|
|
|
|||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||
|
|
|
|
|
|
|
|
|
|
(1) |
Includes financial instruments which are carried at fair value on a recurring basis.
|
(2) |
Carrying values are shown after deducting relevant allowances for credit losses.
|
Billions of yen
|
||||||||||||||||
March 31, 2020
|
||||||||||||||||
Gross fair value of
derivative assets
|
Impact of
master netting
agreements
|
Impact of
collateral
|
Net exposure to
credit risk
|
|||||||||||||
Financial institutions
|
¥ |
|
¥ |
(
|
) | ¥ |
(
|
) | ¥ |
|
Billions of yen
|
||||||||||||||||
March 31, 2021
|
||||||||||||||||
Gross fair value of
derivative assets
|
Impact of
master netting
agreements
|
Impact of
collateral
|
Net exposure to
credit risk
|
|||||||||||||
Financial institutions
|
¥ |
|
¥ |
(
|
) | ¥ |
(
|
) | ¥ |
|
Billions of yen
|
||||||||||||
March 31, 2020
|
||||||||||||
Derivative
assets
|
Derivative
liabilities
|
|||||||||||
Total Notional
(1)
|
Fair value
|
Fair value
(1)
|
||||||||||
Derivatives used for trading and
non-trading
purposes
(2)(3)
:
|
||||||||||||
Equity contracts
|
¥ |
|
¥ |
|
¥ |
|
||||||
Interest rate contracts
|
|
|
|
|||||||||
Credit contracts
|
|
|
|
|||||||||
Foreign exchange contracts
|
|
|
|
|||||||||
Commodity contracts
|
|
|
|
|||||||||
|
|
|
|
|
|
|||||||
Total
|
¥ |
|
¥ |
|
¥ |
|
||||||
|
|
|
|
|
|
|||||||
Derivatives designated as hedging instruments:
|
||||||||||||
Interest rate contracts
|
¥ |
|
¥ |
|
¥ |
|
||||||
Foreign exchange contracts
|
|
|
|
|||||||||
|
|
|
|
|
|
|||||||
Total
|
¥ |
|
¥ |
|
¥ |
|
||||||
|
|
|
|
|
|
|||||||
Total derivatives
|
¥ |
|
¥ |
|
¥ |
|
||||||
|
|
|
|
|
|
|||||||
Billions of yen
|
||||||||||||
March 31, 2021
|
||||||||||||
Derivative
assets
|
Derivative
liabilities
|
|||||||||||
Total Notional
(1)
|
Fair value
|
Fair value
(1)
|
||||||||||
Derivatives used for trading and
non-trading
purposes
(2)(3)
:
|
||||||||||||
Equity contracts
|
¥ |
|
¥ |
|
¥ |
|
||||||
Interest rate contracts
|
|
|
|
|||||||||
Credit contracts
|
|
|
|
|||||||||
Foreign exchange contracts
|
|
|
|
|||||||||
Commodity contracts
|
|
|
|
|||||||||
|
|
|
|
|
|
|||||||
Total
|
¥ |
|
¥ |
|
¥ |
|
||||||
|
|
|
|
|
|
|||||||
Derivatives designated as hedging instruments:
|
||||||||||||
Interest rate contracts
|
¥ |
|
¥ |
|
¥ |
|
||||||
Foreign exchange contracts
|
|
|
|
|||||||||
|
|
|
|
|
|
|||||||
Total
|
¥ |
|
¥ |
|
¥ |
|
||||||
|
|
|
|
|
|
|||||||
Total derivatives
|
¥ |
|
¥ |
|
¥ |
|
||||||
|
|
|
|
|
|
(1) |
Includes the amount of embedded derivatives bifurcated in accordance with ASC 815.
|
(2) |
Each derivative classification includes derivatives referencing multiple risk components. For example, certain interest rate contracts include complex derivatives referencing interest rate risk as well as foreign
|
|
exchange risk or other factors such as prepayment rates. Credit contracts include credit default swaps as well as derivatives referencing corporate and government securities.
|
(3)
|
As of March 31, 2020 and 2021, the amounts reported include derivatives used for
non-trading
purposes which are not designated as fair value or net investment hedges. These amounts have not been separately presented since such amounts were not significant.
|
Billions of yen
|
Billions of yen
|
|||||||||||||||
March 31, 2020
|
March 31, 2021
|
|||||||||||||||
Derivative
assets
|
Derivative
liabilities
(1)
|
Derivative
assets
|
Derivative
liabilities
(1)
|
|||||||||||||
Equity contracts
|
||||||||||||||||
OTC settled bilaterally
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||
Exchange-traded
|
|
|
|
|
||||||||||||
Interest rate contracts
|
||||||||||||||||
OTC settled bilaterally
|
|
|
|
|
||||||||||||
OTC centrally-cleared
|
|
|
|
|
||||||||||||
Exchange-traded
|
|
|
|
|
||||||||||||
Credit contracts
|
||||||||||||||||
OTC settled bilaterally
|
|
|
|
|
||||||||||||
OTC centrally-cleared
|
|
|
|
|
||||||||||||
Exchange-traded
|
|
|
|
|
||||||||||||
Foreign exchange contracts
|
||||||||||||||||
OTC settled bilaterally
|
|
|
|
|
||||||||||||
Commodity contracts
|
||||||||||||||||
OTC settled bilaterally
|
|
|
|
|
||||||||||||
Exchange-traded
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total gross derivative balances
(2)
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||
Less: Amounts offset in the consolidated balance sheets
(3)
|
(
|
) |
(
|
) |
(
|
) |
(
|
) | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Total net amounts reported on the face of the consolidated balance sheets
(4)
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
Billions of yen
|
Billions of yen
|
|||||||||||||||
March 31, 2020
|
March 31, 2021
|
|||||||||||||||
Derivative
assets
|
Derivative
liabilities
(1)
|
Derivative
assets
|
Derivative
liabilities
(1)
|
|||||||||||||
Less: Additional amounts not offset in the consolidated balance sheets
(5)
|
||||||||||||||||
Financial instruments and
non-cash
collateral
|
¥ |
(
|
) | ¥ |
(
|
) | ¥ |
(
|
) | ¥ |
(
|
) | ||||
|
|
|
|
|
|
|
|
|||||||||
Net amount
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||
|
|
|
|
|
|
|
|
(1) |
Includes the amount of embedded derivatives bifurcated in accordance with ASC 815.
|
(2) |
Includes all gross derivative asset and liability balances irrespective of whether they are transacted under a master netting agreement or whether Nomura has obtained sufficient evidence of enforceability of the master netting agreement. As of March 31, 2020, the gross balance of derivative assets and derivative liabilities which are not documented under master netting agreements or are documented under master netting agreements for which Nomura has not yet obtained sufficient evidence of enforceability was ¥
|
(3) |
Represents amounts offset through counterparty netting of derivative assets and liabilities as well as cash collateral netting against net derivatives under master netting and similar agreements for which Nomura has obtained sufficient evidence of enforceability in accordance with ASC 815. As of March 31, 2020, Nomura offset a total of ¥
|
(4) |
Net derivative assets and net derivative liabilities are generally reported within
Trading assets and private equity investments—Trading assets
Trading liabilities
Short-term borrowings
Long-term borrowings
|
(5) |
Represents amounts which are not permitted to be offset on the consolidated balance sheets in accordance with ASC
210-20
and ASC 815 but which provide Nomura with a legally enforceable right of offset in the event of counterparty default. Amounts relating to derivative and collateral agreements where Nomura has not yet obtained sufficient evidence of enforceability of such offsetting rights are excluded. As of March 31, 2020, a total of ¥
|
Billions of yen
|
||||||||||||
Year ended March 31
|
||||||||||||
2019
|
2020
|
2021
|
||||||||||
Derivatives used for trading and
non-trading
purposes
(1)(2)
:
|
||||||||||||
Equity contracts
|
¥ |
(
|
) | ¥ |
|
¥ |
|
|||||
Interest rate contracts
|
|
(
|
) |
|
||||||||
Credit contracts
|
(
|
) |
(
|
) |
(
|
) | ||||||
Foreign exchange contracts
|
(
|
) |
|
(
|
) | |||||||
Commodity contracts
|
|
(
|
) |
|
||||||||
|
|
|
|
|
|
|||||||
Total
|
¥ |
|
¥ |
(
|
) | ¥ |
|
|||||
|
|
|
|
|
|
(1) |
Each derivative classification includes derivatives referencing multiple risk components. For example, interest rates contracts include complex derivatives referencing interest rate risk as well as foreign exchange risk or other factors such as prepayment rates. Credit contracts include credit default swaps as well as derivatives referencing corporate and government securities.
|
(2) |
Includes net gains (losses) on derivatives used for non-trading purposes which are not designated as fair value or net investment hedges. For the years ended March 31, 2019 and 2020, these amounts were not significant. For the year ended March 31, 2021, net losses for these non-trading derivatives were ¥
|
Line items in the statement of financial
position in which the hedged item is included: |
Billions of yen
|
|||||||||||||||
Carrying amount of the hedged liabilities
|
Cumulative gains/(losses) of fair value hedging
adjustment included in the carrying amount of the hedged liabilities |
|||||||||||||||
March 31, 2020
|
March 31, 2021
|
March 31, 2020
|
March 31, 2021
|
|||||||||||||
Long-term borrowings
|
¥ |
|
¥ |
|
¥ |
(
|
¥ |
|
||||||||
|
|
|
|
|
|
|
|
|||||||||
Total
|
¥ |
|
¥ |
|
¥ |
(
|
¥ |
|
||||||||
|
|
|
|
|
|
|
|
Billions of yen
|
||||||||||||
Year ended March 31
|
||||||||||||
2019
|
2020
|
2021
|
||||||||||
Derivatives designated as hedging instruments:
|
||||||||||||
Interest rate contracts
|
¥ |
|
¥ |
(
|
) | ¥ |
|
|||||
|
|
|
|
|
|
|||||||
Total
|
¥ |
|
¥ |
(
|
) | ¥ |
|
|||||
|
|
|
|
|
|
|||||||
Billions of yen
|
||||||||||||
Year ended March 31
|
||||||||||||
2019
|
2020
|
2021
|
||||||||||
Hedged items:
|
||||||||||||
Long-term borrowings
|
¥ |
(
|
) | ¥ |
|
¥ |
(
|
) | ||||
|
|
|
|
|
|
|||||||
Total
|
¥ |
(
|
) | ¥ |
|
¥ |
(
|
) | ||||
|
|
|
|
|
|
Billions of yen
|
||||||||||||
Year ended March 31
|
||||||||||||
2019
|
2020
|
2021
|
||||||||||
Hedging instruments:
|
||||||||||||
Foreign exchange contracts
|
¥ |
|
¥ |
|
¥ |
(
|
) | |||||
|
|
|
|
|
|
|||||||
Total
|
¥ |
|
¥ |
|
¥ |
(
|
) | |||||
|
|
|
|
|
|
Billions of yen
|
||||||||||||||||||||||||||||
March 31, 2020
|
||||||||||||||||||||||||||||
Maximum potential payout/Notional
|
Notional
|
|||||||||||||||||||||||||||
Years to maturity
|
Purchased
credit
protection
|
|||||||||||||||||||||||||||
Carrying value
(Asset) / Liability
(1)
|
Total
|
Less than
1 year
|
1 to 3
years
|
3 to 5
years
|
More than
5 years
|
|||||||||||||||||||||||
Single-name credit default swaps
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||||||
Credit default indices
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Other credit risk related portfolio products
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Credit-risk related options and swaptions
|
|
|
|
|
|
|
|
|||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Total
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Billions of yen
|
||||||||||||||||||||||||||||
March 31, 2021
|
||||||||||||||||||||||||||||
Maximum potential payout/Notional
|
Notional
|
|||||||||||||||||||||||||||
Years to maturity
|
Purchased
credit
protection
|
|||||||||||||||||||||||||||
Carrying value
(Asset) / Liability
(1)
|
Total
|
Less than
1 year
|
1 to 3
years
|
3 to 5
years
|
More than
5 years
|
|||||||||||||||||||||||
Single-name credit default swaps
|
¥ |
(
|
) | ¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
|||||||||||||
Credit default indices
|
(
|
) |
|
|
|
|
|
|
||||||||||||||||||||
Other credit risk related portfolio products
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Credit-risk related options and swaptions
|
|
|
|
|
|
|
|
|||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
¥ |
(
|
) | ¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
|||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
Carrying value amounts are shown on a gross basis prior to cash collateral or counterparty netting. Asset balances represent positive fair value amounts caused by tightening of credit spreads of underlyings since inception of the credit derivative contracts
.
|
Billions of yen
|
||||||||||||||||||||||||||||
March 31, 2020
|
||||||||||||||||||||||||||||
Maximum potential payout/Notional
|
||||||||||||||||||||||||||||
AAA
|
AA
|
A
|
BBB
|
BB
|
Other
(1)
|
Total
|
||||||||||||||||||||||
Single-name credit default swaps
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||||||
Credit default indices
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Other credit risk related portfolio products
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Credit-risk related options and swaptions
|
|
|
|
|
|
|
|
|||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Total
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Billions of yen
|
||||||||||||||||||||||||||||
March 31, 2021
|
||||||||||||||||||||||||||||
Maximum potential payout/Notional
|
||||||||||||||||||||||||||||
AAA
|
AA
|
A
|
BBB
|
BB
|
Other
(1)
|
Total
|
||||||||||||||||||||||
Single-name credit default swaps
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||||||
Credit default indices
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Other credit risk related portfolio products
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Credit-risk related options and swaptions
|
|
|
|
|
|
|
|
|||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Total
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
“Other” includes credit derivatives where the credit rating of the underlying reference asset is below investment grade or where a rating is unavailable.
|
Millions of yen
|
||||||||||||
Year ended March 31
|
||||||||||||
2019
|
2020
|
2021
|
||||||||||
Commissions
|
¥ |
|
¥ |
|
¥ |
|
||||||
Fees from investment banking
|
|
|
|
|||||||||
Asset management and portfolio service fees
|
|
|
|
|||||||||
Other revenue
|
|
|
|
|||||||||
|
|
|
|
|
|
|||||||
Total
|
¥ |
|
¥ |
|
¥ |
|
||||||
|
|
|
|
|
|
Millions of yen
|
||||||||||||
Year ended March 31
|
||||||||||||
2019
|
2020
|
2021
|
||||||||||
Stock Brokerage Commissions
|
¥ |
|
¥ |
|
¥ |
|
||||||
Commissions for distributing of investment trusts
|
|
|
|
|||||||||
Other
|
|
|
|
|||||||||
|
|
|
|
|
|
|||||||
Total
|
¥ |
|
¥ |
|
¥ |
|
||||||
|
|
|
|
|
|
Millions of yen
|
||||||||||||
Year ended March 31
|
||||||||||||
2019
|
2020
|
2021
|
||||||||||
Equity underwriting and distribution
|
¥ |
|
¥ |
|
¥ |
|
||||||
Bond underwriting and distribution
|
|
|
|
|||||||||
Financial advisory fees
|
|
|
|
|||||||||
Other
|
|
|
|
|||||||||
|
|
|
|
|
|
|||||||
Total
|
¥ |
|
¥ |
|
¥ |
|
||||||
|
|
|
|
|
|
Millions of yen
|
||||||||||||
Year ended March 31
|
||||||||||||
2019
|
2020
|
2021
|
||||||||||
Asset management fees
|
¥ |
|
¥ |
|
¥ |
|
||||||
Administration fees
|
|
|
|
|||||||||
Custodial fees
|
|
|
|
|||||||||
|
|
|
|
|
|
|||||||
Total
|
¥ |
|
¥ |
|
¥ |
|
||||||
|
|
|
|
|
|
Type of service provided to
customers
|
|
Overview of key services provided
|
|
Key revenue recognition policies,
assumptions and
judgments
|
Trade execution, clearing services and distribution of fund units
|
|
• Buying and selling of securities on behalf of customers
• Distribution of fund units
• Clearing of securities and derivatives on behalf of customers
|
|
• Trade execution and clearing commissions recognized at a point in time, namely trade date.
• Distribution fees are recognized at a point in time when the fund units have been sold to third party investors.
• Commissions recognized net of soft dollar credits provided to customers where Nomura is acting as agent in providing investment research and
|
Type of service provided to
customers
|
|
Overview of key services provided
|
|
Key revenue recognition policies,
assumptions and
judgments
|
|
|
similar services to the customer.
|
||
Financial advisory services
|
|
• Provision of financial advice to customers in connection with a specific forecasted transaction or transactions such as mergers and acquisitions
• Provision of financial advice not in connection with a specific forecasted transaction or transactions such as general corporate intelligence and similar research
• Issuance of fairness opinions
• Structuring complex financial instruments for customers
|
|
• Fees contingent on the success of an underlying transaction are variable consideration recognized when the underlying transaction has been completed since only at such point is it probable that a significant reversal of revenue will not occur.
• Retainer and milestone fees are recognized either over the period to which they relate or are deferred until consummation of the underlying transaction depending on whether the underlying performance obligation is satisfied at a point in time or over time.
• Judgment is required to make this determination with factors influencing this determination including, but not limited to, whether the fee is in connection with an engagement designed to achieve a specific transaction or outcome for the customer (such as the purchase or sale of a business), the nature and extent of benefit to be provided to the customer prior to, and in addition to such specific transaction or outcome and the fee structure for the engagement.
• Retainer and milestone fees recognized over time are normally recognized on a straight-line basis over the term of the contract based on time elapsed.
|
Type of service provided to
customers
|
|
Overview of key services provided
|
|
Key revenue recognition policies,
assumptions and
judgments
|
Underwriting and syndication services
|
|
• Underwriting of debt, equity and other financial instruments on behalf of customers
• Distributing securities on behalf of issuers
• Arranging loan financing for customers
• Syndicating loan financing on behalf of customer
|
|
• Underwriting and syndication revenues recognized at a point in time when the underlying transaction is complete.
• Commitment fees where drawn down of the facility is deemed remote recognized on a straight-line basis over the life of the facility based on time elapsed.
• Underwriting and syndication costs recognized either as a reduction of revenue or on a gross basis depending on whether Nomura is acting as principal or agent for such amounts.
|
Asset management services
|
|
• Management of funds, investment trusts and other investment vehicles
• Provision of investment advisory services
• Providing custodial and administrative services to customers
|
|
• Management fees earned by Nomura in connection with managing a fund, investment trust or other vehicle generally recognized on a straight-line basis based on time elapsed.
• Performance-based fees are variable consideration recognized when the performance metric has been determined since only at such point is it probable that a significant reversal of revenue will not occur.
• Custodial and administrative fees recognized on a straight-line basis over time based on time elapsed.
|
Millions of yen
|
||||||||
March 31, 2020
|
March 31, 2021
|
|||||||
Customer contract receivables
|
¥ |
|
¥ |
|
||||
Contract liabilities
(1)
|
|
|
(1) |
Contract liabilities primarily rise from investment advisory services and recognized in connection with the term of the contract based on time elapsed.
|
Billions of yen
|
||||||||||||||||
March 31, 2020
|
||||||||||||||||
Assets
|
Liabilities
|
|||||||||||||||
Reverse
repurchase
agreements
|
Securities
borrowing
transactions
|
Repurchase
agreements
|
Securities
lending
transactions
|
|||||||||||||
Total gross balance
(1)
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||
Less: Amounts offset in the consolidated balance sheets
(2)
|
(
|
) |
|
(
|
) |
|
||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total net amounts of reported on the face of the consolidated balance sheets
(3)
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||
|
|
|
|
|
|
|
|
|||||||||
Less: Additional amounts not offset in the consolidated balance sheets
(4)
|
||||||||||||||||
Financial instruments and
non-cash
collateral
|
(
|
) |
(
|
) |
(
|
) |
(
|
) | ||||||||
Cash collateral
|
(
|
) |
|
(
|
) |
|
||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net amount
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||
|
|
|
|
|
|
|
|
|||||||||
Billions of yen
|
||||||||||||||||
March 31, 2021
|
||||||||||||||||
Assets
|
Liabilities
|
|||||||||||||||
Reverse
repurchase
agreements
|
Securities
borrowing
transactions
|
Repurchase
agreements
|
Securities
lending
transactions
|
|||||||||||||
Total gross balance
(1)
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||
Less: Amounts offset in the consolidated balance sheets
(2)
|
(
|
) |
|
(
|
) |
|
||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total net amounts of reported on the face of the consolidated balance sheets
(3)
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||
|
|
|
|
|
|
|
|
|||||||||
Less: Additional amounts not offset in the consolidated balance sheets
(4)
|
||||||||||||||||
Financial instruments and
non-cash
collateral
|
(
|
) |
(
|
) |
(
|
) |
(
|
) | ||||||||
Cash collateral
|
(
|
) |
|
(
|
) |
|
||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net amount
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||
|
|
|
|
|
|
|
|
(1) |
Includes all recognized balances irrespective of whether they are transacted under a master netting agreement or whether Nomura has obtained sufficient evidence of enforceability of the master netting agreement. Amounts include transactions carried at fair value through election of the fair value option. As of March 31, 2020, the gross balance of reverse repurchase agreements and repurchase agreements which were not transacted under master netting agreements or are documented under master netting agreements for which Nomura has not yet obtained sufficient evidence of enforceability was ¥
|
|
and securities lending transactions which were not transacted under master netting agreements or are documented under master netting agreements for which Nomura has not yet obtained sufficient evidence of enforceability was ¥
|
(2) |
Represents amounts offset through counterparty netting under master netting and similar agreements for which Nomura has obtained sufficient evidence of enforceability in accordance with ASC
210-20.
Amounts offset include transactions carried at fair value through election of the fair value option.
|
(3) |
Reverse repurchase agreements and securities borrowing transactions are reported within
Collateralized agreements—Securities purchased under agreements to resell
Collateralized agreements—Securities borrowed
Collateralized financing—Securities sold under agreements to repurchase
Collateralized financing—Securities loaned
Other liabilities
|
(4) |
Represents amounts which are not permitted to be offset on the face of the balance sheet in accordance with ASC
210-20
but which provide Nomura with the right of offset in the event of counterparty default. Amounts relating to agreements where Nomura has not yet obtained sufficient evidence of enforceability of such offsetting rights are excluded.
|
Billions of yen
|
||||||||||||||||||||||||
March 31, 2021
|
||||||||||||||||||||||||
Overnight
and open
(1)
|
Up to
30 days
|
30 - 90
days
|
90 days -
1 year |
Greater
than 1 year
|
Total
|
|||||||||||||||||||
Repurchase agreements
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||||
Securities lending transactions
|
|
|
|
|
|
|
||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Total gross recognized liabilities
(2)
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
Open transactions do not have an explicit contractual maturity date and are terminable on demand by Nomura or the counterparty.
|
(2) |
Repurchase agreements and securities lending transactions are reported within
Collateralized financing—Securities sold under agreements to repurchase
Collateralized financing—Securities loaned
|
|
obligation to return those securities. The liability is reported within
Other liabilities
|
Billions of yen
|
||||||||||||
March 31, 2021
|
||||||||||||
Repurchase
agreements
|
Securities
lending
transactions
|
Total
|
||||||||||
Equities and convertible securities
|
¥ |
|
¥ |
|
¥ |
|
||||||
Japanese government, agency and municipal securities
|
|
|
|
|||||||||
Foreign government, agency and municipal securities
|
|
|
|
|||||||||
Bank and corporate debt securities
|
|
|
|
|||||||||
Commercial mortgage-backed securities (“CMBS”)
|
|
|
|
|||||||||
Residential mortgage-backed securities (“RMBS”)
(1)
|
|
|
|
|||||||||
Collateralized debt obligations (“CDOs”) and other
|
|
|
|
|||||||||
Investment trust funds and other
|
|
|
|
|||||||||
|
|
|
|
|
|
|||||||
Total gross recognized liabilities
(2)
|
¥ |
|
¥ |
|
¥ |
|
||||||
|
|
|
|
|
|
(1) |
Includes ¥
|
(2) |
Repurchase agreements and securities lending transactions are reported within
Collateralized financing—Securities sold under agreements to repurchase
Collateralized financing—Securities loaned
Other liabilities
|
Billions of yen
|
||||||||
March 31
|
||||||||
2020
|
2021
|
|||||||
The fair value of securities received as collateral, securities borrowed as collateral and securities borrowed without collateral where Nomura is permitted by contract or custom to sell or repledge the securities
|
¥ |
|
¥ |
|
||||
The portion of the above that has been sold (reported within
Trading liabilities
|
|
|
Millions of yen
|
||||||||
March 31
|
||||||||
2020
|
2021
|
|||||||
Trading assets:
|
||||||||
Equities and convertible securities
|
¥ |
|
¥ |
|
||||
Government and government agency securities
|
|
|
||||||
Bank and corporate debt securities
|
|
|
||||||
Residential mortgage-backed securities (“RMBS”)
|
|
|
||||||
Collateralized debt obligations (“CDOs”) and other
(1)
|
|
|
||||||
Investment trust funds and other
|
|
|
||||||
|
|
|
|
|||||
¥ |
|
¥ |
|
|||||
|
|
|
|
|||||
Non-trading
debt securities
|
|
|
||||||
Investments in and advances to affiliated companies
|
¥ |
|
¥ |
|
(1) |
Includes CLOs and ABS such as those secured on credit card loans, auto loans and student loans.
|
Millions of yen
|
||||||||
March 31
|
||||||||
2020
|
2021
|
|||||||
Loans and receivables
|
¥ |
|
¥ |
|
||||
Trading assets and private equity and debt investments
|
|
|
||||||
Office buildings, land, equipment and facilities
|
|
|
||||||
Non-trading
debt securities
|
|
|
||||||
Other
|
|
|
||||||
|
|
|
|
|||||
¥ |
|
¥ |
|
|||||
|
|
|
|
Billions of yen
|
||||||||||||||||||||||||
March 31, 2020
|
||||||||||||||||||||||||
Level 1
|
Level 2
|
Level 3
|
Total
|
Investment
grade
|
Other
|
|||||||||||||||||||
Government, agency and municipal securities
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||||
Bank and corporate debt securities
|
|
|
|
|
|
|
||||||||||||||||||
CMBS and RMBS
|
|
|
|
|
|
|
||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Total
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Billions of yen
|
||||||||||||||||||||||||
March 31, 2021
|
||||||||||||||||||||||||
Level 1
|
Level 2
|
Level 3
|
Total
|
Investment
grade
|
Other
|
|||||||||||||||||||
Government, agency and municipal securities
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||||
Bank and corporate debt securities
|
|
|
|
|
|
|
||||||||||||||||||
CMBS and RMBS
|
|
|
|
|
|
|
||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Total
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
Billions of yen
|
||||||||
March 31
|
||||||||
2020
|
2021
|
|||||||
Assets
|
||||||||
Trading assets
|
||||||||
Loans
|
¥ |
|
¥ |
|
||||
|
|
|
|
|||||
Liabilities
|
||||||||
Long-term borrowings
|
¥ |
|
¥ |
|
||||
|
|
|
|
Billions of yen
|
||||||||
March 31
|
||||||||
2020
|
2021
|
|||||||
Consolidated VIE assets
|
||||||||
Cash and cash equivalents
|
¥ |
|
¥ |
|
||||
Trading assets
|
||||||||
Equities
|
|
|
||||||
Debt securities
|
|
|
||||||
CMBS and RMBS
|
|
|
||||||
Investment trust funds and other
|
|
|
||||||
Derivatives
|
|
|
||||||
Private equity and debt investments
|
|
|
||||||
Office buildings, land, equipment and facilities
|
|
|
||||||
Other
|
|
|
||||||
|
|
|
|
|||||
Total
|
¥ |
|
¥ |
|
||||
|
|
|
|
|||||
Consolidated VIE liabilities
|
||||||||
Trading liabilities
|
||||||||
Derivatives
|
|
|
||||||
Borrowings
|
||||||||
Short-term borrowings
|
|
|
||||||
Long-term borrowings
|
|
|
||||||
Other
|
|
|
||||||
|
|
|
|
|||||
Total
|
¥ |
|
¥ |
|
||||
|
|
|
|
Billions of yen
|
||||||||||||
March 31, 2020
|
||||||||||||
Carrying amount of variable interests
|
Maximum exposure
to loss to
unconsolidated VIEs
|
|||||||||||
Assets
|
Liabilities
|
|||||||||||
Trading assets and liabilities
|
||||||||||||
Equities
|
¥ |
|
¥ |
|
¥ |
|
||||||
Debt securities
|
|
|
|
|||||||||
CMBS and RMBS
|
|
|
|
|||||||||
Investment trust funds and other
|
|
|
|
|||||||||
Private equity and debt investments
|
|
|
|
|||||||||
Loans
|
|
|
|
|||||||||
Other
|
|
|
|
|||||||||
Commitments to extend credit and other guarantees
|
|
|
|
|||||||||
|
|
|
|
|
|
|||||||
Total
|
¥ |
|
¥ |
|
¥ |
|
||||||
|
|
|
|
|
|
|||||||
Billions of yen
|
||||||||||||
March 31, 2021
|
||||||||||||
Carrying amount of variable interests
|
Maximum exposure
to loss to
unconsolidated VIEs
|
|||||||||||
Assets
|
Liabilities
|
|||||||||||
Trading assets and liabilities
|
||||||||||||
Equities
|
¥ |
|
¥ |
|
¥ |
|
||||||
Debt securities
|
|
|
|
|||||||||
CMBS and RMBS
|
|
|
|
|||||||||
Investment trust funds and other
|
|
|
|
|||||||||
Private equity and debt investments
|
|
|
|
|||||||||
Loans
|
|
|
|
|||||||||
Other
|
|
|
|
|||||||||
Commitments to extend credit and other guarantees
|
|
|
|
|||||||||
|
|
|
|
|
|
|||||||
Total
|
¥ |
|
¥ |
|
¥ |
|
||||||
|
|
|
|
|
|
Millions of yen
|
||||||||||||
March 31, 2020
|
||||||||||||
Carried at
amortized cost
|
Carried at
fair value
(1)
|
Total
|
||||||||||
Loans receivable
|
||||||||||||
Loans at banks
|
¥ |
|
¥ | — | ¥ |
|
||||||
Short-term secured margin loans
|
|
|
|
|||||||||
Inter-bank money market loans
|
|
— |
|
|||||||||
Corporate loans
|
|
|
|
|||||||||
|
|
|
|
|
|
|||||||
Total loans receivable
|
¥ |
|
¥ |
|
¥ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
Millions of yen
|
||||||||||||
March 31, 2021
|
||||||||||||
Carried at
amortized cost
|
Carried at
fair value
(1)
|
Total
|
||||||||||
Loans receivable
|
||||||||||||
Loans at banks
|
¥ |
|
¥ |
|
¥ |
|
||||||
Short-term secured margin loans
|
|
—
|
|
|||||||||
Inter-bank money market loans
|
|
|
|
|||||||||
Corporate loans
|
|
|
|
|||||||||
|
|
|
|
|
|
|||||||
Total loans receivable
|
¥ |
|
¥ |
|
¥ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
Advances to affiliated companies
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
¥
|
|
|
|
¥
|
|
|
|
¥
|
|
|
|
|
|
|
|
|
(1) |
Includes loans receivable and loan commitments carried at fair value through election of the fair value option.
|
|
•
|
|
Loans receivable and written unfunded loan commitments;
|
|
•
|
|
Cash deposits;
|
|
•
|
|
Collateralized agreements such as reverse repos and securities borrowing transactions;
|
|
•
|
|
Customer contract assets and receivables; and
|
|
•
|
|
Other receivables including margin receivables, security deposits, default fund contributions to central clearing counterparties and net investments in finance leases.
|
Financial instrument
|
|
Methodology to determine current expected credit losses
|
Loans, written loan commitments and certain deposits
|
|
• Full loss rate model developed by Nomura’s Risk department
• Measures expected credit losses based on probability of default (PD), Loss Given Default (LGD) and Exposure at Default (EAD) inputs.
• PD inputs incorporate forward-looking scenarios used by Nomura for internal risk management and capital purposes.
• Immediate reversion method used for periods beyond which reasonable and supportable forecast is not available.
• For financial instruments which have defaulted or are probable of defaulting, expected credit losses measured using discounted cash flow analyses or, where the financial instrument is collateral dependent, based on any shortfall of fair value of the underlying collateral.
|
Collateralized agreements, short-term secured margin loans and cash prime brokerage loans
|
|
• For reverse repos and short-term secured margin loans and cash prime brokerage loans where frequent margining is required and the counterparty has ability to replenish margin, as permitted by a practical expedient provided by ASC 326 expected credit losses are limited to difference between carrying value of the reverse repo or margin loan and fair value of underlying collateral.
• Securities borrowing transactions typically have very short expected lives and are collateralized and therefore expected credit losses are generally determined qualitatively to be insignificant based on historical experience and consistent monitoring of collateral.
|
Customer contract assets and receivables
|
|
• Expected credit losses typically based on ageing analysis where loss rates are applied to the carrying value based on historical experience, the current economic climate and specific information about the ability of the client to pay.
|
Millions of yen
|
||||||||||||||||||||||||
Year ended March 31, 2019
|
||||||||||||||||||||||||
Allowance for doubtful accounts
|
Allowance
for receivables
other than
loans
|
Total
allowance for doubtful accounts |
||||||||||||||||||||||
Loans
at banks
|
Short-term
secured
margin
loans
|
Corporate
loans
|
Subtotal
|
|||||||||||||||||||||
Opening balance
|
¥ |
|
¥ | — | ¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||||
Provision for credit losses
|
|
|
|
|
|
|
||||||||||||||||||
Charge-offs
|
(
|
) |
|
—
|
|
(
|
) |
(
|
) |
(
|
) |
(
|
) | |||||||||||
Other
(1)
|
|
—
|
|
|
|
|
(
|
) |
|
|||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Ending balance
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Millions of yen
|
||||||||||||||||||||||||
Year ended March 31, 2020
|
||||||||||||||||||||||||
Allowance for doubtful accounts
|
Allowance
for
receivables
other than
loans
|
Total
allowance for doubtful accounts |
||||||||||||||||||||||
Loans
at banks
|
Short-term
secured
margin
loans
|
Corporate
loans
|
Subtotal
|
|||||||||||||||||||||
Opening balance
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||||
Provision for credit losses
|
|
|
—
|
|
|
|
|
|
||||||||||||||||
Charge-offs
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
(
|
) |
(
|
) | ||||||||
Other
(1)
|
|
—
|
|
(
|
) |
(
|
) |
(
|
) |
(
|
) |
(
|
) | |||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Ending balance
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
Includes the effect of foreign exchange movements.
|
Millions of yen
|
||||||||||||||||||||||||
Year ended March 31, 2021
|
||||||||||||||||||||||||
Allowance for doubtful accounts
|
Allowance
against
receivables
other than
loans
(2)
|
Total
allowance
for doubtful accounts |
||||||||||||||||||||||
Loans
at banks
|
Short-term
secured
margin
loans
|
Corporate
loans
|
Subtotal
|
|||||||||||||||||||||
Opening balance prior to CECL adoption
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||||
Impact of CECL adoption
(1)
|
|
|
—
|
|
|
|
|
|
||||||||||||||||
Opening balance after CECL adoption
|
|
|
|
|
|
|
||||||||||||||||||
Provision for credit losses
(3)
|
(
|
) |
|
|
|
|
|
|
|
|||||||||||||||
Charge-offs
|
(
|
) |
(
|
) |
(
|
) |
(
|
) |
(
|
) |
(
|
) | ||||||||||||
Other
(4)
|
|
|
|
|
|
|
|
|
||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Ending balance
|
¥ |
|
¥ |
|
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
|||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
The balance recognized on April 1, 2020 on adoption of the CECL impairment model under ASC 326.
|
(2)
|
Includes collateralized agreements, customer contract assets and receivables and other receivables.
|
(3)
|
In March 2021, following the default by the U.S. client an additional allowance for doubtful accounts of ¥
“U.S. Prime Brokerage Event
”
|
(4)
|
Includes the effect of foreign exchange movements and recoveries collected.
|
Millions of yen
|
||||||||||||||||||||||||||||||||
March 31, 2021
|
||||||||||||||||||||||||||||||||
2021
|
2020
|
2019
|
2018
|
2017
|
2016 or
earlier
|
Revolving
|
Total
|
|||||||||||||||||||||||||
Secured loans at banks:
|
||||||||||||||||||||||||||||||||
AAA-BBB
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
|
¥ |
|
|||||||||||||||
BB-CCC
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||
CC-D
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
Others
(1)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Total secured loans at banks
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
|
¥ |
|
|||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Unsecured loans at banks:
|
||||||||||||||||||||||||||||||||
AAA-BBB
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
|
¥ |
|
|||||||||||||||
BB-CCC
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
CC-D
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
Others
(1)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Total unsecured loans at banks
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
|
¥ |
|
|||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Short-term secured margin loans:
|
||||||||||||||||||||||||||||||||
AAA-BBB
|
¥ |
|
|
¥ |
|
|
¥ |
|
|
¥ |
|
|
¥ |
|
|
¥ |
|
|
¥ |
|
|
¥ |
|
|
||||||||
BB-CCC
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
CC-D
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
Others
(1)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Total short-term secured margin loans
|
¥ |
|
¥ |
|
¥ |
|
|
¥ |
|
|
¥ |
|
|
¥ |
|
|
¥ |
|
¥ |
|
||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Unsecured inter-bank money market loans:
|
||||||||||||||||||||||||||||||||
AAA-BBB
|
¥ |
|
¥ |
|
|
¥ |
|
|
¥ |
|
|
¥ |
|
|
¥ |
|
|
¥ |
|
|
¥ |
|
||||||||||
BB-CCC
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
CC-D
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
Others
(1)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Total unsecured inter-bank money market loans
|
¥ |
|
¥ |
|
|
¥ |
|
|
¥ |
|
|
¥ |
|
|
¥ |
|
|
¥ |
|
|
¥ |
|
||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Secured corporate loans:
|
||||||||||||||||||||||||||||||||
AAA-BBB
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||||||||
BB-CCC
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||
CC-D(2)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Others
(1)
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Total secured corporate loans
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Unsecured corporate loans:
|
||||||||||||||||||||||||||||||||
AAA-BBB
|
¥ |
|
|
¥ |
|
|
¥ |
|
|
¥ |
|
|
¥ |
|
|
¥ |
|
|
¥ |
|
|
¥ |
|
|
||||||||
BB-CCC
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
CC-D
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
Others
(1)
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Total unsecured corporate loans
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
|
¥ |
|
¥ |
|
|
¥ |
|
||||||||||||||
Advances to affiliated companie
s
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
AAA-BBB
|
|
¥
|
|
|
|
¥
|
|
|
|
¥
|
|
|
¥
|
|
|
|
¥
|
|
|
|
¥
|
|
|
|
|
¥
|
|
|
|
¥
|
|
|
BB-CCC
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
CC-D
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Others(1)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total advances to affiliated companies
|
|
¥
|
|
|
|
¥
|
|
|
|
¥
|
|
|
¥
|
|
|
|
¥
|
|
|
|
¥
|
|
|
|
|
¥
|
|
|
|
¥
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Total
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
Relate to collateralized exposures where a specified ratio of LTV is maintained.
|
(2)
|
Includes loans of ¥
|
Rating Range
|
Definition
|
|
AAA
|
Highest credit quality. An obligor or facility has extremely strong capacity to meet its financial commitments. ‘AAA range’ is the highest credit rating assigned by Nomura. Extremely low probability of default. | |
AA
|
Very high credit quality category. An obligor or facility has very strong capacity to meet its financial commitments. Very low probability of default but above that of ‘AAA range.’ | |
A
|
High credit quality category. An obligor or facility has strong capacity to meet its financial commitments but is somewhat more susceptible to the adverse effects of changes in circumstances and economic conditions than those in higher-rated categories. Low probability of default but higher than that of ‘AA range.’ | |
BBB
|
Good credit quality category. An obligor or facility has adequate capacity to meet its financial commitments. However, adverse economic conditions or changing circumstances are more likely to lead to a weakened capacity to meet its financial commitments. Medium probability of default but higher than that of ‘A range.’ | |
BB
|
Speculative credit quality category. An obligor or facility is less vulnerable in the near term than other lower-ratings. However, it faces major ongoing uncertainties and exposure to adverse business, financial, or economic conditions which could lead to the inadequate capacity to meet its financial commitments. Medium to high probability of default but higher than that of ‘BBB range.’ | |
B
|
Highly speculative credit quality category. An obligor or facility is more vulnerable than those rated ‘BB range’, but the obligor currently has the capacity to meet its financial commitments. Adverse business, financial, or economic conditions will likely impair the issuer’s or obligor’s capacity or willingness to meet its financial commitments. High probability of default—more than that of ‘BB range.’ | |
CCC
|
Substantial credit risk. An obligor or facility is currently vulnerable, and is dependent upon favorable business, financial, and economic conditions to meet its financial commitments. Strong probability of default—more than that of ‘B range.’ | |
CC
|
An obligor or facility is currently highly vulnerable to nonpayment (default category). | |
C
|
An obligor or facility is currently extremely vulnerable to nonpayment (default category). | |
D
|
Failure of an obligor to make payments in full and on time of any financial obligations, markedly disadvantageous modification to a contractual term compared with the existing obligation, bankruptcy filings, administration, receivership, liquidation or other
winding-up
or cessation of business of an obligor or other similar situations.
|
Millions of yen
|
||||||||||||||||||||||||
March 31
|
||||||||||||||||||||||||
2020
|
2021
|
|||||||||||||||||||||||
Cost
|
Accumulated
depreciation
|
Net carrying
amount
|
Cost
|
Accumulated
depreciation
|
Net carrying
amount
|
|||||||||||||||||||
Real estate
(1)
|
¥ |
|
¥ |
(
|
) | ¥ |
|
¥ |
|
¥ |
(
|
) | ¥ |
|
||||||||||
Aircraft
|
|
(
|
) |
|
|
(
|
) |
|
||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Total
|
¥ |
|
¥ |
(
|
) | ¥ |
|
¥ |
|
¥ |
(
|
) | ¥ |
|
||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
Cost, accumulated depreciation and net carrying amounts include amounts relating to real estate utilized by Nomura.
|
Millions of yen
|
|||||
March 31, 2021
|
|||||
Minimum lease payments
to be received
|
|||||
Years of receipt
|
|||||
Less than 1 year
|
¥ |
|
|||
1 to 2 years
|
|
||||
2 to 3 years
|
|
||||
3 to 4 years
|
|
||||
4 to 5 years
|
|
||||
More than 5 years
|
|
||||
|
|
||||
Total
|
¥ |
|
|||
|
|
Millions of yen
|
||||||||
Year ended March 31
|
||||||||
2020
|
2021
|
|||||||
Lease expense:
|
||||||||
Operating lease costs
|
¥ |
|
¥ |
|
||||
Other income and expenses:
|
||||||||
Gross sublease income
(1)
|
¥ |
|
¥ |
|
(1) |
Gross sublease income represents income from subleases separate from lease payments made by Nomura on the head lease as lessee.
|
Millions of yen
|
||||||||
Year ended March 31
|
||||||||
2020
|
2021
|
|||||||
Operating cash flows for operating leases
|
¥ |
|
¥ |
|
||||
ROU assets recognized in connection with new operating leases
|
¥ |
|
¥ |
|
Millions of yen
|
||||
March 31, 2021
|
||||
Operating leases
|
||||
Years of payment
|
||||
Less than 1 year
|
¥ |
|
||
1 to 2 years
|
|
|||
2 to 3 years
|
|
|||
3 to 4 years
|
|
|||
4 to 5 years
|
|
|||
More than 5 years
|
|
|||
|
|
|||
Total undiscounted lease payments
|
¥ |
|
||
Less: Impact of discounting
|
(
|
) | ||
|
|
|||
Lease liabilities
as reported in the consolidated balance sheets
|
¥ |
|
||
|
|
Year ended March 31
|
||||
2020
|
2021
|
|||
Operating leases
|
Operating leases
|
|||
Weighted-average discount rate used to measure lease liabilities
|
|
|
||
Weighted-average remaining lease term
|
|
|
Millions of yen
|
||||||||
March 31
|
||||||||
2020
|
2021
|
|||||||
Other assets—Other:
|
||||||||
Securities received as collateral
|
¥ |
|
¥ |
|
||||
Goodwill and other intangible assets
|
|
|
||||||
Deferred tax assets net
|
|
|
||||||
Investments in equity securities for other than operating purposes
(1)
|
|
|
||||||
Prepaid expenses
|
|
|
||||||
Other
|
|
|
||||||
|
|
|
|
|||||
Total
|
¥ |
|
¥ |
|
||||
|
|
|
|
|||||
Other liabilities:
|
||||||||
Obligation to return securities received as collateral
|
¥ |
|
¥ |
|
||||
Accrued income taxes
|
|
|
||||||
Other accrued expenses and provisions
|
|
|
||||||
Other
(2)
|
|
|
||||||
|
|
|
|
|||||
Total
|
¥ |
|
¥ |
|
||||
|
|
|
|
(1) |
Include
s
marketable and
non-marketable
equity securities held for other than trading or operating purposes. These investments comprise of listed equity securities and unlisted equity securities of ¥
million respectively, as of March 31, 2021. In principle, these securities are carried at fair value, with changes in fair value recognized within
Revenue—Other
in the consolidated statements of income.
It also includes equity securities without readily determinable fair value
of
million as of March 31, 2021.
|
(2) |
As a result of adopting ASU 2016-02 as of April 1, 2019, operating lease liabilities are presented through
Other liabilities—Other
. See Note 8 “Leases” for further information.
It also includes a total liability
¥
of
Commitments, contingencies and guarantees
” for further information.
|
Millions of yen
|
||||||||||||||||||||||||||||||||||||
Year ended March 31, 2020
|
||||||||||||||||||||||||||||||||||||
Beginning of year
|
Changes during year
|
End of year
|
||||||||||||||||||||||||||||||||||
Gross
carrying
amount
|
Accumulated
Impairment
|
Net
carrying
amount
|
Acquisition
|
Impairment
|
Other
(1)
|
Gross
carrying
amount
|
Accumulated
Impairment
|
Net
carrying
amount
|
||||||||||||||||||||||||||||
Wholesale
|
¥ |
|
¥ |
(
|
) | ¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
(
|
) | ¥ |
|
||||||||||||||||
Other
|
|
|
|
|
|
(
|
) |
|
|
|
||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Total
|
¥ |
|
¥ |
(
|
) | ¥ |
|
¥ |
|
¥ |
|
¥ |
(
|
) | ¥ |
|
¥ |
(
|
) | ¥ |
|
|||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Millions of yen
|
||||||||||||||||||||||||||||||||||||
Year ended March 31, 2021
|
||||||||||||||||||||||||||||||||||||
Beginning of year
|
Changes during year
|
End of year
|
||||||||||||||||||||||||||||||||||
Gross
carrying
amount
|
Accumulated
Impairment
|
Net
carrying
amount
|
Acquisition
(2)
|
Impairment
|
Other
(1)
|
Gross
carrying
amount
|
Accumulated
Impairment
|
Net
carrying
amount
|
||||||||||||||||||||||||||||
Wholesale
|
¥ |
|
¥ |
(
|
) | ¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
(
|
) | ¥ |
|
||||||||||||||||
Other
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Total
|
¥ |
|
¥ |
(
|
) | ¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
(
|
) | ¥ |
|
||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
Includes currency translation adjustments.
|
(2) |
For the year ended March 31, 2021, Nomura recognized goodwill as a result of acquiring
which has been allocated in its entirety to the Wholesale division for segmental reporting and reporting unit
purposes
. See Note 9
Business Combination”
for further information.
|
Millions of yen
|
||||||||||||||||||||||||
March 31, 2020
|
March 31, 2021
|
|||||||||||||||||||||||
Gross
carrying
amount
|
Accumulated
amortization
|
Net carrying
amount
|
Gross
carrying
amount
|
Accumulated
amortization
|
Net carrying
amount
|
|||||||||||||||||||
Client relationships
|
¥ |
|
¥ |
(
|
) | ¥ |
|
¥ |
|
¥ |
(
|
) | ¥ |
|
||||||||||
Other
|
|
(
|
) |
|
|
(
|
) |
|
||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Total
|
¥ |
|
¥ |
(
|
) | ¥ |
|
¥ |
|
¥ |
(
|
) | ¥ |
|
||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
Millions of yen
|
|||||
Year ending March 31
|
Estimated
amortization expense
|
||||
2022
|
¥ |
|
|||
2023
|
|
||||
2024
|
|
||||
2025
|
|
||||
2026
|
|
Millions of yen
|
||||||||
March 31
|
||||||||
2020
|
2021
|
|||||||
Balance at beginning of year
|
¥ |
|
¥ |
|
||||
Liabilities incurred during the current period
|
|
|
||||||
Liabilities settled during the current period
|
(
|
) |
(
|
) | ||||
|
|
|
|
|||||
Revision in estimated cash flows
(1
)
|
|
|
|
|
|
|
|
|
Balance at end of period
|
¥ |
|
¥ |
|
||||
|
|
|
|
(1)
|
During the fiscal year ended March 31, 2021, as a result of the rights conversion of the Tokyo Nihonbashi district redevelopment project, the estimate of future cash flows for the ARO associated with our properties has been changed.
|
Millions of yen
|
||||||||
March 31
|
||||||||
2020
|
2021
|
|||||||
Short-term borrowings
(1)
:
|
||||||||
Commercial paper
|
¥ |
|
¥ |
|
||||
Bank borrowings
|
|
|
||||||
Other
|
|
|
||||||
|
|
|
|
|||||
Total
|
¥ |
|
¥ |
|
||||
|
|
|
|
|||||
Long-term borrowings:
|
||||||||
Long-term borrowings from banks and other financial institutions
(2)
|
¥ |
|
¥ |
|
||||
Bonds and notes issued
(3)
:
|
||||||||
Fixed-rate obligations:
|
||||||||
Japanese yen denominated
|
|
|
||||||
Non-Japanese
yen denominated
|
|
|
||||||
Floating-rate obligations:
|
||||||||
Japanese yen denominated
|
|
|
||||||
Non-Japanese
yen denominated
|
|
|
||||||
Index / Equity-linked obligations:
|
||||||||
Japanese yen denominated
|
|
|
||||||
Non-Japanese
yen denominated
|
|
|
||||||
|
|
|
|
|||||
|
|
|||||||
|
|
|
|
|||||
Subtotal
|
|
|
||||||
|
|
|
|
|||||
Trading balances of secured borrowings
|
|
|
||||||
|
|
|
|
|||||
Total
|
¥ |
|
¥ |
|
||||
|
|
|
|
(1) |
Includes secured borrowings of ¥
|
(2) |
Includes secured borrowings of ¥
|
(3) |
Includes secured borrowings of ¥
|
Millions of yen
|
||||||||
March 31
|
||||||||
2020
|
2021
|
|||||||
Debt issued by the Company
|
¥ |
|
¥ |
|
||||
Debt issued by subsidiaries—guaranteed by the Company
|
|
|
||||||
Debt issued by subsidiaries—not guaranteed by the Company
(1)
|
|
|
||||||
|
|
|
|
|||||
Total
|
¥ |
|
¥ |
|
||||
|
|
|
|
(1) |
Includes trading balances of secured borrowings.
|
March 31
|
||||||||
2020
|
2021
|
|||||||
Short-term borrowings
|
|
% |
|
% | ||||
Long-term borrowings
|
|
% |
|
% | ||||
Fixed-rate obligations
|
|
% |
|
% | ||||
Floating-rate obligations
|
|
% |
|
% | ||||
Index / Equity-linked obligations
|
|
% |
|
% |
Year ending March 31
|
Millions of yen
|
|||
2022
|
¥ |
|
||
2023
|
|
|||
2024
|
|
|||
2025
|
|
|||
2026
|
|
|||
2027 and thereafter
|
|
|||
|
|
|||
Subtotal
|
|
|||
|
|
|||
Trading balances of secured borrowings
|
|
|||
|
|
|||
Total
|
¥ |
|
||
|
|
Millions of yen
except per share data presented in yen
|
||||||||||||
Year ended March 31
|
||||||||||||
2019
|
2020
|
2021
|
||||||||||
Basic—
|
||||||||||||
Net income (loss) attributable to NHI shareholders
|
¥ |
(
|
) | ¥ |
|
¥ |
|
|||||
|
|
|
|
|
|
|||||||
Weighted average number of shares outstanding
|
|
|
|
|||||||||
|
|
|
|
|
|
|||||||
Net income (loss) attributable to NHI shareholders per share
|
¥ |
(
|
) | ¥ |
|
¥ |
|
|||||
|
|
|
|
|
|
|||||||
Diluted—
|
||||||||||||
Net income (loss) attributable to NHI shareholders
|
¥ |
(
|
) | ¥ |
|
¥ |
|
|||||
|
|
|
|
|
|
|||||||
Weighted average number of shares outstanding
|
|
|
|
|||||||||
|
|
|
|
|
|
|||||||
Net income (loss) attributable to NHI shareholders per share
|
¥ |
(
|
) | ¥ |
|
¥ |
|
|||||
|
|
|
|
|
|
Millions of yen
|
||||||||||||
Year ended March 31
|
||||||||||||
2019
|
2020
|
2021
|
||||||||||
Service cost
|
¥ |
|
¥ |
|
¥ |
|
||||||
Interest cost
|
|
|
|
|||||||||
Expected return on plan assets
|
(
|
) |
(
|
) |
(
|
) | ||||||
Amortization of net actuarial losses
|
|
|
|
|||||||||
Amortization of prior service cost
|
(
|
) |
(
|
) |
(
|
) | ||||||
|
|
|
|
|
|
|||||||
Net periodic benefit cost
|
¥ |
|
¥ |
|
¥ |
|
||||||
|
|
|
|
|
|
Millions of yen
|
||||||||
As of or for the year
ended March 31 |
||||||||
2020
|
2021
|
|||||||
Change in projected benefit obligation:
|
||||||||
Projected benefit obligation at beginning of year
|
¥ |
|
¥ |
|
||||
Service cost
|
|
|
||||||
Interest cost
|
|
|
||||||
Actuarial gain
|
(
|
) |
(
|
) | ||||
Benefits paid
|
(
|
) |
(
|
) | ||||
Amendments of pension benefit plans
|
(
|
) | — | |||||
Acquisition, divestitures and other
|
|
|
||||||
|
|
|
|
|||||
Projected benefit obligation at end of year
|
¥ |
|
¥ |
|
||||
|
|
|
|
|||||
Change in plan assets:
|
||||||||
Fair value of plan assets at beginning of year
|
¥ |
|
¥ |
|
||||
Actual return on plan assets
|
(
|
) |
|
|||||
Employer contributions
|
|
|
||||||
Benefits paid
|
(
|
) |
(
|
) | ||||
|
|
|
|
|||||
Fair value of plan assets at end of year
|
¥ |
|
¥ |
|
||||
|
|
|
|
|||||
Funded status at end of year
|
(
|
) |
(
|
) | ||||
|
|
|
|
|||||
Amounts recognized in the consolidated balance sheets
|
¥ |
(
|
) | ¥ |
(
|
) | ||
|
|
|
|
Millions of yen
|
||||||||
March 31
|
||||||||
2020
|
2021
|
|||||||
Plans with ABO in excess of plan assets:
|
||||||||
PBO
|
¥ |
|
¥ |
|
||||
ABO
|
|
|
||||||
Fair value of plan assets
|
|
|
||||||
Plans with PBO in excess of plan assets:
|
||||||||
PBO
|
¥ |
|
¥ |
|
||||
ABO
|
|
|
||||||
Fair value of plan assets
|
|
|
Millions of yen
|
|||||
For the year ended
March 31, 2021
|
|||||
Net actuarial loss
|
¥ |
|
|||
Net prior service cost
|
(
|
) | |||
|
|
||||
Total
|
¥ |
|
|||
|
|
Millions of yen
|
|||||
For the year ending
March 31, 2022
|
|||||
Net actuarial loss
|
¥ |
|
|||
Net prior service cost
|
(
|
) | |||
|
|
||||
Total
|
¥ |
|
|||
|
|
March 31
|
||||||||
2020
|
2021
|
|||||||
Discount rate
|
|
% |
|
% | ||||
Rate of increase in compensation levels
|
|
% |
|
% | ||||
Interest crediting rate
|
|
|
|
%
|
|
|
|
% |
Year ended March 31
|
||||||||||||
2019
|
2020
|
2021
|
||||||||||
Discount rate
|
|
% |
|
% |
|
% | ||||||
Rate of increase in compensation levels
|
|
% |
|
% |
|
% | ||||||
Expected long-term rate of return on plan assets
|
|
% |
|
% |
|
% | ||||||
Interest crediting rate
|
|
|
|
%
|
|
|
|
%
|
|
|
|
% |
Millions of yen
|
||||||||||||||||
March 31, 2020
|
||||||||||||||||
Level 1
|
Level 2
|
Level 3
|
Balance as of
March 31,
2020 |
|||||||||||||
Pension plan assets:
|
||||||||||||||||
Private equity and pooled investments
(1)
|
|
¥
|
|
|
¥
|
|
¥
|
|
¥
|
|
||||||
Japanese government securities
|
|
|
|
|
|
|
|
|
||||||||
Investment trust funds and other
(2)(3)
|
|
|
|
|
|
|
||||||||||
Life insurance company general accounts
|
|
|
|
|
|
|
|
|
||||||||
Other assets
|
|
|
|
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|||||||||
Total
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||
|
|
|
|
|
|
|
|
|||||||||
Millions of yen
|
||||||||||||||||
March 31, 2021
|
||||||||||||||||
Level 1
|
Level 2
|
Level 3
|
Balance as of
March 31,
2021 |
|||||||||||||
Pension plan asset
s
:
|
||||||||||||||||
Private equity and pooled investments
(1)
|
¥
|
|
|
¥
|
|
¥
|
|
¥
|
|
|||||||
Japanese government securities
|
|
|
|
|
|
|
|
|
||||||||
Investment trust funds and other
(2)(3)
|
|
|
|
|
|
|
||||||||||
Life insurance company general accounts
|
|
|
|
|
|
|
|
|
||||||||
Other assets
|
|
|
|
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|||||||||
Total
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||
|
|
|
|
|
|
|
|
(1) |
Includes corporate type equity investments.
|
(2) |
Includes mainly debt investment funds. Hedge funds and real estate funds are also included.
|
(3) |
Certain assets that are measured at fair value using net asset value per share as a practical expedient have not been classified in the fair value hierarchy. As of March 31, 2020 and 2021, the fair values of these assets were
¥
|
Millions of yen
|
||||||||||||||||
Year ended March 31, 2020
|
||||||||||||||||
Balance
as of
April 1,
2019
|
Unrealized
and realized gains / (loss) |
Purchases /
sales and
other
settlement
|
Balance
as of
March 31,
2020
|
|||||||||||||
Private equity and pooled investments
|
¥ |
|
¥ |
(
|
) | ¥ |
|
¥ |
|
|||||||
Investment trust funds and other
|
|
(
|
) |
(
|
) |
|
||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total
|
¥ |
|
¥ |
(
|
) | ¥ |
|
¥ |
|
|||||||
|
|
|
|
|
|
|
|
|||||||||
Millions of yen
|
||||||||||||||||
Year ended March 31, 2021
|
||||||||||||||||
Balance
as of
April 1,
2020
|
Unrealized
and
gains /
(
loss
)
|
Purchases /
sales and
other
settlement
|
Balance
as of
March 31,
2021
|
|||||||||||||
Private equity and pooled investments
|
¥ |
|
¥ |
|
¥ |
(
|
) | ¥ |
|
|||||||
Investment trust funds and other
|
|
|
(
|
) |
|
|||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total
|
¥ |
|
¥ |
|
¥ |
(
|
) | ¥ |
|
|||||||
|
|
|
|
|
|
|
|
Year ending March 31
|
Millions of yen
|
|||
2022
|
¥ |
|
||
2023
|
|
|||
2024
|
|
|||
2025
|
|
|||
2026
|
|
|||
2027-2031
|
|
Outstanding
(number of Nomura
shares)
|
Weighted-average
grant date fair
value per share
|
Weighted-average
remaining life
until expiry
(years)
|
|||||||||||||
Outstanding as of March 31, 2020
|
|
¥ |
|
|
|||||||||||
Granted
|
|
|
|||||||||||||
Forfeited
|
(
|
) |
|
||||||||||||
Delivered
|
(
|
) |
|
||||||||||||
|
|
|
|
||||||||||||
Outstanding as of March 31, 2021
|
|
¥ |
|
|
|||||||||||
|
|
|
|
• |
Expected volatilities based on historical volatility of the Company’s common stock;
|
• |
Expected dividend yield based on the current dividend rate at the time of grant;
|
• |
Expected lives of the awards determined based on historical experience; and
|
• |
Expected risk-free interest rate based on Japanese Yen swap rate with a maturity equal to the expected lives of the options.
|
Year ended March 31
|
||||||||||||
2019
|
2020
|
2021
|
||||||||||
Expected volatility
|
|
% |
|
% |
|
% | ||||||
Expected dividends yield
|
|
% |
|
% |
|
% | ||||||
Expected lives (in years)
|
|
|
|
|||||||||
Risk-free interest rate
|
|
% |
|
% |
|
% |
Outstanding
(number of Nomura
shares)
|
Weighted-average
exercise price
|
Weighted-average
remaining life
until expiry
(years)
|
|||||||||||||
Outstanding as of March 31, 2020
|
|
¥ |
|
|
|||||||||||
Granted
|
|
|
|||||||||||||
Exercised
|
(
|
) |
|
||||||||||||
Forfeited
|
(
|
) |
|
||||||||||||
Expired
|
(
|
) |
|
||||||||||||
|
|
|
|
||||||||||||
Outstanding as of March 31, 2021
|
|
¥ |
|
|
|||||||||||
|
|
|
|
||||||||||||
Exercisable as of March 31, 2021
|
|
¥ |
|
|
|||||||||||
|
|
|
|
Outstanding
(number of Nomura
shares)
|
Weighted-average
grant date fair
value per share
|
Weighted-average
remaining life
until expiry
(years)
|
|||||||||||||
Outstanding as of March 31, 2020
|
|
¥ |
|
|
|||||||||||
Granted
|
|
|
|||||||||||||
Exercised
|
(
|
) |
|
||||||||||||
Forfeited
|
(
|
) |
|
||||||||||||
Expired
|
(
|
) |
|
||||||||||||
|
|
|
|
||||||||||||
Outstanding as of March 31, 2021
|
|
¥ |
|
|
|||||||||||
|
|
|
|
||||||||||||
Exercisable as of March 31, 2021
|
|
¥ |
|
|
|||||||||||
|
|
|
|
NSUs
|
CSUs
|
|||||||||||||||||||
Outstanding
(number of units)
|
Stock
price
|
Outstanding
(number of units)
|
Stock
price
|
|||||||||||||||||
Outstanding as of March 31, 2020
|
|
¥ |
|
|
¥ |
|
||||||||||||||
Granted
|
|
|
(1)
|
|
|
|||||||||||||||
Vested
|
(
|
) |
|
(2)
|
(
|
) |
|
(2)
|
||||||||||||
Forfeited
|
(
|
) |
|
|||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Outstanding as of March 31, 2021
|
|
¥ |
|
(3)
|
|
¥ |
|
(3)
|
||||||||||||
|
|
|
|
|
|
|
|
(1) |
Weighted-average price of the Company’s common stock used to determine number of awards granted.
|
(2) |
Weighted-average price of the Company’s common stock used to determine the final cash settlement amount of the awards.
|
(3) |
The price of the Company’s common stock used to remeasure the fair value of the remaining outstanding unvested awards as of March 31, 2021.
|
Outstanding
(number of units)
|
Index price
(1)
|
|||||||||
Outstanding as of March 31, 2020
|
|
$ |
|
|||||||
Granted
|
|
|
||||||||
Vested
|
(
|
) |
|
(2)
|
||||||
Forfeited
|
|
|||||||||
|
|
|
|
|||||||
Outstanding as of March 31, 2021
|
|
$ |
|
(3)
|
||||||
|
|
|
|
(1) |
The price of each unit is determined using
1/1000
th of the index price.
|
(2) |
Weighted-average index price used to determine the final cash settlement amount of the awards.
|
(3) |
Index price used to remeasure the total fair value of the remaining outstanding unvested awards as of March 31, 2021.
|
Millions of yen
|
||||||||||||
Year ended March 31
|
||||||||||||
2019
|
2020
|
2021
|
||||||||||
Current:
|
||||||||||||
Domestic
|
¥ |
|
¥ |
|
¥ |
|
||||||
Foreign
|
|
|
|
|||||||||
|
|
|
|
|
|
|||||||
Subtotal
|
|
|
|
|||||||||
|
|
|
|
|
|
|||||||
Deferred:
|
||||||||||||
Domestic
|
|
(
|
) |
(
|
) | |||||||
Foreign
|
(
|
) |
(
|
) |
(
|
) | ||||||
|
|
|
|
|
|
|||||||
Subtotal
|
|
(
|
) |
(
|
) | |||||||
|
|
|
|
|
|
|||||||
Total
|
¥ |
|
¥ |
|
¥ |
|
||||||
|
|
|
|
|
|
Year ended March 31
|
||||||||||||
2019
|
2020
|
2021
|
||||||||||
Nomura’s effective statutory tax rate
|
|
% |
|
% |
|
% | ||||||
Impact of:
|
||||||||||||
Changes in deferred tax valuation allowances
|
(
|
) |
(
|
) |
|
|||||||
Additional taxable income
|
(
|
) |
|
|
||||||||
Non-deductible
expenses
(1)
|
(
|
) |
|
|
||||||||
Non-taxable
income
(2)
|
|
(
|
) |
(
|
) | |||||||
Dividends from foreign subsidiaries
|
|
|
|
|||||||||
Tax effect of undistributed earnings of foreign subsidiaries
|
(
|
) |
|
|
||||||||
Different tax rate applicable to income (loss) of foreign subsidiaries
|
(
|
) |
(
|
) |
(
|
) | ||||||
Effect of changes in foreign tax laws
|
|
(
|
) |
|
||||||||
Tax benefit recognized on the outside basis differences for investment in subsidiaries and affiliates
(3)
|
|
(
|
) |
(
|
) | |||||||
Other
|
(
|
) |
|
(
|
) | |||||||
|
|
|
|
|
|
|||||||
Effective tax rate
|
(
|
)% |
|
% |
|
% | ||||||
|
|
|
|
|
|
(1) |
Non-deductible
expenses
|
(2) |
Non-taxable
income
non-taxable
dividend income from affiliated Nomura companies, including deemed dividend (which decreased Nomura’s effective tax rate by
|
(3)
|
Tax benefit recognized on the outside basis differences for investment in subsidiaries and affiliates
Changes in deferred tax valuation allowances
|
Millions of yen
|
||||||||
March 31
|
||||||||
2020
|
2021
|
|||||||
Deferred tax assets
|
||||||||
Depreciation, amortization and valuation of fixed assets
|
¥ |
|
¥ |
|
||||
Investments in subsidiaries and affiliates
|
|
|
||||||
Valuation of financial instruments
|
|
|
||||||
Accrued pension and severance costs
|
|
|
||||||
Other accrued expenses and provisions
|
|
|
||||||
Operating losses
|
|
|
||||||
Lease liabilities
|
|
|
||||||
Other
|
|
|
||||||
|
|
|
|
|||||
Gross deferred tax assets
|
|
|
||||||
Less
—
|
(
|
) |
(
|
) | ||||
|
|
|
|
|||||
Total deferred tax assets
|
|
|
||||||
|
|
|
|
|||||
Deferred tax liabilities
|
||||||||
Investments in subsidiaries and affiliates
|
|
|
||||||
Valuation of financial instruments
|
|
|
||||||
Undistributed earnings of foreign subsidiaries
|
|
|
||||||
Valuation of fixed assets
|
|
|
||||||
Right-of-use
|
|
|
||||||
Other
|
|
|
||||||
|
|
|
|
|||||
Total deferred tax liabilities
|
|
|
||||||
|
|
|
|
|||||
Net deferred tax assets (liabilities)
|
¥ |
(
|
) | ¥ |
(
|
) | ||
|
|
|
|
Millions of yen
|
||||||||||||
Year ended March 31
|
||||||||||||
2019
|
2020
|
2021
|
||||||||||
Balance at beginning of year
|
¥ |
|
¥ |
|
¥ |
|
||||||
Net change during the year
|
|
(1)
|
(
|
)
(2)
|
|
(3)
|
||||||
|
|
|
|
|
|
|||||||
Balance at end of year
|
¥ |
|
¥ |
|
¥ |
|
||||||
|
|
|
|
|
|
(1) |
Primarily includes an increase of ¥
|
(2) |
Primarily includes a reduction of ¥
|
(3) |
Primarily includes an increase of ¥
million of valuation allowances of certain foreign subsidiaries mainly due to an increase in valuation allowances related to operating loss carryforwards, a reduction of
million of valuation allowances mainly due to an increase in valuation of financial instruments, and a reduction of
million of valuation allowances related to Japanese subsidiaries and the Company mainly due to an increase of valuation of financial instruments and a decrease of accrued pension and severance costs. In total,
million of allowances increased for the year ended March 31, 2021.
|
Jurisdiction
|
Year
|
|||
Japan
|
|
(1)
|
||
United Kingdom
|
|
|||
United States
|
|
(1) |
The earliest year in which Nomura remains subject to examination for transfer pricing issues is 2015.
|
Millions of yen
|
|||||||||||||||||||||||||
For the year ended March 31, 2020
|
|||||||||||||||||||||||||
Balance at
beginning
of year
|
Other
comprehensive
income (loss)
before
reclassifications
|
Reclassifications out of
accumulated other
comprehensive
income (loss)
|
Net change
during the
year
|
Balance at
end of year
|
|||||||||||||||||||||
Cumulative translation adjustments
|
¥ |
|
¥ |
(
|
) | ¥ |
|
¥ |
(
|
) | ¥ |
(
|
) | ||||||||||||
Pension liability adjustment
(1)
|
(
|
) |
|
|
|
(
|
) | ||||||||||||||||||
Own credit adjustments
(2)
|
|
|
(
|
) |
|
|
|||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Total
|
¥ |
(
|
) | ¥ |
(
|
) | ¥ |
|
¥ |
|
¥ |
(
|
) | ||||||||||||
|
|
|
|
|
|
|
|
|
|
(1) |
See Note 13 “
Employee benefit plans
|
(2) |
See Note 2 “
Fair value measurements
|
Millions of yen
|
|||||||||||||||||||||||||
For the year ended March 31, 2021
|
|||||||||||||||||||||||||
Balance at
beginning
of year
|
Other
comprehensive
income (loss)
before
reclassifications
|
Reclassifications out of
accumulated other
comprehensive
income (loss)
|
Net change
during the
year
|
Balance at
end of year
|
|||||||||||||||||||||
Cumulative translation adjustments
|
¥ |
(
|
) | ¥ |
|
¥ |
(
|
) | ¥ |
|
¥ |
|
|||||||||||||
Pension liability adjustment
(1)
|
(
|
) |
|
|
|
(
|
) | ||||||||||||||||||
Own credit adjustments
(2)
|
|
(
|
) |
(
|
) |
(
|
) |
(
|
) | ||||||||||||||||
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Total
|
¥ |
(
|
) | ¥ |
(
|
) | ¥ |
(
|
) | ¥ |
(
|
) | ¥ |
(
|
) | ||||||||||
|
|
|
|
|
|
|
|
|
|
(1) |
See Note 13 “
Employee benefit plans
|
(2) |
See Note 2 “
Fair value measurements
|
Millions of yen
|
|||||||||||||||
For the year ended March 31
|
|||||||||||||||
2020
|
2021
|
Affected line items in consolidated
statements of income
|
|||||||||||||
Reclassifications out of
accumulated other
comprehensive income (loss)
|
Reclassifications out of
accumulated other
comprehensive income (loss)
|
||||||||||||||
Cumulative translation adjustments:
|
|||||||||||||||
¥ |
(
|
) | ¥ |
|
Revenue—Other /
Non-interest
expenses—Other
|
||||||||||
|
— | Income tax expense | |||||||||||||
|
|
|
|
||||||||||||
(
|
) |
|
Net income (loss) | ||||||||||||
|
|
|
|
||||||||||||
|
— | Net income attributable to noncontrolling interests | |||||||||||||
|
|
|
|
||||||||||||
¥ |
(
|
) | ¥ |
|
Net income (loss)
attributable to NHI
shareholders
|
||||||||||
|
|
|
|
||||||||||||
Millions of yen
|
|||||||||||||||
For the year ended March 31
|
|||||||||||||||
2020
|
2021
|
Affected line items in consolidated
statements of income |
|||||||||||||
Reclassifications out of
accumulated other
comprehensive income (loss)
|
Reclassifications out of
accumulated other
comprehensive income (loss)
|
||||||||||||||
Pension liability adjustment:
|
|||||||||||||||
¥ |
(
|
) | ¥ |
(
|
) |
Non-interest
expenses—Compensation
and benefits /
Revenue—Other
|
|||||||||
|
|
Income tax expense | |||||||||||||
|
|
|
|
||||||||||||
(
|
) |
(
|
) | Net income (loss) | |||||||||||
|
|
|
|
||||||||||||
|
— | Net income attributable to noncontrolling interests | |||||||||||||
|
|
|
|
||||||||||||
¥ |
(
|
) | ¥ |
(
|
) |
Net income (loss)
attributable to NHI
shareholders
|
|||||||||
|
|
|
|
Millions of yen
|
|||||||||||||||
For the year ended March 31
|
|||||||||||||||
2020
|
2021
|
Affected line items in consolidated
statements of income |
|||||||||||||
Reclassifications out of
accumulated other
comprehensive income (loss)
|
Reclassifications out of
accumulated other
comprehensive income (loss)
|
||||||||||||||
Own credit adjustments:
|
|||||||||||||||
¥ |
|
¥ |
|
Revenue—Net gain on
trading
|
|||||||||||
(
|
) |
(
|
) | Income tax expense | |||||||||||
|
|
|
|
||||||||||||
|
|
Net income (loss) | |||||||||||||
|
|
|
|
||||||||||||
|
— | Net income attributable to noncontrolling interests | |||||||||||||
|
|
|
|
||||||||||||
¥ |
|
¥ |
|
Net income (loss)
attributable to NHI
shareholders
|
|||||||||||
|
|
|
|
Number of Shares
|
||||||||||||
Year ended March 31
|
||||||||||||
2019
|
2020
|
2021
|
||||||||||
Common stock outstanding at beginning of year
|
|
|
|
|||||||||
Decrease of common stock by cancellation of treasury stock
|
(
|
) | — |
(
|
) | |||||||
Common stock held in treasury:
|
||||||||||||
Repurchases of common stock
|
(
|
) |
(
|
) |
(
|
) | ||||||
Sales of common stock
|
|
|
|
|||||||||
Common stock issued to employees
|
|
|
|
|||||||||
Cancellation of treasury stock
|
|
— |
|
|||||||||
Other net change in treasury stock
|
(
|
) | — | — | ||||||||
|
|
|
|
|
|
|||||||
Common stock outstanding at end of year
|
|
|
|
|||||||||
|
|
|
|
|
|
Millions of yen
|
||||||||
March 31
|
||||||||
2020
|
2021
|
|||||||
Total assets
|
¥ |
|
¥ |
|
||||
Total liabilities
|
|
|
Millions of yen
|
||||||||||||
Year ended March 31
|
||||||||||||
2019
|
2020
|
2021
(1)
|
||||||||||
Net revenues
|
¥ |
|
¥ |
|
¥ |
|
||||||
Non-interest
expenses
|
|
|
|
|||||||||
Net income attributable to the companies
|
|
|
|
Millions of yen
|
||||||||
March 31
|
||||||||
2020
|
2021
|
|||||||
Investments in affiliated companies
|
¥ |
|
¥ |
|
||||
Advances to affiliated companies
|
|
|
—
|
|
|
|
|
|
Other receivables from affiliated comp
a
nies
(1)
|
|
|
||||||
Other payables to affiliated companies
(1)
|
|
|
(1) |
As a result of adopting ASU
2016-02
as of April 1, 2019, ROU assets and operating lease liabilities are included by ¥
mil
and ¥
mil
as of March 31,
|
Millions of yen
|
||||||||||||
Year ended March 31
|
||||||||||||
2019
|
2020
|
2021
|
||||||||||
Revenues
|
¥ |
|
¥ |
|
¥ |
|
||||||
Non-interest
expenses
|
|
|
|
|||||||||
Purchase of software, securities and tangible assets
|
|
|
|
Millions of yen
|
||||||||
March 31
|
||||||||
2020
|
2021
|
|||||||
Carrying amount
|
¥ |
|
¥ |
|
||||
Fair value
|
|
|
Millions of yen
|
||||||||||||
Year ended March 31
|
||||||||||||
2019
|
2020
|
2021
|
||||||||||
Equity in earnings of equity-method investees
(1)
|
¥ |
|
¥ |
|
¥ |
|
||||||
Dividends from equity-method investees
|
|
|
|
(1) |
Equity in earnings of equity-method investees is reported within
Revenue-Other
|
Millions of yen
|
||||||||
March 31, 2020
|
March 31, 2021
|
|||||||
Commitments to extend credit
|
||||||||
Liquidity facilities to central clearing counterparties
|
¥ |
|
¥ |
|
||||
Other commitments to extend credit
|
|
|
||||||
|
|
|
|
|||||
Total
|
¥ |
|
¥ |
|
||||
|
|
|
|
|||||
Commitments to invest
|
¥ |
|
¥ |
|
Millions of yen
|
||||||||||||||||||||
Total
contractual
amount
|
Years to maturity
|
|||||||||||||||||||
Less than
1 year
|
1 to 3
years
|
3 to 5
years
|
More than
5 years
|
|||||||||||||||||
Commitments to extend credit
|
||||||||||||||||||||
Liquidity facilities to central clearing counterparties
|
¥ |
|
¥ |
|
¥ |
—
|
¥ |
—
|
¥ |
—
|
||||||||||
Other commitments to extend credit
|
|
|
|
|
|
|||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Commitments to invest
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
Millions of yen
|
||||||||||||||||||||||||||||
Total
|
Years of payment
|
|||||||||||||||||||||||||||
Less than
1 year
|
1 to 2
years
|
2 to 3
years
|
3 to 4
years
|
4 to 5
years
|
More than
5 years
|
|||||||||||||||||||||||
Purchase obligations
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥
|
Millions of yen
|
||||||||||||||||
March 31
|
||||||||||||||||
2020
|
2021
|
|||||||||||||||
Carrying
value
|
Maximum
potential
payout /
Notional total
|
Carrying
value
|
Maximum
potential
payout /
Notional total
|
|||||||||||||
Derivative contracts
(1)(2)
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||
Standby letters of credit and other guarantees
(3)
(4)
|
— |
|
— |
|
(1) |
Credit derivatives are disclosed in Note 3 “
Derivative instruments and hedging activities
|
(2) |
Derivative contracts primarily consist of equity, interest rate and foreign exchange contracts.
|
(3) |
The amounts of collaterals held in connection with standby letters of credit and other guarantees as of March 31, 2020
¥
n
.
|
(4)
|
As of March 31, 2021, primarily related to a certain sponsored repo program where Nomura guarantees to a 3rd party clearinghouse the payment of its clients’ obligations. Our exposure under this guarantee is minimized through effectively obtainingcollaterals whose amount is approximately equal to the maximum potential payout of the guarantee.
|
Millions of yen
|
||||||||||||||||||||||||
Carrying
value
|
Maximum potential payout/Notional
|
|||||||||||||||||||||||
Total
|
Years to Maturity
|
|||||||||||||||||||||||
Less than
1 year
|
1 to 3 years
|
3 to 5 years
|
More than
5 years
|
|||||||||||||||||||||
Derivative contracts
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||||
Standby letters of credit and other guarantees
|
— |
|
|
|
|
|
Millions of yen
|
||||||||||||||||||||
Retail
|
Asset
Management
|
Wholesale
(1)
|
Other
(Incl. elimination)
|
Total
|
||||||||||||||||
Year ended March 31, 2019
|
||||||||||||||||||||
Non-interest
revenue
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||
Net interest revenue
|
|
|
|
(
|
) |
|
||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net revenue
|
|
|
|
|
|
|||||||||||||||
Non-interest
expenses
|
|
|
|
|
|
|||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Income (loss) before income taxes
|
¥ |
|
¥ |
|
¥ |
(
|
) | ¥ |
(
|
) | ¥ |
(
|
) | |||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Year ended March 31, 2020
|
||||||||||||||||||||
Non-interest
revenue
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||
Net interest revenue
|
|
|
|
(
|
) |
|
||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net revenue
|
|
|
|
|
|
|||||||||||||||
Non-interest
expenses
|
|
|
|
|
|
|||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Income (loss) before income taxes
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Year ended March 31, 2021
|
||||||||||||||||||||
Non-interest
revenue
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||
Net interest revenue
|
|
|
|
(
|
) |
|
||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net revenue
|
|
|
|
|
|
|||||||||||||||
Non-interest
expenses
|
|
|
|
|
|
|||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Income (loss) before income taxes
|
¥ |
|
¥ |
|
¥ |
|
¥ |
(
|
) | ¥ |
|
|||||||||
|
|
|
|
|
|
|
|
|
|
(1)
|
Non-interest revenue
Non-interest expense
Loss Arising from U.S. Prime Brokerage Event
|
Millions of yen
|
||||||||||||
Year ended March 31
|
||||||||||||
2019
|
2020
|
2021
|
||||||||||
Net gain (loss) related to economic hedging transactions
|
¥ |
|
¥ |
|
¥ |
(
|
) | |||||
Realized gain on investments in equity securities held for operating purposes
|
|
|
|
|||||||||
Equity in earnings of affiliates
(1)
|
|
|
(
|
) | ||||||||
Corporate items
|
(
|
) |
(
|
) |
|
|||||||
Other
(2)(3)(4)
|
(
|
) |
|
|
||||||||
|
|
|
|
|
|
|||||||
Total
|
¥ |
(
|
) | ¥ |
|
¥ |
(
|
) | ||||
|
|
|
|
|
|
(1) |
Includes an impairment loss of ¥
Non-interest
expenses—Other
|
(2) |
The income before income taxes for the year ended March 31, 2021 includes a gain of ¥
|
(3) |
Includes gain of ¥
|
(4) |
Includes the impact of Nomura’s own creditworthiness.
|
Millions of yen
|
||||||||||||
Year ended March 31
|
||||||||||||
2019
|
2020
|
2021
|
||||||||||
Net revenue
|
¥ |
|
¥ |
|
¥ |
|
||||||
Unrealized gain (loss) on investments in equity securities held for operating purposes
|
(
|
) |
(
|
) |
|
|||||||
|
|
|
|
|
|
|||||||
Consolidated net revenue
|
¥ |
|
¥ |
|
¥ |
|
||||||
|
|
|
|
|
|
|||||||
Non-interest
expenses
|
¥ |
|
¥ |
|
¥ |
|
||||||
Unrealized gain (loss) on investments in equity securities held for operating purposes
|
— |
—
|
—
|
|||||||||
|
|
|
|
|
|
|||||||
Consolidated
non-interest
expenses
|
¥ |
|
¥ |
|
¥ |
|
||||||
|
|
|
|
|
|
|||||||
Income (loss) before income taxes
|
¥ |
(
|
) | ¥ |
|
¥ |
|
|||||
Unrealized gain (loss) on investments in equity securities held for operating purposes
|
(
|
) |
(
|
) |
|
|||||||
|
|
|
|
|
|
|||||||
Consolidated income (loss) before income taxes
|
¥ |
(
|
) | ¥ |
|
¥ |
|
|||||
|
|
|
|
|
|
Millions of yen
|
||||||||||||
Year ended March 31
|
||||||||||||
2019
|
2020
|
2021
(2
)
|
||||||||||
Net revenue
(1)
:
|
||||||||||||
Americas
|
¥ |
|
¥ |
|
¥ |
|
||||||
Europe
|
|
|
|
|||||||||
Asia and Oceania
|
|
|
|
|||||||||
|
|
|
|
|
|
|||||||
Subtotal
|
|
|
|
|||||||||
Japan
|
|
|
|
|||||||||
|
|
|
|
|
|
|||||||
Consolidated
|
¥ |
|
¥ |
|
¥ |
|
||||||
|
|
|
|
|
|
|||||||
Income (loss) before income taxes:
|
||||||||||||
Americas
|
¥ |
(
|
) | ¥ |
|
¥ |
(
|
) | ||||
Europe
|
(
|
) |
(
|
) |
|
|||||||
Asia and Oceania
|
|
|
|
|||||||||
|
|
|
|
|
|
|||||||
Subtotal
|
(
|
) |
|
(
|
) | |||||||
Japan
|
|
|
|
|||||||||
|
|
|
|
|
|
|||||||
Consolidated
|
¥ |
(
|
) | ¥ |
|
¥ |
|
|||||
|
|
|
|
|
|
March 31
|
||||||||||||
2019
|
2020
|
2021
|
||||||||||
Long-lived assets:
|
||||||||||||
Americas
|
¥ |
|
¥ |
|
¥ |
|
||||||
Europe
|
|
|
|
|||||||||
Asia and Oceania
|
|
|
|
|||||||||
|
|
|
|
|
|
|||||||
Subtotal
|
|
|
|
|||||||||
Japan
|
|
|
|
|||||||||
|
|
|
|
|
|
|||||||
Consolidated
|
¥ |
|
¥ |
|
¥ |
|
||||||
|
|
|
|
|
|
(1)
|
There is no revenue derived from transactions with a single major external customer.
|
(2)
|
Includes losses arising from the U.S. Prime Brokerage Event. See Note. 23 “
Loss Arising from U.S. Prime Brokerage Event
|
Exhibit
Number |
|
Description
|
1.1
|
|
|
1.2
|
|
|
1.3
|
|
|
1.4
|
|
|
1.5
|
|
|
1.6
|
|
|
2.1
|
|
|
2.2
|
|
|
4.1
|
|
|
8.1
|
|
|
11.1
|
|
|
11.2
|
|
|
12.1
|
|
|
12.2
|
|
|
13.1
|
|
|
13.2
|
|
|
15.1
|
|
|
17.1
|
|
|
101.INS
|
|
Inline XBRL Instance Document—the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document
|
101.SCH
|
|
Inline XBRL Taxonomy Extension Schema Document
|
101.CAL
|
|
Inline XBRL Taxonomy Extension Calculation Linkbase Document
|
101.DEF
|
|
Inline XBRL Taxonomy Extension Definition Linkbase Document
|
101.LAB
|
|
Inline XBRL Taxonomy Extension Label Linkbase Document
|
101.PRE
|
|
Inline XBRL Taxonomy Extension Presentation Linkbase Document
|
104
|
|
The cover page for the Company’s Annual Report on Form
20-F
for the year ended March 31, 2021, has been formatted in Inline XBRL
|
(1)
|
The Company has entered into Limitation of Liability Agreements substantially in the form of this exhibit with all of its outside directors and director Shoji Ogawa.
|
NOMURA HOLDINGS, INC.
|
||||
By:
|
|
/s/ K
ENTARO
O
KUDA
|
||
|
Name:
|
|
Kentaro Okuda
|
|
|
Title:
|
|
Representative Executive Officer,
President and Group Chief Executive Officer
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
---|
DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
---|
No information found
Customers
Customer name | Ticker |
---|---|
Expeditors International of Washington, Inc. | EXPD |
Terex Corporation | TEX |
No Suppliers Found
Price
Yield
Owner | Position | Direct Shares | Indirect Shares |
---|